{"id": "16_33_1_30", "text": "Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs.", "text_with_entity_marker": "[E1]Artemis[/E1] C-terminal region facilitates V(D)J recombination through its interactions with [E2]DNA Ligase IV[/E2] and DNA-PKcs.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Artemis", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DNA Ligase IV", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "16_33_1_31", "text": "Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs.", "text_with_entity_marker": "[E1]Artemis[/E1] C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and [E2]DNA-PKcs[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Artemis", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DNA-PKcs", "entity_2_idx": [[106, 114]], "entity_2_idx_in_text_with_entity_marker": [119, 127], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "16_34_7_32", "text": "Our data reveal that the C-terminal region of Artemis influences V(D)J recombination through its interaction with both Ligase IV and DNA-PKcs.", "text_with_entity_marker": "Our data reveal that the C-terminal region of [E1]Artemis[/E1] influences V(D)J recombination through its interaction with both [E2]Ligase IV[/E2] and DNA-PKcs.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Artemis", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Ligase IV", "entity_2_idx": [[119, 128]], "entity_2_idx_in_text_with_entity_marker": [132, 141], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "16_34_7_33", "text": "Our data reveal that the C-terminal region of Artemis influences V(D)J recombination through its interaction with both Ligase IV and DNA-PKcs.", "text_with_entity_marker": "Our data reveal that the C-terminal region of [E1]Artemis[/E1] influences V(D)J recombination through its interaction with both Ligase IV and [E2]DNA-PKc[/E2]s.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Artemis", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DNA-PKc", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "295_591_1_411", "text": "Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC.", "text_with_entity_marker": "[E1]Cryopyrin[/E1]-induced [E2]interleukin 1beta[/E2] secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cryopyrin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "interleukin 1beta", "entity_2_idx": [[18, 35]], "entity_2_idx_in_text_with_entity_marker": [31, 48], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "86_174_5_114", "text": "Helix 7 and helix 12 of LcrV interact to form an intramolecular coiled coil; these new results suggest that the intramolecular coiled coil in LcrV is required for LcrG interaction and activation of the T3SS.", "text_with_entity_marker": "Helix 7 and helix 12 of [E1]LcrV[/E1] interact to form an intramolecular coiled coil; these new results suggest that the intramolecular coiled coil in LcrV is required for [E2]LcrG[/E2] interaction and activation of the T3SS.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LcrV", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "LcrG", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "292_585_1_403", "text": "Rad9 BRCT domain interaction with phosphorylated H2AX regulates the G1 checkpoint in budding yeast.", "text_with_entity_marker": "[E1]Rad9[/E1] BRCT domain interaction with phosphorylated [E2]H2AX[/E2] regulates the G1 checkpoint in budding yeast.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rad9", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "H2AX", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "292_586_3_404", "text": "Furthermore, we show that the tandem BRCT domain of Rad9 interacts directly with phosphorylated H2A in vitro and that a rad9 point mutation that abolishes this interaction results in in vivo phenotypes that are similar to those caused by an H2A phosphorylation site mutation", "text_with_entity_marker": "Furthermore, we show that the tandem BRCT domain of [E1]Rad9[/E1] interacts directly with phosphorylated [E2]H2A[/E2] in vitro and that a rad9 point mutation that abolishes this interaction results in in vivo phenotypes that are similar to those caused by an H2A phosphorylation site mutation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rad9", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "345_691_1_456", "text": "Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis.", "text_with_entity_marker": "Interaction partners of [E1]Dlk/ZIP kinase[/E1]: co-expression of Dlk/ZIP kinase and [E2]Par-4[/E2] results in cytoplasmic retention and apoptosis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dlk/ZIP kinase", "entity_1_idx": [[24, 38]], "entity_1_idx_in_text_with_entity_marker": [28, 42], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Par-4", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "345_692_6_457", "text": "Complex formation between Dlk and Par-4 was confirmed by GST pull-down experiments and kinase reactions in vitro and coexpression experiments in vivo", "text_with_entity_marker": "Complex formation between [E1]Dlk[/E1] and [E2]Par-4[/E2] was confirmed by GST pull-down experiments and kinase reactions in vitro and coexpression experiments in vivo", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dlk", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Par-4", "entity_2_idx": [[34, 39]], "entity_2_idx_in_text_with_entity_marker": [47, 52], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "106_214_8_138", "text": "Our findings indicate that 14-3-3eta is a regulator that functionally links parkin and alpha-SN", "text_with_entity_marker": "Our findings indicate that [E1]14-3-3eta[/E1] is a regulator that functionally links [E2]parkin[/E2] and alpha-SN", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "14-3-3eta", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "parkin", "entity_2_idx": [[76, 82]], "entity_2_idx_in_text_with_entity_marker": [89, 95], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "106_214_8_139", "text": "Our findings indicate that 14-3-3eta is a regulator that functionally links parkin and alpha-SN", "text_with_entity_marker": "Our findings indicate that [E1]14-3-3eta[/E1] is a regulator that functionally links parkin and [E2]alpha-SN[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "14-3-3eta", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "alpha-SN", "entity_2_idx": [[87, 95]], "entity_2_idx_in_text_with_entity_marker": [100, 108], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "13_28_3_25", "text": "In the present study, we demonstrate that expression of Sin3 results in posttranslational stabilization of both exogenous and endogenous p53, due to an inhibition of proteasome-mediated degradation of this protein", "text_with_entity_marker": "In the present study, we demonstrate that expression of [E1]Sin3[/E1] results in posttranslational stabilization of both exogenous and endogenous [E2]p53[/E2], due to an inhibition of proteasome-mediated degradation of this protein", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Sin3", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[137, 140]], "entity_2_idx_in_text_with_entity_marker": [150, 153], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "159_319_1_210", "text": "An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway.", "text_with_entity_marker": "An ITIM-like motif within the [E1]CCK2[/E1] receptor sequence required for interaction with [E2]SHP-2[/E2] and the activation of the AKT pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CCK2", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SHP-2", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "159_320_8_211", "text": "Mutational analysis of the key ITIM residue 438 confirmed that the CCK2R ITIM sequence is required for interaction with SHP-2 and the activation of the AKT pathway.", "text_with_entity_marker": "Mutational analysis of the key ITIM residue 438 confirmed that the [E1]CCK2R[/E1] ITIM sequence is required for interaction with [E2]SHP-2[/E2] and the activation of the AKT pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CCK2R", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SHP-2", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "318_637_1_431", "text": "The Cap-binding protein eIF4E promotes folding of a functional domain of yeast translation initiation factor eIF4G1.", "text_with_entity_marker": "The Cap-binding protein [E1]eIF4E[/E1] promotes folding of a functional domain of yeast translation initiation factor [E2]eIF4G1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "eIF4E", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "eIF4G1", "entity_2_idx": [[109, 115]], "entity_2_idx_in_text_with_entity_marker": [122, 128], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "318_638_7_432", "text": "These data suggest that the association of yeast eIF4E with eIF4G1 leads to the formation of a structured domain within eIF4G1 that could serve as a specific site for interactions with other components of the translational apparatus", "text_with_entity_marker": "These data suggest that the association of yeast [E1]eIF4E[/E1] with [E2]eIF4G1[/E2] leads to the formation of a structured domain within eIF4G1 that could serve as a specific site for interactions with other components of the translational apparatus", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "eIF4E", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "eIF4G1", "entity_2_idx": [[60, 66]], "entity_2_idx_in_text_with_entity_marker": [73, 79], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "80_162_6_106", "text": "The interaction of Wbp2 with TAZ is dependent on the WW domain of TAZ and the PPXY-containing C-terminal region of Wbp2", "text_with_entity_marker": "The interaction of [E1]Wbp2[/E1] with [E2]TAZ[/E2] is dependent on the WW domain of TAZ and the PPXY-containing C-terminal region of Wbp2", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Wbp2", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TAZ", "entity_2_idx": [[29, 32]], "entity_2_idx_in_text_with_entity_marker": [42, 45], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "325_652_2_439", "text": "We show that the N-terminal domain of USP7 binds two closely spaced 4-residue sites in both p53 and MDM2, falling between p53 residues 359-367 and MDM2 residues 147-159", "text_with_entity_marker": "We show that the N-terminal domain of [E1]USP7[/E1] binds two closely spaced 4-residue sites in both [E2]p53[/E2] and MDM2, falling between p53 residues 359-367 and MDM2 residues 147-159", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "USP7", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "325_652_2_440", "text": "We show that the N-terminal domain of USP7 binds two closely spaced 4-residue sites in both p53 and MDM2, falling between p53 residues 359-367 and MDM2 residues 147-159", "text_with_entity_marker": "We show that the N-terminal domain of [E1]USP7[/E1] binds two closely spaced 4-residue sites in both p53 and [E2]MDM2[/E2], falling between p53 residues 359-367 and MDM2 residues 147-159", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "USP7", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MDM2", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "103_207_1_129", "text": "Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9.", "text_with_entity_marker": "Interaction of [E1]Daxx[/E1], a [E2]Fas[/E2] binding protein, with sentrin and Ubc9.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[23, 26]], "entity_2_idx_in_text_with_entity_marker": [36, 39], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "103_207_1_130", "text": "Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9.", "text_with_entity_marker": "Interaction of [E1]Daxx[/E1], a Fas binding protein, with [E2]sentrin[/E2] and Ubc9.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "sentrin", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "103_207_1_131", "text": "Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9.", "text_with_entity_marker": "Interaction of [E1]Daxx[/E1], a Fas binding protein, with sentrin and [E2]Ubc9[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Ubc9", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "103_208_9_132", "text": "Colocalization of Fas, sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of Daxx", "text_with_entity_marker": "Colocalization of Fas, sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of [E1]Daxx[/E1][E2]Fas[/E2], sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of Daxx", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[18, 21]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "103_208_9_133", "text": "Colocalization of Fas, sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of Daxx", "text_with_entity_marker": "Colocalization of Fas, sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of [E1]Daxx[/E1][E2]sentrin[/E2], and Ubc9 binding regions suggests the importance of that region upon the regulation of Daxx", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "sentrin", "entity_2_idx": [[23, 30]], "entity_2_idx_in_text_with_entity_marker": [136, 143], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "103_208_9_134", "text": "Colocalization of Fas, sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of Daxx", "text_with_entity_marker": "Colocalization of Fas, sentrin, and Ubc9 binding regions suggests the importance of that region upon the regulation of [E1]Daxx[/E1][E2]Ubc9[/E2] binding regions suggests the importance of that region upon the regulation of Daxx", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Ubc9", "entity_2_idx": [[36, 40]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "294_589_1_407", "text": "Superadditive and subadditive effects of \"hot spot\" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.", "text_with_entity_marker": "Superadditive and subadditive effects of \"hot spot\" mutations within the interfaces of placental [E1]ribonuclease inhibitor[/E1] with [E2]angiogenin[/E2] and ribonuclease A.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ribonuclease inhibitor", "entity_1_idx": [[97, 119]], "entity_1_idx_in_text_with_entity_marker": [101, 123], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "angiogenin", "entity_2_idx": [[125, 135]], "entity_2_idx_in_text_with_entity_marker": [138, 148], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "294_589_1_408", "text": "Superadditive and subadditive effects of \"hot spot\" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.", "text_with_entity_marker": "Superadditive and subadditive effects of \"hot spot\" mutations within the interfaces of placental [E1]ribonuclease inhibitor[/E1] with angiogenin and [E2]ribonuclease A.[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ribonuclease inhibitor", "entity_1_idx": [[97, 119]], "entity_1_idx_in_text_with_entity_marker": [101, 123], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ribonuclease A.", "entity_2_idx": [[140, 155]], "entity_2_idx_in_text_with_entity_marker": [153, 168], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "294_590_1_409", "text": "Previous single-site mutagenesis studies on the complexes of ribonuclease inhibitor (RI) with angiogenin (Ang) and RNase A suggested that in both cases a substantial fraction of the binding energy is concentrated within one small part of the crystallographically observed interface, involving RI residues 434-438", "text_with_entity_marker": "Previous single-site mutagenesis studies on the complexes of [E1]ribonuclease inhibitor (RI)[/E1] with [E2]angiogenin (Ang)[/E2] and RNase A suggested that in both cases a substantial fraction of the binding energy is concentrated within one small part of the crystallographically observed interface, involving RI residues 434-438", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ribonuclease inhibitor (RI)", "entity_1_idx": [[61, 88]], "entity_1_idx_in_text_with_entity_marker": [65, 92], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "angiogenin (Ang)", "entity_2_idx": [[94, 110]], "entity_2_idx_in_text_with_entity_marker": [107, 123], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "294_590_1_410", "text": "Previous single-site mutagenesis studies on the complexes of ribonuclease inhibitor (RI) with angiogenin (Ang) and RNase A suggested that in both cases a substantial fraction of the binding energy is concentrated within one small part of the crystallographically observed interface, involving RI residues 434-438", "text_with_entity_marker": "Previous single-site mutagenesis studies on the complexes of [E1]ribonuclease inhibitor (RI)[/E1] with angiogenin (Ang) and [E2]RNase A[/E2] suggested that in both cases a substantial fraction of the binding energy is concentrated within one small part of the crystallographically observed interface, involving RI residues 434-438", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ribonuclease inhibitor (RI)", "entity_1_idx": [[61, 88]], "entity_1_idx_in_text_with_entity_marker": [65, 92], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RNase A", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "15_31_1_26", "text": "AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.", "text_with_entity_marker": "[E1]AXIN[/E1] is an essential co-activator for the promyelocytic leukemia protein in [E2]p53[/E2] activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AXIN", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "15_31_1_27", "text": "AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.", "text_with_entity_marker": "AXIN is an essential co-activator for the [E1]promyelocytic leukemia protein[/E1] in [E2]p53[/E2] activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "promyelocytic leukemia protein", "entity_1_idx": [[42, 72]], "entity_1_idx_in_text_with_entity_marker": [46, 76], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "15_32_2_28", "text": "Both PML and the key Wnt signaling regulator AXIN regulate p53-dependent apoptosis in response to DNA damage", "text_with_entity_marker": "Both PML and the key Wnt signaling regulator [E1]AXIN[/E1] regulate [E2]p53[/E2]-dependent apoptosis in response to DNA damage", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AXIN", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "15_32_2_29", "text": "Both PML and the key Wnt signaling regulator AXIN regulate p53-dependent apoptosis in response to DNA damage", "text_with_entity_marker": "Both [E1]PML[/E1] and the key Wnt signaling regulator AXIN regulate [E2]p53[/E2]-dependent apoptosis in response to DNA damage", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PML", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "197_395_1_259", "text": "The plastid division protein AtMinD1 is a Ca2+-ATPase stimulated by AtMinE1.", "text_with_entity_marker": "The plastid division protein AtMinD1 is a Ca2+-ATPase stimulated by [E1]AtMinE1[/E1][E2]AtMinD1[/E2] is a Ca2+-ATPase stimulated by AtMinE1.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "AtMinE1", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AtMinD1", "entity_2_idx": [[29, 36]], "entity_2_idx_in_text_with_entity_marker": [88, 95], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "197_396_2_260", "text": "In Escherichia coli precise Z-ring placement at midcell depends on controlled oscillatory behavior of MinD and MinE: In the presence of ATP MinD interacts with the FtsZ inhibitor MinC and migrates to the membrane where the MinD-MinC complex recruits MinE, followed by MinD-mediated ATP hydrolysis and membrane release", "text_with_entity_marker": "In Escherichia coli precise Z-ring placement at midcell depends on controlled oscillatory behavior of [E1]MinD[/E1] and MinE: In the presence of ATP MinD interacts with the FtsZ inhibitor [E2]MinC[/E2] and migrates to the membrane where the MinD-MinC complex recruits MinE, followed by MinD-mediated ATP hydrolysis and membrane release", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "MinD", "entity_1_idx": [[102, 106]], "entity_1_idx_in_text_with_entity_marker": [106, 110], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MinC", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "109_219_1_144", "text": "Negative modulation of androgen receptor transcriptional activity by Daxx.", "text_with_entity_marker": "Negative modulation of androgen receptor transcriptional activity by [E1]Daxx[/E1][E2]androgen receptor[/E2] transcriptional activity by Daxx.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "androgen receptor", "entity_2_idx": [[23, 40]], "entity_2_idx_in_text_with_entity_marker": [86, 103], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "109_220_3_145", "text": "We report here that Daxx functions as a negative AR coregulator through direct protein-protein interactions", "text_with_entity_marker": "We report here that [E1]Daxx[/E1] functions as a negative [E2]AR[/E2] coregulator through direct protein-protein interactions", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Daxx", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AR", "entity_2_idx": [[49, 51]], "entity_2_idx_in_text_with_entity_marker": [62, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "118_238_3_162", "text": "Here we show that Dsh binding by Drosophila Nkd in vitro is mediated by the EFX domain as well as an adjacent C-terminal sequence", "text_with_entity_marker": "Here we show that Dsh binding by Drosophila [E1]Nkd[/E1][E2]Dsh[/E2] binding by Drosophila Nkd in vitro is mediated by the EFX domain as well as an adjacent C-terminal sequence", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Nkd", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Dsh", "entity_2_idx": [[18, 21]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "201_403_1_266", "text": "Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system.", "text_with_entity_marker": "Specific interaction of the potassium channel beta-subunit [E1]minK[/E1] with the sarcomeric protein [E2]T-cap[/E2] suggests a T-tubule-myofibril linking system.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "minK", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "T-cap", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "201_404_4_267", "text": "We report here that minK specifically interacts with the sarcomeric Z-line component, T-cap (also called telethonin)", "text_with_entity_marker": "We report here that [E1]minK[/E1] specifically interacts with the sarcomeric Z-line component, [E2]T-cap[/E2] (also called telethonin)", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "minK", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "T-cap", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "234_470_4_304", "text": "The S.pombe protein, named Seb1 for seven binding, was essential for cell viability, and bound directly to Rpb7 in vitro", "text_with_entity_marker": "The S.pombe protein, named [E1]Seb1[/E1] for seven binding, was essential for cell viability, and bound directly to [E2]Rpb7[/E2] in vitro", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Seb1", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rpb7", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "316_633_1_428", "text": "Disruption of the CED-9.CED-4 complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans.", "text_with_entity_marker": "Disruption of the CED-9.CED-4 complex by [E1]EGL-1[/E1][E2]CED-9[/E2].CED-4 complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "EGL-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CED-9", "entity_2_idx": [[18, 23]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "316_633_1_429", "text": "Disruption of the CED-9.CED-4 complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans.", "text_with_entity_marker": "Disruption of the CED-9.CED-4 complex by [E1]EGL-1[/E1][E2]CED-4[/E2] complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "EGL-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CED-4", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "72_145_1_98", "text": "Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.", "text_with_entity_marker": "[E1]Apolipoprotein A-I[/E1] activates Cdc42 signaling through the [E2]ABCA1[/E2] transporter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Apolipoprotein A-I", "entity_1_idx": [[0, 18]], "entity_1_idx_in_text_with_entity_marker": [4, 22], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ABCA1", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "72_145_1_99", "text": "Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.", "text_with_entity_marker": "Apolipoprotein A-I activates Cdc42 signaling through the [E1]ABCA1[/E1][E2]Cdc42[/E2] signaling through the ABCA1 transporter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ABCA1", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cdc42", "entity_2_idx": [[29, 34]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "72_146_8_100", "text": "We conclude that ABCA1 transduces signals from apoA-I by complexing and activating Cdc42 and downstream kinases and, therefore, acts as a full apoA-I receptor.", "text_with_entity_marker": "We conclude that ABCA1 transduces signals from [E1]apoA-I[/E1][E2]ABCA1[/E2] transduces signals from apoA-I by complexing and activating Cdc42 and downstream kinases and, therefore, acts as a full apoA-I receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "apoA-I", "entity_1_idx": [[47, 53]], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ABCA1", "entity_2_idx": [[17, 22]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "72_146_8_101", "text": "We conclude that ABCA1 transduces signals from apoA-I by complexing and activating Cdc42 and downstream kinases and, therefore, acts as a full apoA-I receptor.", "text_with_entity_marker": "We conclude that [E1]ABCA1[/E1] transduces signals from apoA-I by complexing and activating [E2]Cdc42[/E2] and downstream kinases and, therefore, acts as a full apoA-I receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ABCA1", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cdc42", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "133_267_1_182", "text": "The Grb2/PLD2 interaction is essential for lipase activity, intracellular localization and signaling in response to EGF.", "text_with_entity_marker": "The [E1]Grb2[/E1]/[E2]PLD2[/E2] interaction is essential for lipase activity, intracellular localization and signaling in response to EGF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PLD2", "entity_2_idx": [[9, 13]], "entity_2_idx_in_text_with_entity_marker": [22, 26], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "133_268_10_183", "text": "These results demonstrate for the first time that the presence of Grb2 and its interaction with localized intracellular structures is essential for PLD2 activity and signaling in vivo.", "text_with_entity_marker": "These results demonstrate for the first time that the presence of [E1]Grb2[/E1] and its interaction with localized intracellular structures is essential for [E2]PLD2[/E2] activity and signaling in vivo.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[66, 70]], "entity_1_idx_in_text_with_entity_marker": [70, 74], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PLD2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "233_468_3_303", "text": "ZIP kinase physically binds to ATF4, a member of the activating transcription factor/cyclic AMP-responsive element-binding protein (ATF/CREB) family, through interaction between their leucine zippers", "text_with_entity_marker": "[E1]ZIP kinase[/E1] physically binds to [E2]ATF4[/E2], a member of the activating transcription factor/cyclic AMP-responsive element-binding protein (ATF/CREB) family, through interaction between their leucine zippers", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ZIP kinase", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ATF4", "entity_2_idx": [[31, 35]], "entity_2_idx_in_text_with_entity_marker": [44, 48], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "347_696_5_460", "text": "In addition, we find that Mad3p interacts with Mad2p and the cell cycle regulator Cdc20p", "text_with_entity_marker": "In addition, we find that [E1]Mad3p[/E1] interacts with [E2]Mad2p[/E2] and the cell cycle regulator Cdc20p", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Mad3p", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Mad2p", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "347_696_5_461", "text": "In addition, we find that Mad3p interacts with Mad2p and the cell cycle regulator Cdc20p", "text_with_entity_marker": "In addition, we find that [E1]Mad3p[/E1] interacts with Mad2p and the cell cycle regulator [E2]Cdc20p[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Mad3p", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cdc20p", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "311_623_1_421", "text": "ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1.", "text_with_entity_marker": "ALS-linked mutations in [E1]ubiquilin-2[/E1] or [E2]hnRNPA1[/E2] reduce interaction between ubiquilin-2 and hnRNPA1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ubiquilin-2", "entity_1_idx": [[24, 35]], "entity_1_idx_in_text_with_entity_marker": [28, 39], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "hnRNPA1", "entity_2_idx": [[39, 46]], "entity_2_idx_in_text_with_entity_marker": [52, 59], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "311_624_8_422", "text": "We confirmed the interaction between wild-type (WT) ubiquilin-2 and hnRNPA1 proteins in vitro and in cells", "text_with_entity_marker": "We confirmed the interaction between wild-type (WT) [E1]ubiquilin-2[/E1] and [E2]hnRNPA1[/E2] proteins in vitro and in cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ubiquilin-2", "entity_1_idx": [[52, 63]], "entity_1_idx_in_text_with_entity_marker": [56, 67], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "hnRNPA1", "entity_2_idx": [[68, 75]], "entity_2_idx_in_text_with_entity_marker": [81, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d193.s1641_AIMed.d193.s1641.p0", "text": "Physical and functional interactions between the transcriptional inhibitors Id3 and ITF-2b. Evidence toward a novel mechanism regulating muscle-specific gene expression.", "text_with_entity_marker": "Physical and functional interactions between the transcriptional inhibitors [E1]Id3[/E1] and [E2]ITF-2b[/E2]. Evidence toward a novel mechanism regulating muscle-specific gene expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Id3", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ITF-2b", "entity_2_idx": [[84, 90]], "entity_2_idx_in_text_with_entity_marker": [97, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d193.s1642_AIMed.d193.s1642.p3", "text": "We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3/HLH462.", "text_with_entity_marker": "We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, [E1]ITF-2b[/E1], that interacts with the transcriptional inhibitor [E2]Id3[/E2]/HLH462.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ITF-2b", "entity_1_idx": [[114, 120]], "entity_1_idx_in_text_with_entity_marker": [118, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Id3", "entity_2_idx": [[172, 175]], "entity_2_idx_in_text_with_entity_marker": [185, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d193.s1642_AIMed.d193.s1642.p4", "text": "We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3/HLH462.", "text_with_entity_marker": "We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, [E1]ITF-2b[/E1], that interacts with the transcriptional inhibitor Id3/[E2]HLH462[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ITF-2b", "entity_1_idx": [[114, 120]], "entity_1_idx_in_text_with_entity_marker": [118, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HLH462", "entity_2_idx": [[176, 182]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d193.s1647_AIMed.d193.s1647.p0", "text": "Further investigation indicated that the ITF-2b/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/HLH462.", "text_with_entity_marker": "Further investigation indicated that the [E1]ITF-2b[/E1]/[E2]MyoD[/E2] heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/HLH462.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ITF-2b", "entity_1_idx": [[41, 47]], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MyoD", "entity_2_idx": [[48, 52]], "entity_2_idx_in_text_with_entity_marker": [61, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p3", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated collagenase I ([E1]MMP-1[/E1]) is absolutely required for interaction with its specific inhibitor, [E2]tissue inhibitor of metalloproteinases-1[/E2] (TIMP-1).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tissue inhibitor of metalloproteinases-1", "entity_2_idx": [[124, 164]], "entity_2_idx_in_text_with_entity_marker": [137, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p4", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated collagenase I ([E1]MMP-1[/E1]) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 ([E2]TIMP-1[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p4", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of [E1]gelatinase A[/E1] and gelatinase B, does not interact with [E2]TIMP-1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gelatinase A", "entity_1_idx": [[109, 121]], "entity_1_idx_in_text_with_entity_marker": [113, 125], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p5", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and [E1]gelatinase B[/E1], does not interact with [E2]TIMP-1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gelatinase B", "entity_1_idx": [[126, 138]], "entity_1_idx_in_text_with_entity_marker": [130, 142], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1765_AIMed.d204.s1765.p0", "text": "In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.", "text_with_entity_marker": "In summary, we have shown that the integrity of the catalytic domain of [E1]MMP-1[/E1] and its ability to bind Zn2+ is absolutely required for complex formation with [E2]TIMP-1[/E2], which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[157, 163]], "entity_2_idx_in_text_with_entity_marker": [170, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1446_AIMed.d172.s1446.p2", "text": "Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.", "text_with_entity_marker": "[E1]Vascular endothelial growth factor-related protein[/E1]: a ligand and specific activator of the tyrosine kinase receptor [E2]Flt4[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Vascular endothelial growth factor-related protein", "entity_1_idx": [[0, 50]], "entity_1_idx_in_text_with_entity_marker": [4, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flt4", "entity_2_idx": [[116, 120]], "entity_2_idx_in_text_with_entity_marker": [129, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1448_AIMed.d172.s1448.p1", "text": "Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).", "text_with_entity_marker": "[E1]Flt1[/E1] and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by [E2]vascular endothelial growth factor[/E2] (VEGF).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Flt1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[119, 153]], "entity_2_idx_in_text_with_entity_marker": [132, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1448_AIMed.d172.s1448.p2", "text": "Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).", "text_with_entity_marker": "[E1]Flt1[/E1] and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor ([E2]VEGF[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Flt1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[155, 159]], "entity_2_idx_in_text_with_entity_marker": [168, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1448_AIMed.d172.s1448.p3", "text": "Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).", "text_with_entity_marker": "Flt1 and [E1]Flk1[/E1] have been shown to play key roles in vascular development; these two receptors bind and are activated by [E2]vascular endothelial growth factor[/E2] (VEGF).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Flk1", "entity_1_idx": [[9, 13]], "entity_1_idx_in_text_with_entity_marker": [13, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[119, 153]], "entity_2_idx_in_text_with_entity_marker": [132, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1448_AIMed.d172.s1448.p4", "text": "Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).", "text_with_entity_marker": "Flt1 and [E1]Flk1[/E1] have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor ([E2]VEGF[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Flk1", "entity_1_idx": [[9, 13]], "entity_1_idx_in_text_with_entity_marker": [13, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[155, 159]], "entity_2_idx_in_text_with_entity_marker": [168, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1451_AIMed.d172.s1451.p5", "text": "This protein, designated VEGF-related protein (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.", "text_with_entity_marker": "This protein, designated [E1]VEGF-related protein[/E1] (VRP), specifically binds to the extracellular domain of [E2]Flt4[/E2], stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VEGF-related protein", "entity_1_idx": [[25, 45]], "entity_1_idx_in_text_with_entity_marker": [29, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flt4", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1451_AIMed.d172.s1451.p7", "text": "This protein, designated VEGF-related protein (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.", "text_with_entity_marker": "This protein, designated VEGF-related protein ([E1]VRP[/E1]), specifically binds to the extracellular domain of [E2]Flt4[/E2], stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VRP", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flt4", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p0", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between [E1]YY1[/E1] and [E2]p300[/E2], a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YY1", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[54, 58]], "entity_2_idx_in_text_with_entity_marker": [67, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p3", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between YY1 and [E1]p300[/E1], a coactivator for [E2]CREB[/E2], is not sufficient for repression of CREB-mediated transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[78, 82]], "entity_2_idx_in_text_with_entity_marker": [91, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d185.s1569_AIMed.d185.s1569.p1", "text": "Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain.", "text_with_entity_marker": "[E1]Stat3[/E1] recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the [E2]interleukin-10 receptor[/E2] intracellular domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Stat3", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin-10 receptor", "entity_2_idx": [[95, 118]], "entity_2_idx_in_text_with_entity_marker": [108, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d185.s1572_AIMed.d185.s1572.p0", "text": "In all cells tested, IL-10 activated Stat1 and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.", "text_with_entity_marker": "In all cells tested, [E1]IL-10[/E1] activated [E2]Stat1[/E2] and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-10", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Stat1", "entity_2_idx": [[37, 42]], "entity_2_idx_in_text_with_entity_marker": [50, 55], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d185.s1572_AIMed.d185.s1572.p1", "text": "In all cells tested, IL-10 activated Stat1 and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.", "text_with_entity_marker": "In all cells tested, [E1]IL-10[/E1] activated Stat1 and [E2]Stat3[/E2] and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-10", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Stat3", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d185.s1573_AIMed.d185.s1573.p0", "text": "IL-10 also activated Stat5 in Ba/F3 cells that stably expressed the murine IL-10 receptor.", "text_with_entity_marker": "[E1]IL-10[/E1] also activated [E2]Stat5[/E2] in Ba/F3 cells that stably expressed the murine IL-10 receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-10", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Stat5", "entity_2_idx": [[21, 26]], "entity_2_idx_in_text_with_entity_marker": [34, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d185.s1574_AIMed.d185.s1574.p3", "text": "Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine IL-10 receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.", "text_with_entity_marker": "Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine [E1]IL-10 receptor[/E1] were found to be redundantly required for receptor function and for activation of [E2]Stat3[/E2] but not for Stat1 or Stat5.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-10 receptor", "entity_1_idx": [[133, 147]], "entity_1_idx_in_text_with_entity_marker": [137, 151], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Stat3", "entity_2_idx": [[230, 235]], "entity_2_idx_in_text_with_entity_marker": [243, 248], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d185.s1577_AIMed.d185.s1577.p3", "text": "These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.", "text_with_entity_marker": "These data demonstrate that [E1]Stat3[/E1] but not Stat1 or Stat5 is directly recruited to the ligand-activated [E2]IL-10 receptor[/E2] by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Stat3", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10 receptor", "entity_2_idx": [[103, 117]], "entity_2_idx_in_text_with_entity_marker": [116, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d32.s269_AIMed.d32.s269.p2", "text": "We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.", "text_with_entity_marker": "We have shown previously that Phe93 in the extracellular domain of the [E1]erythropoietin[/E1] (EPO) receptor ([E2]EPOR[/E2]) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "erythropoietin", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EPOR", "entity_2_idx": [[102, 106]], "entity_2_idx_in_text_with_entity_marker": [115, 119], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1155_AIMed.d137.s1155.p1", "text": "The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.", "text_with_entity_marker": "The POU domains of the [E1]Oct1[/E1] and Oct2 transcription factors mediate specific interaction with [E2]TBP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oct1", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[93, 96]], "entity_2_idx_in_text_with_entity_marker": [106, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1155_AIMed.d137.s1155.p2", "text": "The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.", "text_with_entity_marker": "The POU domains of the Oct1 and [E1]Oct2[/E1] transcription factors mediate specific interaction with [E2]TBP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oct2", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[93, 96]], "entity_2_idx_in_text_with_entity_marker": [106, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1158_AIMed.d137.s1158.p0", "text": "By using several different experimental systems we show that TBP efficiently associates with Oct1 and Oct2.", "text_with_entity_marker": "By using several different experimental systems we show that [E1]TBP[/E1] efficiently associates with [E2]Oct1[/E2] and Oct2.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Oct1", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1158_AIMed.d137.s1158.p1", "text": "By using several different experimental systems we show that TBP efficiently associates with Oct1 and Oct2.", "text_with_entity_marker": "By using several different experimental systems we show that [E1]TBP[/E1] efficiently associates with Oct1 and [E2]Oct2[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Oct2", "entity_2_idx": [[102, 106]], "entity_2_idx_in_text_with_entity_marker": [115, 119], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1161_AIMed.d137.s1161.p0", "text": "We show that the POU homeodomain of Oct2 and the evolutionarily conserved C-terminal core domain of TBP are both required and sufficient for the interaction.", "text_with_entity_marker": "We show that the POU homeodomain of [E1]Oct2[/E1] and the evolutionarily conserved C-terminal core domain of [E2]TBP[/E2] are both required and sufficient for the interaction.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oct2", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1162_AIMed.d137.s1162.p1", "text": "The Oct1 POU domain, which is highly homologous to the Oct2 POU domain, likewise mediates interaction with TBP.", "text_with_entity_marker": "The [E1]Oct1[/E1] POU domain, which is highly homologous to the Oct2 POU domain, likewise mediates interaction with [E2]TBP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oct1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[107, 110]], "entity_2_idx_in_text_with_entity_marker": [120, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1163_AIMed.d137.s1163.p0", "text": "The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.", "text_with_entity_marker": "The interaction can also be observed in vivo, as [E1]TBP[/E1] can be co-precipitated with [E2]Oct2[/E2] from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Oct2", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1163_AIMed.d137.s1163.p5", "text": "The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.", "text_with_entity_marker": "The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and [E1]TBP[/E1] co-immunoprecipitates with the endogenous [E2]Oct1[/E2] from HeLa cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Oct1", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s927_AIMed.d110.s927.p0", "text": "TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "text_with_entity_marker": "[E1]TAFII55[/E1] is shown to interact with the largest subunit ([E2]TAFII230[/E2]) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII230", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s927_AIMed.d110.s927.p2", "text": "TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "text_with_entity_marker": "[E1]TAFII55[/E1] is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including [E2]Sp1[/E2], YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sp1", "entity_2_idx": [[147, 150]], "entity_2_idx_in_text_with_entity_marker": [160, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s927_AIMed.d110.s927.p3", "text": "TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "text_with_entity_marker": "[E1]TAFII55[/E1] is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, [E2]YY1[/E2], USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "YY1", "entity_2_idx": [[152, 155]], "entity_2_idx_in_text_with_entity_marker": [165, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s927_AIMed.d110.s927.p4", "text": "TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "text_with_entity_marker": "[E1]TAFII55[/E1] is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, [E2]USF[/E2], CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "USF", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s927_AIMed.d110.s927.p5", "text": "TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "text_with_entity_marker": "[E1]TAFII55[/E1] is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, [E2]CTF[/E2], adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CTF", "entity_2_idx": [[162, 165]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s927_AIMed.d110.s927.p6", "text": "TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "text_with_entity_marker": "[E1]TAFII55[/E1] is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral [E2]E1A[/E2], and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s928_AIMed.d110.s928.p0", "text": "The TAFII55-interacting region of Sp1 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila TAFII110.", "text_with_entity_marker": "The [E1]TAFII55[/E1]-interacting region of [E2]Sp1[/E2] was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila TAFII110.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAFII55", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sp1", "entity_2_idx": [[34, 37]], "entity_2_idx_in_text_with_entity_marker": [47, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s928_AIMed.d110.s928.p2", "text": "The TAFII55-interacting region of Sp1 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila TAFII110.", "text_with_entity_marker": "The TAFII55-interacting region of [E1]Sp1[/E1] was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila [E2]TAFII110[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Sp1", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII110", "entity_2_idx": [[185, 193]], "entity_2_idx_in_text_with_entity_marker": [198, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1374_AIMed.d163.s1374.p1", "text": "A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.", "text_with_entity_marker": "A protein, [E1]sorting nexin-1[/E1] (SNX1), was identified in a human cell line that bound to a region of the [E2]epidermal growth factor receptor[/E2] (EGFR) containing the lysosomal targeting code.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "sorting nexin-1", "entity_1_idx": [[11, 26]], "entity_1_idx_in_text_with_entity_marker": [15, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor receptor", "entity_2_idx": [[101, 133]], "entity_2_idx_in_text_with_entity_marker": [114, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1374_AIMed.d163.s1374.p2", "text": "A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.", "text_with_entity_marker": "A protein, [E1]sorting nexin-1[/E1] (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor ([E2]EGFR[/E2]) containing the lysosomal targeting code.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "sorting nexin-1", "entity_1_idx": [[11, 26]], "entity_1_idx_in_text_with_entity_marker": [15, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[135, 139]], "entity_2_idx_in_text_with_entity_marker": [148, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1374_AIMed.d163.s1374.p3", "text": "A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.", "text_with_entity_marker": "A protein, sorting nexin-1 ([E1]SNX1[/E1]), was identified in a human cell line that bound to a region of the [E2]epidermal growth factor receptor[/E2] (EGFR) containing the lysosomal targeting code.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SNX1", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor receptor", "entity_2_idx": [[101, 133]], "entity_2_idx_in_text_with_entity_marker": [114, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1374_AIMed.d163.s1374.p4", "text": "A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.", "text_with_entity_marker": "A protein, sorting nexin-1 ([E1]SNX1[/E1]), was identified in a human cell line that bound to a region of the epidermal growth factor receptor ([E2]EGFR[/E2]) containing the lysosomal targeting code.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SNX1", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[135, 139]], "entity_2_idx_in_text_with_entity_marker": [148, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d224.s1950_AIMed.d224.s1950.p8", "text": "Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.", "text_with_entity_marker": "Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that [E1]HLA-E[/E1] associates with the transporter associated with antigen processing (TAP) and [E2]calreticulin[/E2], and that HLA-E expression is TAP-dependent and tapasin-dependent.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HLA-E", "entity_1_idx": [[102, 107]], "entity_1_idx_in_text_with_entity_marker": [106, 111], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[185, 197]], "entity_2_idx_in_text_with_entity_marker": [198, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d190.s1612_AIMed.d190.s1612.p4", "text": "In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.", "text_with_entity_marker": "In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the [E1]Grb2[/E1]/[E2]c-Cbl[/E2] complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[95, 99]], "entity_1_idx_in_text_with_entity_marker": [99, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Cbl", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d190.s1613_AIMed.d190.s1613.p8", "text": "By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and TPO, induce c-Cbl tyrosine phosphorylation.", "text_with_entity_marker": "By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: [E1]SCF[/E1] and TPO, induce [E2]c-Cbl[/E2] tyrosine phosphorylation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SCF", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Cbl", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d190.s1613_AIMed.d190.s1613.p9", "text": "By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and TPO, induce c-Cbl tyrosine phosphorylation.", "text_with_entity_marker": "By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and [E1]TPO[/E1], induce [E2]c-Cbl[/E2] tyrosine phosphorylation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TPO", "entity_1_idx": [[114, 117]], "entity_1_idx_in_text_with_entity_marker": [118, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Cbl", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d190.s1619_AIMed.d190.s1619.p0", "text": "By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.", "text_with_entity_marker": "By contrast the [E1]Ras[/E1] exchanger factor ([E2]Sos1[/E2]) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sos1", "entity_2_idx": [[38, 42]], "entity_2_idx_in_text_with_entity_marker": [51, 55], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d190.s1620_AIMed.d190.s1620.p2", "text": "Taken together our results demonstrate that c-Cbl plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2/c-Cbl complex when non-tyrosine or tyrosine kinase receptors are activated.", "text_with_entity_marker": "Taken together our results demonstrate that c-Cbl plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with [E1]Grb2[/E1]/[E2]c-Cbl[/E2] complex when non-tyrosine or tyrosine kinase receptors are activated.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[220, 224]], "entity_1_idx_in_text_with_entity_marker": [224, 228], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Cbl", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d116.s977_AIMed.d116.s977.p0", "text": "Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product.", "text_with_entity_marker": "Activity of RNA polymerase I transcription factor [E1]UBF[/E1] blocked by [E2]Rb[/E2] gene product.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UBF", "entity_1_idx": [[50, 53]], "entity_1_idx_in_text_with_entity_marker": [54, 57], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[65, 67]], "entity_2_idx_in_text_with_entity_marker": [78, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d116.s980_AIMed.d116.s980.p12", "text": "Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.", "text_with_entity_marker": "Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) [E1]Rb[/E1] specifically inhibits the activity of the RNA polymerase I transcription factor [E2]UBF[/E2] (upstream binding factor) in vitro.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[324, 326]], "entity_1_idx_in_text_with_entity_marker": [328, 330], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "UBF", "entity_2_idx": [[407, 410]], "entity_2_idx_in_text_with_entity_marker": [420, 423], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d116.s980_AIMed.d116.s980.p13", "text": "Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.", "text_with_entity_marker": "Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) [E1]Rb[/E1] specifically inhibits the activity of the RNA polymerase I transcription factor UBF ([E2]upstream binding factor[/E2]) in vitro.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[324, 326]], "entity_1_idx_in_text_with_entity_marker": [328, 330], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "upstream binding factor", "entity_2_idx": [[412, 435]], "entity_2_idx_in_text_with_entity_marker": [425, 448], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d116.s981_AIMed.d116.s981.p0", "text": "This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between Rb and UBF.", "text_with_entity_marker": "This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between [E1]Rb[/E1] and [E2]UBF[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[130, 132]], "entity_1_idx_in_text_with_entity_marker": [134, 136], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "UBF", "entity_2_idx": [[137, 140]], "entity_2_idx_in_text_with_entity_marker": [150, 153], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s665_AIMed.d78.s665.p0", "text": "Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .", "text_with_entity_marker": "Here , we demonstrate that [E1]TR6[/E1] specifically binds two cellular ligands , [E2]LIGHT[/E2] ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TR6", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LIGHT", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s665_AIMed.d78.s665.p1", "text": "Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .", "text_with_entity_marker": "Here , we demonstrate that [E1]TR6[/E1] specifically binds two cellular ligands , LIGHT ( [E2]herpes virus entry mediator ( HVEM ) - L[/E2] ) and Fas ligand ( FasL / CD95L ) .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TR6", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "herpes virus entry mediator ( HVEM ) - L", "entity_2_idx": [[81, 121]], "entity_2_idx_in_text_with_entity_marker": [94, 134], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s665_AIMed.d78.s665.p3", "text": "Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .", "text_with_entity_marker": "Here , we demonstrate that [E1]TR6[/E1] specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and [E2]Fas ligand[/E2] ( FasL / CD95L ) .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TR6", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas ligand", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s665_AIMed.d78.s665.p4", "text": "Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .", "text_with_entity_marker": "Here , we demonstrate that [E1]TR6[/E1] specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( [E2]FasL[/E2] / CD95L ) .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TR6", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FasL", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s665_AIMed.d78.s665.p5", "text": "Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .", "text_with_entity_marker": "Here , we demonstrate that [E1]TR6[/E1] specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / [E2]CD95L[/E2] ) .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TR6", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD95L", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s668_AIMed.d78.s668.p6", "text": "It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / TR2 receptors .", "text_with_entity_marker": "It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both [E1]lymphotoxin beta[/E1] receptor ( [E2]LTbetaR[/E2] ) and HVEM / TR2 receptors .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "lymphotoxin beta", "entity_1_idx": [[110, 126]], "entity_1_idx_in_text_with_entity_marker": [114, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LTbetaR", "entity_2_idx": [[138, 145]], "entity_2_idx_in_text_with_entity_marker": [151, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s669_AIMed.d78.s669.p5", "text": "Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .", "text_with_entity_marker": "Our data suggest that TR6 inhibits the interactions of [E1]LIGHT[/E1] with [E2]HVEM[/E2] / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LIGHT", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HVEM", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s669_AIMed.d78.s669.p6", "text": "Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .", "text_with_entity_marker": "Our data suggest that TR6 inhibits the interactions of [E1]LIGHT[/E1] with HVEM / [E2]TR2[/E2] and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LIGHT", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TR2", "entity_2_idx": [[73, 76]], "entity_2_idx_in_text_with_entity_marker": [86, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d78.s669_AIMed.d78.s669.p7", "text": "Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .", "text_with_entity_marker": "Our data suggest that TR6 inhibits the interactions of [E1]LIGHT[/E1] with HVEM / TR2 and [E2]LTbetaR[/E2] , thereby suppressing LIGHT-mediated HT29 cell death .", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LIGHT", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LTbetaR", "entity_2_idx": [[81, 88]], "entity_2_idx_in_text_with_entity_marker": [94, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s699_AIMed.d82.s699.p0", "text": "Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa FKBP12-rapamycin-binding domain within FRAP.", "text_with_entity_marker": "Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa [E1]FKBP12[/E1]-rapamycin-binding domain within [E2]FRAP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FKBP12", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FRAP", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s821_AIMed.d97.s821.p2", "text": "In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently BMP-4, bound to BMPR-II.", "text_with_entity_marker": "In transfected COS-1 cells, [E1]osteogenic protein (OP)-1[/E1]/BMP-7, and less efficiently BMP-4, bound to [E2]BMPR-II[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "osteogenic protein (OP)-1", "entity_1_idx": [[28, 53]], "entity_1_idx_in_text_with_entity_marker": [32, 57], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s821_AIMed.d97.s821.p4", "text": "In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently BMP-4, bound to BMPR-II.", "text_with_entity_marker": "In transfected COS-1 cells, osteogenic protein (OP)-1/[E1]BMP-7[/E1], and less efficiently BMP-4, bound to [E2]BMPR-II[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-7", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s821_AIMed.d97.s821.p5", "text": "In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently BMP-4, bound to BMPR-II.", "text_with_entity_marker": "In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently [E1]BMP-4[/E1], bound to [E2]BMPR-II[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-4", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s823_AIMed.d97.s823.p1", "text": "Binding of OP-1/BMP-7 to BMPR-II was also observed in nontransfected cell lines.", "text_with_entity_marker": "Binding of [E1]OP-1[/E1]/BMP-7 to [E2]BMPR-II[/E2] was also observed in nontransfected cell lines.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "OP-1", "entity_1_idx": [[11, 15]], "entity_1_idx_in_text_with_entity_marker": [15, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[25, 32]], "entity_2_idx_in_text_with_entity_marker": [38, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s823_AIMed.d97.s823.p2", "text": "Binding of OP-1/BMP-7 to BMPR-II was also observed in nontransfected cell lines.", "text_with_entity_marker": "Binding of OP-1/[E1]BMP-7[/E1] to [E2]BMPR-II[/E2] was also observed in nontransfected cell lines.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-7", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[25, 32]], "entity_2_idx_in_text_with_entity_marker": [38, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s824_AIMed.d97.s824.p0", "text": "Moreover, a transcriptional activation signal was transduced by BMPR-II in the presence of type I receptors after stimulation by OP-1/BMP-7.", "text_with_entity_marker": "Moreover, a transcriptional activation signal was transduced by [E1]BMPR-II[/E1] in the presence of type I receptors after stimulation by [E2]OP-1[/E2]/BMP-7.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMPR-II", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "OP-1", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s824_AIMed.d97.s824.p1", "text": "Moreover, a transcriptional activation signal was transduced by BMPR-II in the presence of type I receptors after stimulation by OP-1/BMP-7.", "text_with_entity_marker": "Moreover, a transcriptional activation signal was transduced by [E1]BMPR-II[/E1] in the presence of type I receptors after stimulation by OP-1/[E2]BMP-7[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMPR-II", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP-7", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s532_AIMed.d61.s532.p0", "text": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "text_with_entity_marker": "An expression plasmid encoding the human 75-kDa [E1]tumor necrosis factor (TNF) type 2 receptor[/E1] ([E2]TNF-R2[/E2]) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tumor necrosis factor (TNF) type 2 receptor", "entity_1_idx": [[48, 91]], "entity_1_idx_in_text_with_entity_marker": [52, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s532_AIMed.d61.s532.p1", "text": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "text_with_entity_marker": "An expression plasmid encoding the human 75-kDa [E1]tumor necrosis factor (TNF) type 2 receptor[/E1] (TNF-R2) was constructed and used to generate a stable human cell line (293/[E2]TNF-R2[/E2]) overexpressing TNF-R2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tumor necrosis factor (TNF) type 2 receptor", "entity_1_idx": [[48, 91]], "entity_1_idx_in_text_with_entity_marker": [52, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[168, 174]], "entity_2_idx_in_text_with_entity_marker": [181, 187], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s532_AIMed.d61.s532.p2", "text": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "text_with_entity_marker": "An expression plasmid encoding the human 75-kDa [E1]tumor necrosis factor (TNF) type 2 receptor[/E1] (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing [E2]TNF-R2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tumor necrosis factor (TNF) type 2 receptor", "entity_1_idx": [[48, 91]], "entity_1_idx_in_text_with_entity_marker": [52, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[191, 197]], "entity_2_idx_in_text_with_entity_marker": [204, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s532_AIMed.d61.s532.p3", "text": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "text_with_entity_marker": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor ([E1]TNF-R2[/E1]) was constructed and used to generate a stable human cell line (293/[E2]TNF-R2[/E2]) overexpressing TNF-R2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[168, 174]], "entity_2_idx_in_text_with_entity_marker": [181, 187], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s532_AIMed.d61.s532.p4", "text": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "text_with_entity_marker": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor ([E1]TNF-R2[/E1]) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing [E2]TNF-R2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[191, 197]], "entity_2_idx_in_text_with_entity_marker": [204, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s532_AIMed.d61.s532.p5", "text": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.", "text_with_entity_marker": "An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/[E1]TNF-R2[/E1]) overexpressing [E2]TNF-R2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[168, 174]], "entity_1_idx_in_text_with_entity_marker": [172, 178], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[191, 197]], "entity_2_idx_in_text_with_entity_marker": [204, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s533_AIMed.d61.s533.p0", "text": "Ligand binding analysis revealed high affinity binding (Kd = 0.2 nM) with approximately 94,000 +/- 7,500 sites/cell for 125I-TNF-alpha and approximately 5-fold lower affinity for TNF-beta (Kd = 1.1 nM) with 264,000 +/- 2,000 sites/cell.", "text_with_entity_marker": "Ligand binding analysis revealed high affinity binding (Kd = 0.2 nM) with approximately 94,000 +/- 7,500 sites/cell for 125I-[E1]TNF-alpha[/E1] and approximately 5-fold lower affinity for [E2]TNF-beta[/E2] (Kd = 1.1 nM) with 264,000 +/- 2,000 sites/cell.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[125, 134]], "entity_1_idx_in_text_with_entity_marker": [129, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p0", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-[E1]TNF-alpha[/E1] and 125I-[E2]TNF-beta[/E2] to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[41, 49]], "entity_2_idx_in_text_with_entity_marker": [54, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p1", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-[E1]TNF-alpha[/E1] and 125I-TNF-beta to 293/[E2]TNF-R2[/E2] cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[57, 63]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p2", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-[E1]TNF-alpha[/E1] and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for [E2]TNF-alpha[/E2] and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-alpha", "entity_2_idx": [[147, 156]], "entity_2_idx_in_text_with_entity_marker": [160, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p3", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-[E1]TNF-alpha[/E1] and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for [E2]TNF-beta[/E2], suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[185, 193]], "entity_2_idx_in_text_with_entity_marker": [198, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p4", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-[E1]TNF-alpha[/E1] and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three [E2]TNF-R2[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[243, 249]], "entity_2_idx_in_text_with_entity_marker": [256, 262], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p5", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-[E1]TNF-beta[/E1] to 293/[E2]TNF-R2[/E2] cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-beta", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[57, 63]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p6", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-[E1]TNF-beta[/E1] to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for [E2]TNF-alpha[/E2] and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-beta", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-alpha", "entity_2_idx": [[147, 156]], "entity_2_idx_in_text_with_entity_marker": [160, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p7", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-[E1]TNF-beta[/E1] to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for [E2]TNF-beta[/E2], suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-beta", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[185, 193]], "entity_2_idx_in_text_with_entity_marker": [198, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p8", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-[E1]TNF-beta[/E1] to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three [E2]TNF-R2[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-beta", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[243, 249]], "entity_2_idx_in_text_with_entity_marker": [256, 262], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p9", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/[E1]TNF-R2[/E1] cells yielded predominant complexes with apparent molecular weights of 211,000 for [E2]TNF-alpha[/E2] and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-alpha", "entity_2_idx": [[147, 156]], "entity_2_idx_in_text_with_entity_marker": [160, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p10", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/[E1]TNF-R2[/E1] cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for [E2]TNF-beta[/E2], suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[185, 193]], "entity_2_idx_in_text_with_entity_marker": [198, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p11", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/[E1]TNF-R2[/E1] cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three [E2]TNF-R2[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[243, 249]], "entity_2_idx_in_text_with_entity_marker": [256, 262], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p12", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for [E1]TNF-alpha[/E1] and 205,000 and 244,000 for [E2]TNF-beta[/E2], suggesting these complexes contain two or three TNF-R2 molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[147, 156]], "entity_1_idx_in_text_with_entity_marker": [151, 160], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[185, 193]], "entity_2_idx_in_text_with_entity_marker": [198, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p13", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for [E1]TNF-alpha[/E1] and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three [E2]TNF-R2[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[147, 156]], "entity_1_idx_in_text_with_entity_marker": [151, 160], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[243, 249]], "entity_2_idx_in_text_with_entity_marker": [256, 262], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s534_AIMed.d61.s534.p14", "text": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.", "text_with_entity_marker": "Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for [E1]TNF-beta[/E1], suggesting these complexes contain two or three [E2]TNF-R2[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-beta", "entity_1_idx": [[185, 193]], "entity_1_idx_in_text_with_entity_marker": [189, 197], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[243, 249]], "entity_2_idx_in_text_with_entity_marker": [256, 262], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s535_AIMed.d61.s535.p0", "text": "Immunoprecipitation of TNF-R2 from 32P-labeled 293/TNF-R2 cells demonstrated that the receptor is phosphorylated.", "text_with_entity_marker": "Immunoprecipitation of [E1]TNF-R2[/E1] from 32P-labeled 293/[E2]TNF-R2[/E2] cells demonstrated that the receptor is phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[23, 29]], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[51, 57]], "entity_2_idx_in_text_with_entity_marker": [64, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s537_AIMed.d61.s537.p0", "text": "TNF-alpha treatment of 293/TNF-R2 cells did not significantly affect the degree or pattern of phosphorylation.", "text_with_entity_marker": "[E1]TNF-alpha[/E1] treatment of 293/[E2]TNF-R2[/E2] cells did not significantly affect the degree or pattern of phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-R2", "entity_2_idx": [[27, 33]], "entity_2_idx_in_text_with_entity_marker": [40, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s539_AIMed.d61.s539.p0", "text": "Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or TNF-beta.", "text_with_entity_marker": "Shedding of the extracellular domain of [E1]TNF-R2[/E1] was induced by 4 beta-phorbol 12-myristate 13-acetate but not by [E2]TNF-alpha[/E2] or TNF-beta.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[40, 46]], "entity_1_idx_in_text_with_entity_marker": [44, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-alpha", "entity_2_idx": [[112, 121]], "entity_2_idx_in_text_with_entity_marker": [125, 134], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s539_AIMed.d61.s539.p1", "text": "Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or TNF-beta.", "text_with_entity_marker": "Shedding of the extracellular domain of [E1]TNF-R2[/E1] was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or [E2]TNF-beta[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R2", "entity_1_idx": [[40, 46]], "entity_1_idx_in_text_with_entity_marker": [44, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[125, 133]], "entity_2_idx_in_text_with_entity_marker": [138, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d61.s539_AIMed.d61.s539.p2", "text": "Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or TNF-beta.", "text_with_entity_marker": "Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by [E1]TNF-alpha[/E1] or [E2]TNF-beta[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-alpha", "entity_1_idx": [[112, 121]], "entity_1_idx_in_text_with_entity_marker": [116, 125], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-beta", "entity_2_idx": [[125, 133]], "entity_2_idx_in_text_with_entity_marker": [138, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s957_AIMed.d113.s957.p0", "text": "The BAG-1 protein shares no significant homology with Bcl-2 or other Bcl-2 family proteins, which can form homo- and heterodimers.", "text_with_entity_marker": "The [E1]BAG-1[/E1] protein shares no significant homology with [E2]Bcl-2[/E2] or other Bcl-2 family proteins, which can form homo- and heterodimers.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAG-1", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s957_AIMed.d113.s957.p1", "text": "The BAG-1 protein shares no significant homology with Bcl-2 or other Bcl-2 family proteins, which can form homo- and heterodimers.", "text_with_entity_marker": "The [E1]BAG-1[/E1] protein shares no significant homology with Bcl-2 or other [E2]Bcl-2[/E2] family proteins, which can form homo- and heterodimers.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAG-1", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s957_AIMed.d113.s957.p2", "text": "The BAG-1 protein shares no significant homology with Bcl-2 or other Bcl-2 family proteins, which can form homo- and heterodimers.", "text_with_entity_marker": "The BAG-1 protein shares no significant homology with [E1]Bcl-2[/E1] or other [E2]Bcl-2[/E2] family proteins, which can form homo- and heterodimers.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s958_AIMed.d113.s958.p0", "text": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "text_with_entity_marker": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of [E1]BAG-1[/E1] and [E2]Bcl-2[/E2] provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAG-1", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s958_AIMed.d113.s958.p1", "text": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "text_with_entity_marker": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of [E1]BAG-1[/E1] and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either [E2]BAG-1[/E2] or Bcl-2 protein alone.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAG-1", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BAG-1", "entity_2_idx": [[330, 335]], "entity_2_idx_in_text_with_entity_marker": [343, 348], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s958_AIMed.d113.s958.p2", "text": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "text_with_entity_marker": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of [E1]BAG-1[/E1] and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or [E2]Bcl-2[/E2] protein alone.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAG-1", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[339, 344]], "entity_2_idx_in_text_with_entity_marker": [352, 357], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s958_AIMed.d113.s958.p3", "text": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "text_with_entity_marker": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and [E1]Bcl-2[/E1] provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either [E2]BAG-1[/E2] or Bcl-2 protein alone.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[97, 102]], "entity_1_idx_in_text_with_entity_marker": [101, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BAG-1", "entity_2_idx": [[330, 335]], "entity_2_idx_in_text_with_entity_marker": [343, 348], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s958_AIMed.d113.s958.p4", "text": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "text_with_entity_marker": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and [E1]Bcl-2[/E1] provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or [E2]Bcl-2[/E2] protein alone.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[97, 102]], "entity_1_idx_in_text_with_entity_marker": [101, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[339, 344]], "entity_2_idx_in_text_with_entity_marker": [352, 357], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s958_AIMed.d113.s958.p5", "text": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.", "text_with_entity_marker": "In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either [E1]BAG-1[/E1] or [E2]Bcl-2[/E2] protein alone.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAG-1", "entity_1_idx": [[330, 335]], "entity_1_idx_in_text_with_entity_marker": [334, 339], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[339, 344]], "entity_2_idx_in_text_with_entity_marker": [352, 357], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s960_AIMed.d113.s960.p0", "text": "The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of Bcl-2 and BAG-1.", "text_with_entity_marker": "The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to [E1]Bcl-2[/E1]-independent pathways may instead reflect a need for the combination of [E2]Bcl-2[/E2] and BAG-1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[154, 159]], "entity_1_idx_in_text_with_entity_marker": [158, 163], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-2", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s960_AIMed.d113.s960.p1", "text": "The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of Bcl-2 and BAG-1.", "text_with_entity_marker": "The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to [E1]Bcl-2[/E1]-independent pathways may instead reflect a need for the combination of Bcl-2 and [E2]BAG-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[154, 159]], "entity_1_idx_in_text_with_entity_marker": [158, 163], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BAG-1", "entity_2_idx": [[241, 246]], "entity_2_idx_in_text_with_entity_marker": [254, 259], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d113.s960_AIMed.d113.s960.p2", "text": "The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of Bcl-2 and BAG-1.", "text_with_entity_marker": "The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of [E1]Bcl-2[/E1] and [E2]BAG-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[231, 236]], "entity_1_idx_in_text_with_entity_marker": [235, 240], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BAG-1", "entity_2_idx": [[241, 246]], "entity_2_idx_in_text_with_entity_marker": [254, 259], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s475_AIMed.d54.s475.p0", "text": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "text_with_entity_marker": "[E1]PDGF-C[/E1] is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of [E2]neuropilin-1[/E2], and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-C", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "neuropilin-1", "entity_2_idx": [[105, 117]], "entity_2_idx_in_text_with_entity_marker": [118, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s475_AIMed.d54.s475.p1", "text": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "text_with_entity_marker": "[E1]PDGF-C[/E1] is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular [E2]endothelial growth factor[/E2] (25%) and PDGF A-chain (23%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-C", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelial growth factor", "entity_2_idx": [[212, 237]], "entity_2_idx_in_text_with_entity_marker": [225, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s475_AIMed.d54.s475.p2", "text": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "text_with_entity_marker": "[E1]PDGF-C[/E1] is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and [E2]PDGF A[/E2]-chain (23%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-C", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF A", "entity_2_idx": [[248, 254]], "entity_2_idx_in_text_with_entity_marker": [261, 267], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s475_AIMed.d54.s475.p3", "text": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "text_with_entity_marker": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of [E1]neuropilin-1[/E1], and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular [E2]endothelial growth factor[/E2] (25%) and PDGF A-chain (23%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuropilin-1", "entity_1_idx": [[105, 117]], "entity_1_idx_in_text_with_entity_marker": [109, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelial growth factor", "entity_2_idx": [[212, 237]], "entity_2_idx_in_text_with_entity_marker": [225, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s475_AIMed.d54.s475.p4", "text": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "text_with_entity_marker": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of [E1]neuropilin-1[/E1], and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and [E2]PDGF A[/E2]-chain (23%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuropilin-1", "entity_1_idx": [[105, 117]], "entity_1_idx_in_text_with_entity_marker": [109, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF A", "entity_2_idx": [[248, 254]], "entity_2_idx_in_text_with_entity_marker": [261, 267], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s475_AIMed.d54.s475.p5", "text": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).", "text_with_entity_marker": "PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular [E1]endothelial growth factor[/E1] (25%) and [E2]PDGF A[/E2]-chain (23%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "endothelial growth factor", "entity_1_idx": [[212, 237]], "entity_1_idx_in_text_with_entity_marker": [216, 241], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF A", "entity_2_idx": [[248, 254]], "entity_2_idx_in_text_with_entity_marker": [261, 267], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s478_AIMed.d54.s478.p0", "text": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "text_with_entity_marker": "[E1]PDGF-CC[/E1] exhibits greater mitogenic potency than [E2]PDGF-AA[/E2] and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-CC", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-AA", "entity_2_idx": [[48, 55]], "entity_2_idx_in_text_with_entity_marker": [61, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s478_AIMed.d54.s478.p1", "text": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "text_with_entity_marker": "[E1]PDGF-CC[/E1] exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than [E2]PDGF-AB[/E2] and PDGF-BB on several mesenchymal cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-CC", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-AB", "entity_2_idx": [[106, 113]], "entity_2_idx_in_text_with_entity_marker": [119, 126], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s478_AIMed.d54.s478.p2", "text": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "text_with_entity_marker": "[E1]PDGF-CC[/E1] exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and [E2]PDGF-BB[/E2] on several mesenchymal cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-CC", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-BB", "entity_2_idx": [[118, 125]], "entity_2_idx_in_text_with_entity_marker": [131, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s478_AIMed.d54.s478.p3", "text": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "text_with_entity_marker": "PDGF-CC exhibits greater mitogenic potency than [E1]PDGF-AA[/E1] and comparable or greater mitogenic activity than [E2]PDGF-AB[/E2] and PDGF-BB on several mesenchymal cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-AA", "entity_1_idx": [[48, 55]], "entity_1_idx_in_text_with_entity_marker": [52, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-AB", "entity_2_idx": [[106, 113]], "entity_2_idx_in_text_with_entity_marker": [119, 126], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s478_AIMed.d54.s478.p4", "text": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "text_with_entity_marker": "PDGF-CC exhibits greater mitogenic potency than [E1]PDGF-AA[/E1] and comparable or greater mitogenic activity than PDGF-AB and [E2]PDGF-BB[/E2] on several mesenchymal cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-AA", "entity_1_idx": [[48, 55]], "entity_1_idx_in_text_with_entity_marker": [52, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-BB", "entity_2_idx": [[118, 125]], "entity_2_idx_in_text_with_entity_marker": [131, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s478_AIMed.d54.s478.p5", "text": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.", "text_with_entity_marker": "PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than [E1]PDGF-AB[/E1] and [E2]PDGF-BB[/E2] on several mesenchymal cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-AB", "entity_1_idx": [[106, 113]], "entity_1_idx_in_text_with_entity_marker": [110, 117], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-BB", "entity_2_idx": [[118, 125]], "entity_2_idx_in_text_with_entity_marker": [131, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s479_AIMed.d54.s479.p0", "text": "Analysis of PDGF-CC in vivo in a diabetic mouse model of delayed wound healing showed that PDGF-CC significantly enhanced repair of a full-thickness skin excision.", "text_with_entity_marker": "Analysis of [E1]PDGF-CC[/E1] in vivo in a diabetic mouse model of delayed wound healing showed that [E2]PDGF-CC[/E2] significantly enhanced repair of a full-thickness skin excision.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-CC", "entity_1_idx": [[12, 19]], "entity_1_idx_in_text_with_entity_marker": [16, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-CC", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d54.s480_AIMed.d54.s480.p0", "text": "Together, these studies describe a third member of the PDGF family (PDGF-C) as a potent mitogen for cells of mesenchymal origin in in vitro and in vivo systems with a binding pattern similar to PDGF-AB.", "text_with_entity_marker": "Together, these studies describe a third member of the PDGF family ([E1]PDGF-C[/E1]) as a potent mitogen for cells of mesenchymal origin in in vitro and in vivo systems with a binding pattern similar to [E2]PDGF-AB[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF-C", "entity_1_idx": [[68, 74]], "entity_1_idx_in_text_with_entity_marker": [72, 78], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PDGF-AB", "entity_2_idx": [[194, 201]], "entity_2_idx_in_text_with_entity_marker": [207, 214], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d200.s1725_AIMed.d200.s1725.p0", "text": "Interactions with human PARP and mouse replication factor 1a were confirmed using glutathione transferase-tagged cDNAs.", "text_with_entity_marker": "Interactions with human [E1]PARP[/E1] and mouse [E2]replication factor 1a[/E2] were confirmed using glutathione transferase-tagged cDNAs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PARP", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "replication factor 1a", "entity_2_idx": [[39, 60]], "entity_2_idx_in_text_with_entity_marker": [52, 73], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s214_AIMed.d26.s214.p0", "text": "Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.", "text_with_entity_marker": "Differential expression of [E1]granulysin[/E1] and [E2]perforin[/E2] by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "perforin", "entity_2_idx": [[42, 50]], "entity_2_idx_in_text_with_entity_marker": [55, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s214_AIMed.d26.s214.p1", "text": "Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.", "text_with_entity_marker": "Differential expression of [E1]granulysin[/E1] and perforin by NK cells in cancer patients and correlation of impaired [E2]granulysin[/E2] expression withprogression of cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "granulysin", "entity_2_idx": [[110, 120]], "entity_2_idx_in_text_with_entity_marker": [123, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s214_AIMed.d26.s214.p2", "text": "Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.", "text_with_entity_marker": "Differential expression of granulysin and [E1]perforin[/E1] by NK cells in cancer patients and correlation of impaired [E2]granulysin[/E2] expression withprogression of cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "perforin", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "granulysin", "entity_2_idx": [[110, 120]], "entity_2_idx_in_text_with_entity_marker": [123, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s216_AIMed.d26.s216.p0", "text": "The aim of the present study was to elucidate whether intracellular expression of granulysin and perforin by NK cells might be associated with progression of cancer.", "text_with_entity_marker": "The aim of the present study was to elucidate whether intracellular expression of [E1]granulysin[/E1] and [E2]perforin[/E2] by NK cells might be associated with progression of cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "perforin", "entity_2_idx": [[97, 105]], "entity_2_idx_in_text_with_entity_marker": [110, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s217_AIMed.d26.s217.p0", "text": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) CD16(+) cells in healthy controls.", "text_with_entity_marker": "Flow cytometric analysis demonstrated high levels of [E1]perforin[/E1] and [E2]granulysin[/E2] expression by CD3(-) CD16(+) cells in healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "perforin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "granulysin", "entity_2_idx": [[66, 76]], "entity_2_idx_in_text_with_entity_marker": [79, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s217_AIMed.d26.s217.p1", "text": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) CD16(+) cells in healthy controls.", "text_with_entity_marker": "Flow cytometric analysis demonstrated high levels of [E1]perforin[/E1] and granulysin expression by [E2]CD3[/E2](-) CD16(+) cells in healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "perforin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[91, 94]], "entity_2_idx_in_text_with_entity_marker": [104, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s217_AIMed.d26.s217.p2", "text": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) CD16(+) cells in healthy controls.", "text_with_entity_marker": "Flow cytometric analysis demonstrated high levels of [E1]perforin[/E1] and granulysin expression by CD3(-) [E2]CD16[/E2](+) cells in healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "perforin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD16", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s217_AIMed.d26.s217.p3", "text": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) CD16(+) cells in healthy controls.", "text_with_entity_marker": "Flow cytometric analysis demonstrated high levels of perforin and [E1]granulysin[/E1] expression by [E2]CD3[/E2](-) CD16(+) cells in healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[91, 94]], "entity_2_idx_in_text_with_entity_marker": [104, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s217_AIMed.d26.s217.p4", "text": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) CD16(+) cells in healthy controls.", "text_with_entity_marker": "Flow cytometric analysis demonstrated high levels of perforin and [E1]granulysin[/E1] expression by CD3(-) [E2]CD16[/E2](+) cells in healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD16", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s217_AIMed.d26.s217.p5", "text": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) CD16(+) cells in healthy controls.", "text_with_entity_marker": "Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by [E1]CD3[/E1](-) [E2]CD16[/E2](+) cells in healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD3", "entity_1_idx": [[91, 94]], "entity_1_idx_in_text_with_entity_marker": [95, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD16", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s218_AIMed.d26.s218.p0", "text": "In contrast, cancer patients exhibited significantly decreased levels of granulysin expression ( P<0.005), despite having equally high levels of perforin expression in comparison with healthy controls.", "text_with_entity_marker": "In contrast, cancer patients exhibited significantly decreased levels of [E1]granulysin[/E1] expression ( P<0.005), despite having equally high levels of [E2]perforin[/E2] expression in comparison with healthy controls.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[73, 83]], "entity_1_idx_in_text_with_entity_marker": [77, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "perforin", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s219_AIMed.d26.s219.p0", "text": "The tumor-free patients expressed granulysin at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of granulysin compared to healthy controls ( P<0.0001).", "text_with_entity_marker": "The tumor-free patients expressed [E1]granulysin[/E1] at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of [E2]granulysin[/E2] compared to healthy controls ( P<0.0001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "granulysin", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d26.s223_AIMed.d26.s223.p0", "text": "In conclusion, impaired expression of granulysin by NK cells correlates with progression of cancer, and determination of granulysin expression might prove informative for assessing the immunological condition of cancer patients.", "text_with_entity_marker": "In conclusion, impaired expression of [E1]granulysin[/E1] by NK cells correlates with progression of cancer, and determination of [E2]granulysin[/E2] expression might prove informative for assessing the immunological condition of cancer patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "granulysin", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "granulysin", "entity_2_idx": [[121, 131]], "entity_2_idx_in_text_with_entity_marker": [134, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d86.s728_AIMed.d86.s728.p0", "text": "For the calibration, we used two sets of proteins, the Myc-Max-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.", "text_with_entity_marker": "For the calibration, we used two sets of proteins, the [E1]Myc[/E1]-[E2]Max[/E2]-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myc", "entity_1_idx": [[55, 58]], "entity_1_idx_in_text_with_entity_marker": [59, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Max", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d86.s728_AIMed.d86.s728.p1", "text": "For the calibration, we used two sets of proteins, the Myc-Max-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.", "text_with_entity_marker": "For the calibration, we used two sets of proteins, the [E1]Myc[/E1]-Max-[E2]Mxi1[/E2] helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myc", "entity_1_idx": [[55, 58]], "entity_1_idx_in_text_with_entity_marker": [59, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Mxi1", "entity_2_idx": [[63, 67]], "entity_2_idx_in_text_with_entity_marker": [76, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d86.s728_AIMed.d86.s728.p2", "text": "For the calibration, we used two sets of proteins, the Myc-Max-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.", "text_with_entity_marker": "For the calibration, we used two sets of proteins, the Myc-[E1]Max[/E1]-[E2]Mxi1[/E2] helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Max", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Mxi1", "entity_2_idx": [[63, 67]], "entity_2_idx_in_text_with_entity_marker": [76, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d141.s1193_AIMed.d141.s1193.p0", "text": "Cotransfection experiments indicate that CIP1 and SV40 T antigen function in a mutually antagonistic manner to control cell cycle progression.", "text_with_entity_marker": "Cotransfection experiments indicate that [E1]CIP1[/E1] and [E2]SV40 T antigen[/E2] function in a mutually antagonistic manner to control cell cycle progression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SV40 T antigen", "entity_2_idx": [[50, 64]], "entity_2_idx_in_text_with_entity_marker": [63, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s716_AIMed.d84.s716.p0", "text": "Finally, our data highlight the crucial role of the juxtamembrane domain in signaling by both the IR and the IGF-IR.", "text_with_entity_marker": "Finally, our data highlight the crucial role of the juxtamembrane domain in signaling by both the [E1]IR[/E1] and the [E2]IGF-IR[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IR", "entity_1_idx": [[98, 100]], "entity_1_idx_in_text_with_entity_marker": [102, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-IR", "entity_2_idx": [[109, 115]], "entity_2_idx_in_text_with_entity_marker": [122, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s256_AIMed.d31.s256.p0", "text": "A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.", "text_with_entity_marker": "A newly identified member of tumor necrosis factor receptor superfamily ([E1]TR6[/E1]) suppresses [E2]LIGHT[/E2]-mediated apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR6", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LIGHT", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s257_AIMed.d31.s257.p0", "text": "TR6 (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.", "text_with_entity_marker": "[E1]TR6[/E1] ([E2]decoy receptor 3[/E2] (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR6", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "decoy receptor 3", "entity_2_idx": [[5, 21]], "entity_2_idx_in_text_with_entity_marker": [18, 34], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s257_AIMed.d31.s257.p1", "text": "TR6 (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.", "text_with_entity_marker": "[E1]TR6[/E1] (decoy receptor 3 ([E2]DcR3[/E2])) is a new member of the tumor necrosis factor receptor (TNFR) family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR6", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DcR3", "entity_2_idx": [[23, 27]], "entity_2_idx_in_text_with_entity_marker": [36, 40], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s257_AIMed.d31.s257.p2", "text": "TR6 (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.", "text_with_entity_marker": "TR6 ([E1]decoy receptor 3[/E1] ([E2]DcR3[/E2])) is a new member of the tumor necrosis factor receptor (TNFR) family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "decoy receptor 3", "entity_1_idx": [[5, 21]], "entity_1_idx_in_text_with_entity_marker": [9, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DcR3", "entity_2_idx": [[23, 27]], "entity_2_idx_in_text_with_entity_marker": [36, 40], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s264_AIMed.d31.s264.p0", "text": "TR6 inhibited LIGHT-induced cytotoxicity in HT29 cells.", "text_with_entity_marker": "[E1]TR6[/E1] inhibited [E2]LIGHT[/E2]-induced cytotoxicity in HT29 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR6", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LIGHT", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s267_AIMed.d31.s267.p0", "text": "Thus, TR6 may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.", "text_with_entity_marker": "Thus, [E1]TR6[/E1] may play a regulatory role for suppressing in [E2]FasL[/E2]- and LIGHT-mediated cell death.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR6", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FasL", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s267_AIMed.d31.s267.p1", "text": "Thus, TR6 may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.", "text_with_entity_marker": "Thus, [E1]TR6[/E1] may play a regulatory role for suppressing in FasL- and [E2]LIGHT[/E2]-mediated cell death.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR6", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LIGHT", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d31.s267_AIMed.d31.s267.p2", "text": "Thus, TR6 may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.", "text_with_entity_marker": "Thus, TR6 may play a regulatory role for suppressing in [E1]FasL[/E1]- and [E2]LIGHT[/E2]-mediated cell death.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FasL", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LIGHT", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1091_AIMed.d128.s1091.p0", "text": "The X-ray structure of a growth hormone-prolactin receptor complex.", "text_with_entity_marker": "The X-ray structure of a [E1]growth hormone[/E1]-[E2]prolactin[/E2] receptor complex.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "growth hormone", "entity_1_idx": [[25, 39]], "entity_1_idx_in_text_with_entity_marker": [29, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "prolactin", "entity_2_idx": [[40, 49]], "entity_2_idx_in_text_with_entity_marker": [53, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1092_AIMed.d128.s1092.p0", "text": "The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "text_with_entity_marker": "The human pituitary hormones, [E1]growth hormone[/E1] ([E2]hGH[/E2]) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "growth hormone", "entity_1_idx": [[30, 44]], "entity_1_idx_in_text_with_entity_marker": [34, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hGH", "entity_2_idx": [[46, 49]], "entity_2_idx_in_text_with_entity_marker": [59, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1092_AIMed.d128.s1092.p1", "text": "The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "text_with_entity_marker": "The human pituitary hormones, [E1]growth hormone[/E1] (hGH) and [E2]prolactin[/E2] (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "growth hormone", "entity_1_idx": [[30, 44]], "entity_1_idx_in_text_with_entity_marker": [34, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "prolactin", "entity_2_idx": [[55, 64]], "entity_2_idx_in_text_with_entity_marker": [68, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1092_AIMed.d128.s1092.p2", "text": "The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "text_with_entity_marker": "The human pituitary hormones, [E1]growth hormone[/E1] (hGH) and prolactin ([E2]hPRL[/E2]), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "growth hormone", "entity_1_idx": [[30, 44]], "entity_1_idx_in_text_with_entity_marker": [34, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hPRL", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1092_AIMed.d128.s1092.p3", "text": "The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "text_with_entity_marker": "The human pituitary hormones, growth hormone ([E1]hGH[/E1]) and [E2]prolactin[/E2] (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hGH", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "prolactin", "entity_2_idx": [[55, 64]], "entity_2_idx_in_text_with_entity_marker": [68, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1092_AIMed.d128.s1092.p4", "text": "The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "text_with_entity_marker": "The human pituitary hormones, growth hormone ([E1]hGH[/E1]) and prolactin ([E2]hPRL[/E2]), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hGH", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hPRL", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1092_AIMed.d128.s1092.p5", "text": "The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "text_with_entity_marker": "The human pituitary hormones, growth hormone (hGH) and [E1]prolactin[/E1] ([E2]hPRL[/E2]), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "prolactin", "entity_1_idx": [[55, 64]], "entity_1_idx_in_text_with_entity_marker": [59, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hPRL", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s820_AIMed.d97.s820.p0", "text": "Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to DAF-4, a BMP type II receptor from Caenorhabditis elegans.", "text_with_entity_marker": "Here we report the cDNA cloning and characterization of a human type II receptor for BMPs ([E1]BMPR-II[/E1]), which is distantly related to [E2]DAF-4[/E2], a BMP type II receptor from Caenorhabditis elegans.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMPR-II", "entity_1_idx": [[91, 98]], "entity_1_idx_in_text_with_entity_marker": [95, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DAF-4", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s820_AIMed.d97.s820.p1", "text": "Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to DAF-4, a BMP type II receptor from Caenorhabditis elegans.", "text_with_entity_marker": "Here we report the cDNA cloning and characterization of a human type II receptor for BMPs ([E1]BMPR-II[/E1]), which is distantly related to DAF-4, a [E2]BMP type II receptor[/E2] from Caenorhabditis elegans.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMPR-II", "entity_1_idx": [[91, 98]], "entity_1_idx_in_text_with_entity_marker": [95, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP type II receptor", "entity_2_idx": [[140, 160]], "entity_2_idx_in_text_with_entity_marker": [153, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d97.s820_AIMed.d97.s820.p2", "text": "Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to DAF-4, a BMP type II receptor from Caenorhabditis elegans.", "text_with_entity_marker": "Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to [E1]DAF-4[/E1], a [E2]BMP type II receptor[/E2] from Caenorhabditis elegans.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DAF-4", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP type II receptor", "entity_2_idx": [[140, 160]], "entity_2_idx_in_text_with_entity_marker": [153, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d224.s1953_AIMed.d224.s1953.p0", "text": "The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E.", "text_with_entity_marker": "The correlation between [E1]HLA-E[/E1] and MHC class I surface expression might be relevant to the function of [E2]HLA-E[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HLA-E", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HLA-E", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d224.s1954_AIMed.d224.s1954.p0", "text": "Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.", "text_with_entity_marker": "Our results also show that, although these [E1]HLA-E[/E1] binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the [E2]TAP[/E2] complex and loaded onto HLA-E molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HLA-E", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAP", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d224.s1954_AIMed.d224.s1954.p1", "text": "Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.", "text_with_entity_marker": "Our results also show that, although these [E1]HLA-E[/E1] binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto [E2]HLA-E[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HLA-E", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HLA-E", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d224.s1954_AIMed.d224.s1954.p2", "text": "Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.", "text_with_entity_marker": "Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the [E1]TAP[/E1] complex and loaded onto [E2]HLA-E[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TAP", "entity_1_idx": [[181, 184]], "entity_1_idx_in_text_with_entity_marker": [185, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HLA-E", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1846_AIMed.d213.s1846.p0", "text": "In addition, previous work indicated that p300 and CBP might be involved in YY1-mediated repression.", "text_with_entity_marker": "In addition, previous work indicated that [E1]p300[/E1] and [E2]CBP[/E2] might be involved in YY1-mediated repression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p300", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[51, 54]], "entity_2_idx_in_text_with_entity_marker": [64, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1846_AIMed.d213.s1846.p1", "text": "In addition, previous work indicated that p300 and CBP might be involved in YY1-mediated repression.", "text_with_entity_marker": "In addition, previous work indicated that [E1]p300[/E1] and CBP might be involved in [E2]YY1[/E2]-mediated repression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p300", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "YY1", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1846_AIMed.d213.s1846.p2", "text": "In addition, previous work indicated that p300 and CBP might be involved in YY1-mediated repression.", "text_with_entity_marker": "In addition, previous work indicated that p300 and [E1]CBP[/E1] might be involved in [E2]YY1[/E2]-mediated repression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CBP", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "YY1", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s109_AIMed.d13.s109.p0", "text": "We performed cell-free in vitro infection of primary bone marrow derived CD34+ cells using semi-purified HHV8 and a mature IL-2 dependent T cell line, KIT 225, using highly concentrated viral stocks prepared from an infectious molecular clone of HTLV-1.", "text_with_entity_marker": "We performed cell-free in vitro infection of primary bone marrow derived [E1]CD34[/E1]+ cells using semi-purified HHV8 and a mature [E2]IL-2[/E2] dependent T cell line, KIT 225, using highly concentrated viral stocks prepared from an infectious molecular clone of HTLV-1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s112_AIMed.d13.s112.p0", "text": "Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "text_with_entity_marker": "Of these 400, [E1]interferon regulatory factor 4[/E1] ([E2]IRF4[/E2]), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon regulatory factor 4", "entity_1_idx": [[14, 44]], "entity_1_idx_in_text_with_entity_marker": [18, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRF4", "entity_2_idx": [[46, 50]], "entity_2_idx_in_text_with_entity_marker": [59, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s112_AIMed.d13.s112.p1", "text": "Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "text_with_entity_marker": "Of these 400, [E1]interferon regulatory factor 4[/E1] (IRF4), [E2]cyclin B2[/E2], TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon regulatory factor 4", "entity_1_idx": [[14, 44]], "entity_1_idx_in_text_with_entity_marker": [18, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cyclin B2", "entity_2_idx": [[53, 62]], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s112_AIMed.d13.s112.p2", "text": "Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "text_with_entity_marker": "Of these 400, [E1]interferon regulatory factor 4[/E1] (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and [E2]pim 2[/E2] were up-regulated more than 3.5 fold.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon regulatory factor 4", "entity_1_idx": [[14, 44]], "entity_1_idx_in_text_with_entity_marker": [18, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pim 2", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s112_AIMed.d13.s112.p3", "text": "Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "text_with_entity_marker": "Of these 400, interferon regulatory factor 4 ([E1]IRF4[/E1]), [E2]cyclin B2[/E2], TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRF4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cyclin B2", "entity_2_idx": [[53, 62]], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s112_AIMed.d13.s112.p4", "text": "Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "text_with_entity_marker": "Of these 400, interferon regulatory factor 4 ([E1]IRF4[/E1]), cyclin B2, TBP-associated factor, eukaryotic elongation factor and [E2]pim 2[/E2] were up-regulated more than 3.5 fold.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRF4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pim 2", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d13.s112_AIMed.d13.s112.p5", "text": "Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.", "text_with_entity_marker": "Of these 400, interferon regulatory factor 4 (IRF4), [E1]cyclin B2[/E1], TBP-associated factor, eukaryotic elongation factor and [E2]pim 2[/E2] were up-regulated more than 3.5 fold.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cyclin B2", "entity_1_idx": [[53, 62]], "entity_1_idx_in_text_with_entity_marker": [57, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pim 2", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s735_AIMed.d87.s735.p0", "text": "The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and IGF-1R and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).", "text_with_entity_marker": "The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of [E1]IR[/E1] and [E2]IGF-1R[/E2] and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IR", "entity_1_idx": [[90, 92]], "entity_1_idx_in_text_with_entity_marker": [94, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R", "entity_2_idx": [[97, 103]], "entity_2_idx_in_text_with_entity_marker": [110, 116], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s735_AIMed.d87.s735.p1", "text": "The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and IGF-1R and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).", "text_with_entity_marker": "The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of [E1]IR[/E1] and IGF-1R and [E2]p85[/E2] or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IR", "entity_1_idx": [[90, 92]], "entity_1_idx_in_text_with_entity_marker": [94, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[108, 111]], "entity_2_idx_in_text_with_entity_marker": [121, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s735_AIMed.d87.s735.p2", "text": "The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and IGF-1R and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).", "text_with_entity_marker": "The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and [E1]IGF-1R[/E1] and [E2]p85[/E2] or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IGF-1R", "entity_1_idx": [[97, 103]], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[108, 111]], "entity_2_idx_in_text_with_entity_marker": [121, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s738_AIMed.d87.s738.p0", "text": "The internal binding site thus revealed was not altered by further mutating Y960/F for IR or Y950/F for IGF-1R.", "text_with_entity_marker": "The internal binding site thus revealed was not altered by further mutating Y960/F for [E1]IR[/E1] or Y950/F for [E2]IGF-1R[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IR", "entity_1_idx": [[87, 89]], "entity_1_idx_in_text_with_entity_marker": [91, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R", "entity_2_idx": [[104, 110]], "entity_2_idx_in_text_with_entity_marker": [117, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s987_AIMed.d117.s987.p0", "text": "Activin type I receptors, SKR1 and SKR2, were first cloned from well differentiated human hepatoma cells (HepG2).", "text_with_entity_marker": "Activin type I receptors, [E1]SKR1[/E1] and [E2]SKR2[/E2], were first cloned from well differentiated human hepatoma cells (HepG2).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SKR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SKR2", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d100.s849_AIMed.d100.s849.p0", "text": "The hTAFII250 gene is identical to a gene, CCG1, (ref 7,8), implicated in cell-cycle progression.", "text_with_entity_marker": "The [E1]hTAFII250[/E1] gene is identical to a gene, [E2]CCG1[/E2], (ref 7,8), implicated in cell-cycle progression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII250", "entity_1_idx": [[4, 13]], "entity_1_idx_in_text_with_entity_marker": [8, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCG1", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s226_AIMed.d27.s226.p0", "text": "Activin A, a member of the TGFbeta superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.", "text_with_entity_marker": "[E1]Activin A[/E1], a member of the [E2]TGFbeta[/E2] superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Activin A", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TGFbeta", "entity_2_idx": [[27, 34]], "entity_2_idx_in_text_with_entity_marker": [40, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s229_AIMed.d27.s229.p0", "text": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.", "text_with_entity_marker": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as [E1]p16[/E1] and [E2]p21[/E2] and regulators of apoptosis such as p53 and members of the bcl-2 family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[89, 92]], "entity_1_idx_in_text_with_entity_marker": [93, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[97, 100]], "entity_2_idx_in_text_with_entity_marker": [110, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s229_AIMed.d27.s229.p1", "text": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.", "text_with_entity_marker": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as [E1]p16[/E1] and p21 and regulators of apoptosis such as [E2]p53[/E2] and members of the bcl-2 family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[89, 92]], "entity_1_idx_in_text_with_entity_marker": [93, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[137, 140]], "entity_2_idx_in_text_with_entity_marker": [150, 153], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s229_AIMed.d27.s229.p2", "text": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.", "text_with_entity_marker": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as [E1]p16[/E1] and p21 and regulators of apoptosis such as p53 and members of the [E2]bcl-2[/E2] family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[89, 92]], "entity_1_idx_in_text_with_entity_marker": [93, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "bcl-2", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s229_AIMed.d27.s229.p3", "text": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.", "text_with_entity_marker": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and [E1]p21[/E1] and regulators of apoptosis such as [E2]p53[/E2] and members of the bcl-2 family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[97, 100]], "entity_1_idx_in_text_with_entity_marker": [101, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[137, 140]], "entity_2_idx_in_text_with_entity_marker": [150, 153], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s229_AIMed.d27.s229.p4", "text": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.", "text_with_entity_marker": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and [E1]p21[/E1] and regulators of apoptosis such as p53 and members of the [E2]bcl-2[/E2] family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[97, 100]], "entity_1_idx_in_text_with_entity_marker": [101, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "bcl-2", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d27.s229_AIMed.d27.s229.p5", "text": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.", "text_with_entity_marker": "Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as [E1]p53[/E1] and members of the [E2]bcl-2[/E2] family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[137, 140]], "entity_1_idx_in_text_with_entity_marker": [141, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "bcl-2", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p14", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, [E1]actin-binding protein[/E1] [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[189, 210]], "entity_1_idx_in_text_with_entity_marker": [193, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p0", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the [E1]cyclin dependent kinase inhibitor[/E1] [E2]p27kip1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[247, 280]], "entity_1_idx_in_text_with_entity_marker": [251, 284], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27kip1", "entity_2_idx": [[281, 288]], "entity_2_idx_in_text_with_entity_marker": [294, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p12", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the [E1]cyclin dependent kinase inhibitor[/E1] [E2]p16ink4a[/E2] and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[161, 194]], "entity_1_idx_in_text_with_entity_marker": [165, 198], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p16ink4a", "entity_2_idx": [[195, 203]], "entity_2_idx_in_text_with_entity_marker": [208, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d555.s0_BioInfer.d555.s0.p1", "text": "Such motifs are known to bind to profilins (PFNs), small proteins engaged in the control of actin dynamics.", "text_with_entity_marker": "Such motifs are known to bind to profilins ([E1]PFNs[/E1]), small proteins engaged in the control of [E2]actin[/E2] dynamics.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PFNs", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d555.s0_BioInfer.d555.s0.p2", "text": "Such motifs are known to bind to profilins (PFNs), small proteins engaged in the control of actin dynamics.", "text_with_entity_marker": "Such motifs are known to bind to [E1]profilins[/E1] (PFNs), small proteins engaged in the control of [E2]actin[/E2] dynamics.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p0", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp2[/E1]/3 complex from Acanthamoeba binds [E2]profilin[/E2] and cross-links actin filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p1", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp[/E1]2/3 complex from Acanthamoeba binds [E2]profilin[/E2] and cross-links actin filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[0, 3], [5, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p4", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp2[/E1]/3 complex from Acanthamoeba binds profilin and cross-links [E2]actin[/E2] filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p5", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp[/E1]2/3 complex from Acanthamoeba binds profilin and cross-links [E2]actin[/E2] filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[0, 3], [5, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p0", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E1]profilin[/E1] for barbed ends of actin filaments and its high affinity for [E2]actin[/E2] monomers.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[229, 234]], "entity_2_idx_in_text_with_entity_marker": [242, 247], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p7", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E1]profilin[/E1] for barbed ends of [E2]actin[/E2] filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p9", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds [E2]Arp2[/E2]/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p13", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds [E2]Arp[/E2]2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[68, 71], [73, 74]], "entity_2_idx_in_text_with_entity_marker": [81, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s2_BioInfer.d77.s2.p1", "text": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.", "text_with_entity_marker": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the [E1]actin[/E1]-binding site of [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[88, 93]], "entity_1_idx_in_text_with_entity_marker": [92, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[110, 118]], "entity_2_idx_in_text_with_entity_marker": [123, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s2_BioInfer.d77.s2.p2", "text": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.", "text_with_entity_marker": "Here we show that the [E1]Arp2[/E1] subunit of the complex can be chemically cross-linked to the actin-binding site of [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[110, 118]], "entity_2_idx_in_text_with_entity_marker": [123, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p4", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E1]histones[/E1] H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[387, 395]], "entity_1_idx_in_text_with_entity_marker": [391, 399], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p14", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E1]histones[/E1] [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[387, 395]], "entity_1_idx_in_text_with_entity_marker": [391, 399], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p25", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian [E1]histone[/E1] [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p37", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and [E2]H4[/E2], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[60, 62]], "entity_2_idx_in_text_with_entity_marker": [73, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p40", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones [E2]H2A[/E2], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p41", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, [E2]H3[/E2], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[52, 54]], "entity_2_idx_in_text_with_entity_marker": [65, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p42", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, [E2]H2B[/E2], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p57", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E1]histone[/E1] [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[375, 382]], "entity_1_idx_in_text_with_entity_marker": [379, 386], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p61", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p84", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E1]histone[/E1] [E2]H3[/E2] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[245, 252]], "entity_1_idx_in_text_with_entity_marker": [249, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[253, 255]], "entity_2_idx_in_text_with_entity_marker": [266, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p2", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of [E1]FLICE[/E1], Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FLICE", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p10", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, [E1]TRADD[/E1], and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p17", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, [E1]FADD[/E1], DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p24", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, [E1]FAF[/E1], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FAF", "entity_1_idx": [[84, 87]], "entity_1_idx_in_text_with_entity_marker": [88, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p25", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p26", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, [E1]DR3[/E1], FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR3", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p27", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p28", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p29", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and [E1]RIP[/E1] was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d685.s0_BioInfer.d685.s0.p0", "text": "The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.", "text_with_entity_marker": "The resulting [E1]beta-catenin[/E1] product is unable to bind [E2]alpha-catenin[/E2] that is responsible for actin filament binding and organization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[53, 66]], "entity_2_idx_in_text_with_entity_marker": [66, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d685.s0_BioInfer.d685.s0.p2", "text": "The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.", "text_with_entity_marker": "The resulting beta-catenin product is unable to bind [E1]alpha-catenin[/E1] that is responsible for [E2]actin[/E2] filament binding and organization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[53, 66]], "entity_1_idx_in_text_with_entity_marker": [57, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d219.s0_BioInfer.d219.s0.p2", "text": "From these we have isolated eight viable and lethal alleles of the muscle myosin heavy chain gene, and seven viable alleles of the indirect flight muscle (IFM)-specific Act88F actin gene.", "text_with_entity_marker": "From these we have isolated eight viable and lethal alleles of the muscle myosin heavy chain gene, and seven viable alleles of the indirect flight muscle (IFM)-specific [E1]Act88F[/E1] [E2]actin[/E2] gene.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Act88F", "entity_1_idx": [[169, 175]], "entity_1_idx_in_text_with_entity_marker": [173, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p1", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the [E1]HHR23B[/E1]/p58 and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HHR23B", "entity_1_idx": [[134, 140]], "entity_1_idx_in_text_with_entity_marker": [138, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p2", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/[E1]p58[/E1] and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p58", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p3", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and [E1]HHR23A[/E1] subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HHR23A", "entity_1_idx": [[149, 155]], "entity_1_idx_in_text_with_entity_marker": [153, 159], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p13", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the [E1]HHR23B[/E1]/[E2]p58[/E2] and HHR23A subunits of XPC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HHR23B", "entity_1_idx": [[134, 140]], "entity_1_idx_in_text_with_entity_marker": [138, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p58", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p14", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the [E1]HHR23B[/E1]/p58 and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HHR23B", "entity_1_idx": [[134, 140]], "entity_1_idx_in_text_with_entity_marker": [138, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p18", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/[E1]p58[/E1] and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p58", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d94.s0_BioInfer.d94.s0.p0", "text": "Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "text_with_entity_marker": "Because both proteins exchange rapidly between actin molecules, low concentrations of [E1]profilin[/E1] can overcome the inhibitory effects of high concentrations of [E2]thymosin beta 4[/E2] on the nucleotide exchange.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[86, 94]], "entity_1_idx_in_text_with_entity_marker": [90, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[157, 172]], "entity_2_idx_in_text_with_entity_marker": [170, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d94.s0_BioInfer.d94.s0.p1", "text": "Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "text_with_entity_marker": "Because both proteins exchange rapidly between [E1]actin[/E1] molecules, low concentrations of [E2]profilin[/E2] can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[86, 94]], "entity_2_idx_in_text_with_entity_marker": [99, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d94.s0_BioInfer.d94.s0.p2", "text": "Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "text_with_entity_marker": "Because both proteins exchange rapidly between [E1]actin[/E1] molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of [E2]thymosin beta 4[/E2] on the nucleotide exchange.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[157, 172]], "entity_2_idx_in_text_with_entity_marker": [170, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p0", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of [E1]SIR4[/E1] enhanced [E2]mURA3[/E2] and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIR4", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mURA3", "entity_2_idx": [[26, 31]], "entity_2_idx_in_text_with_entity_marker": [39, 44], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p1", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced [E1]mURA3[/E1] and MET15 silencing, but deletion of SIR1 or [E2]SIR3[/E2] did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "mURA3", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR3", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p2", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced [E1]mURA3[/E1] and MET15 silencing, but deletion of [E2]SIR1[/E2] or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "mURA3", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p6", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of [E1]SIR4[/E1] enhanced mURA3 and [E2]MET15[/E2] silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIR4", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MET15", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p8", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced mURA3 and [E1]MET15[/E1] silencing, but deletion of SIR1 or [E2]SIR3[/E2] did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MET15", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR3", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p9", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced mURA3 and [E1]MET15[/E1] silencing, but deletion of [E2]SIR1[/E2] or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MET15", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p0", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] inhibits beta-catenin signaling by preventing formation of a beta-catenin*[E2]T-cell factor[/E2]*DNA complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T-cell factor", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p1", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "alpha-catenin inhibits [E1]beta-catenin[/E1] signaling by preventing formation of a beta-catenin*[E2]T-cell factor[/E2]*DNA complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T-cell factor", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p2", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a [E1]beta-catenin[/E1]*[E2]T-cell factor[/E2]*DNA complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[75, 87]], "entity_1_idx_in_text_with_entity_marker": [79, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T-cell factor", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p3", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] inhibits [E2]beta-catenin[/E2] signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[23, 35]], "entity_2_idx_in_text_with_entity_marker": [36, 48], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p4", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] inhibits beta-catenin signaling by preventing formation of a [E2]beta-catenin[/E2]*T-cell factor*DNA complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[75, 87]], "entity_2_idx_in_text_with_entity_marker": [88, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s0_BioInfer.d660.s0.p0", "text": "The polypeptide folds and the actin-binding surfaces of the amoeba profilins are very similar to those of bovine and human profilins.", "text_with_entity_marker": "The polypeptide folds and the [E1]actin[/E1]-binding surfaces of the amoeba [E2]profilins[/E2] are very similar to those of bovine and human profilins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[67, 76]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s0_BioInfer.d660.s0.p1", "text": "The polypeptide folds and the actin-binding surfaces of the amoeba profilins are very similar to those of bovine and human profilins.", "text_with_entity_marker": "The polypeptide folds and the actin-binding surfaces of the amoeba [E1]profilins[/E1] are very similar to those of bovine and human [E2]profilins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[123, 132]], "entity_2_idx_in_text_with_entity_marker": [136, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s0_BioInfer.d660.s0.p2", "text": "The polypeptide folds and the actin-binding surfaces of the amoeba profilins are very similar to those of bovine and human profilins.", "text_with_entity_marker": "The polypeptide folds and the [E1]actin[/E1]-binding surfaces of the amoeba profilins are very similar to those of bovine and human [E2]profilins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[123, 132]], "entity_2_idx_in_text_with_entity_marker": [136, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s1_BioInfer.d660.s1.p0", "text": "The proximity of these sites to the actin binding site provides an explanation for the competition between actin and lipids for binding profilin.", "text_with_entity_marker": "The proximity of these sites to the [E1]actin[/E1] binding site provides an explanation for the competition between actin and lipids for binding [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s1_BioInfer.d660.s1.p1", "text": "The proximity of these sites to the actin binding site provides an explanation for the competition between actin and lipids for binding profilin.", "text_with_entity_marker": "The proximity of these sites to the actin binding site provides an explanation for the competition between [E1]actin[/E1] and lipids for binding [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s2_BioInfer.d660.s2.p0", "text": "X-ray structures of isoforms of the actin-binding protein profilin that differ in their affinity for phosphatidylinositol phosphates.", "text_with_entity_marker": "X-ray structures of isoforms of the [E1]actin-binding protein[/E1] [E2]profilin[/E2] that differ in their affinity for phosphatidylinositol phosphates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[36, 57]], "entity_1_idx_in_text_with_entity_marker": [40, 61], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[58, 66]], "entity_2_idx_in_text_with_entity_marker": [71, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d783.s0_BioInfer.d783.s0.p1", "text": "Unlike fimbrin, L-plastin's actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.", "text_with_entity_marker": "Unlike fimbrin, [E1]L-plastin[/E1]'s [E2]actin[/E2]-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "L-plastin", "entity_1_idx": [[16, 25]], "entity_1_idx_in_text_with_entity_marker": [20, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[28, 33]], "entity_2_idx_in_text_with_entity_marker": [41, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d783.s0_BioInfer.d783.s0.p2", "text": "Unlike fimbrin, L-plastin's actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.", "text_with_entity_marker": "Unlike [E1]fimbrin[/E1], L-plastin's [E2]actin[/E2]-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[7, 14]], "entity_1_idx_in_text_with_entity_marker": [11, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[28, 33]], "entity_2_idx_in_text_with_entity_marker": [41, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s0_BioInfer.d3.s0.p0", "text": "Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin.", "text_with_entity_marker": "Absence of [E1]alpha-syntrophin[/E1] leads to structurally aberrant neuromuscular synapses deficient in [E2]utrophin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[11, 27]], "entity_1_idx_in_text_with_entity_marker": [15, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[95, 103]], "entity_2_idx_in_text_with_entity_marker": [108, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p2", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, [E1]alpha-syntrophin[/E1] has an important role in synapse formation and in the organization of utrophin, [E2]acetylcholine receptor[/E2], and acetylcholinesterase at the neuromuscular synapse.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholine receptor", "entity_2_idx": [[103, 125]], "entity_2_idx_in_text_with_entity_marker": [116, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p4", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, [E1]alpha-syntrophin[/E1] has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and [E2]acetylcholinesterase[/E2] at the neuromuscular synapse.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholinesterase", "entity_2_idx": [[131, 151]], "entity_2_idx_in_text_with_entity_marker": [144, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p5", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, [E1]alpha-syntrophin[/E1] has an important role in synapse formation and in the organization of [E2]utrophin[/E2], acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d22.s0_BioInfer.d22.s0.p1", "text": "Additional studies demonstrated the gamma-catenin distribution to be remarkably similar to that of beta-catenin, whereas alpha-catenin staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "text_with_entity_marker": "Additional studies demonstrated the [E1]gamma-catenin[/E1] distribution to be remarkably similar to that of [E2]beta-catenin[/E2], whereas alpha-catenin staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[36, 49]], "entity_1_idx_in_text_with_entity_marker": [40, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d417.s0_BioInfer.d417.s0.p0", "text": "Mechanism of regulation of actin polymerization by Physarum profilin.", "text_with_entity_marker": "Mechanism of regulation of [E1]actin[/E1] polymerization by Physarum [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d417.s1_BioInfer.d417.s1.p0", "text": "The apparent critical concentration for polymerization of actin is increased by the addition of profilin.", "text_with_entity_marker": "The apparent critical concentration for polymerization of [E1]actin[/E1] is increased by the addition of [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[96, 104]], "entity_2_idx_in_text_with_entity_marker": [109, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p2", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "END5 encodes a proline-rich protein ([E1]End5p[/E1] or verprolin) required for a polarised cortical [E2]actin[/E2] cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "End5p", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p3", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "[E1]END5[/E1] encodes a proline-rich protein (End5p or [E2]verprolin[/E2]) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "END5", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "verprolin", "entity_2_idx": [[46, 55]], "entity_2_idx_in_text_with_entity_marker": [59, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p4", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "END5 encodes a proline-rich protein (End5p or [E1]verprolin[/E1]) required for a polarised cortical [E2]actin[/E2] cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[46, 55]], "entity_1_idx_in_text_with_entity_marker": [50, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p1", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, actin-binding protein, [E2]gelsolin[/E2], and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[56, 64]], "entity_2_idx_in_text_with_entity_marker": [69, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p4", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, [E2]actin-binding protein[/E2], gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[33, 54]], "entity_2_idx_in_text_with_entity_marker": [46, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p8", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, actin-binding protein, gelsolin, and [E2]profilin[/E2], influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[70, 78]], "entity_2_idx_in_text_with_entity_marker": [83, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p9", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, actin-binding protein, gelsolin, and [E1]profilin[/E1], influence gelation, solation, and polymerization, respectively, of [E2]actin[/E2] in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[70, 78]], "entity_1_idx_in_text_with_entity_marker": [74, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d712.s0_BioInfer.d712.s0.p0", "text": "These results suggest that profilin may be involved in the pathogenesis of glomerulonephritis by reorganizing actin cytoskeleton.", "text_with_entity_marker": "These results suggest that [E1]profilin[/E1] may be involved in the pathogenesis of glomerulonephritis by reorganizing [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p0", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases PP1 and PP2A associate with and activate the [E1]actin-binding protein[/E1] [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[69, 90]], "entity_1_idx_in_text_with_entity_marker": [73, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p4", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases [E1]PP1[/E1] and PP2A associate with and activate the actin-binding protein [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PP1", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p5", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases PP1 and [E1]PP2A[/E1] associate with and activate the actin-binding protein [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PP2A", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p1", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, [E1]Fas[/E1], TRADD or [E2]RIP[/E2] suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p2", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, Fas, TRADD or [E2]RIP[/E2] suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p4", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, [E1]TRADD[/E1] or [E2]RIP[/E2] suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p7", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from [E1]FADD[/E1]'s functions at activated [E2]death receptors[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[149, 153]], "entity_1_idx_in_text_with_entity_marker": [153, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "death receptors", "entity_2_idx": [[179, 194]], "entity_2_idx_in_text_with_entity_marker": [192, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p9", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, [E2]Fas[/E2], TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[95, 98]], "entity_2_idx_in_text_with_entity_marker": [108, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p11", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, [E1]Fas[/E1], [E2]TRADD[/E2] or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p13", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, Fas, [E2]TRADD[/E2] or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d495.s0_BioInfer.d495.s0.p0", "text": "Profilin I and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.", "text_with_entity_marker": "Profilin I and [E1]profilin II[/E1] have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric [E2]actin[/E2] to the same extent.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[15, 26]], "entity_1_idx_in_text_with_entity_marker": [19, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d495.s0_BioInfer.d495.s0.p1", "text": "Profilin I and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.", "text_with_entity_marker": "[E1]Profilin I[/E1] and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric [E2]actin[/E2] to the same extent.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilin I", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d495.s0_BioInfer.d495.s0.p2", "text": "Profilin I and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.", "text_with_entity_marker": "[E1]Profilin I[/E1] and [E2]profilin II[/E2] have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilin I", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[15, 26]], "entity_2_idx_in_text_with_entity_marker": [28, 39], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d642.s0_BioInfer.d642.s0.p1", "text": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two calponin-homology domains of fimbrin.", "text_with_entity_marker": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two [E1]calponin[/E1]-homology domains of [E2]fimbrin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "calponin", "entity_1_idx": [[108, 116]], "entity_1_idx_in_text_with_entity_marker": [112, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d642.s0_BioInfer.d642.s0.p2", "text": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two calponin-homology domains of fimbrin.", "text_with_entity_marker": "The map locates the N-terminal calcium-binding domain and identifies [E1]actin[/E1]-binding site residues on the two calponin-homology domains of [E2]fimbrin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p1", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of [E1]histone[/E1] [E2]H4[/E2] versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[79, 86]], "entity_1_idx_in_text_with_entity_marker": [83, 90], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[87, 89]], "entity_2_idx_in_text_with_entity_marker": [100, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p15", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, [E1]histone[/E1] [E2]H4[/E2] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[153, 160]], "entity_1_idx_in_text_with_entity_marker": [157, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p25", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified [E1]acetylase[/E1], histone H4 in nucleosomes was acetylated to a much greater extent than was histone [E2]H3[/E2], whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "acetylase", "entity_1_idx": [[142, 151]], "entity_1_idx_in_text_with_entity_marker": [146, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[236, 238]], "entity_2_idx_in_text_with_entity_marker": [249, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p26", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone [E1]H3[/E1], whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[236, 238]], "entity_1_idx_in_text_with_entity_marker": [240, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p29", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was [E1]histone[/E1] [E2]H3[/E2], whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[228, 235]], "entity_1_idx_in_text_with_entity_marker": [232, 239], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[236, 238]], "entity_2_idx_in_text_with_entity_marker": [249, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p32", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] [E2]H3[/E2]: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[120, 122]], "entity_2_idx_in_text_with_entity_marker": [133, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p37", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified [E1]acetylase[/E1], histone [E2]H4[/E2] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "acetylase", "entity_1_idx": [[142, 151]], "entity_1_idx_in_text_with_entity_marker": [146, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p40", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone [E1]H4[/E1] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s0_BioInfer.d433.s0.p0", "text": "Monoclonal antibodies recognizing the N- and C-terminal regions of talin disrupt actin stress fibers when microinjected into human fibroblasts.", "text_with_entity_marker": "Monoclonal antibodies recognizing the N- and C-terminal regions of [E1]talin[/E1] disrupt [E2]actin[/E2] stress fibers when microinjected into human fibroblasts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s1_BioInfer.d433.s1.p0", "text": "These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.", "text_with_entity_marker": "These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody [E1]TD77[/E1], raising the possibility that it binds to a novel functionally important ligand-binding site in the [E2]talin[/E2] molecule.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TD77", "entity_1_idx": [[129, 133]], "entity_1_idx_in_text_with_entity_marker": [133, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s1_BioInfer.d433.s1.p1", "text": "These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.", "text_with_entity_marker": "These results show that the C-terminal [E1]actin[/E1]-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the [E2]talin[/E2] molecule.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s2_BioInfer.d433.s2.p0", "text": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "text_with_entity_marker": "To investigate the possibility that [E1]TD77[/E1] disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional [E2]talin[/E2] fusion proteins were generated and analyzed for TD77 and actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TD77", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s2_BioInfer.d433.s2.p1", "text": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "text_with_entity_marker": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal [E1]actin[/E1] binding site, additional [E2]talin[/E2] fusion proteins were generated and analyzed for TD77 and actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[108, 113]], "entity_1_idx_in_text_with_entity_marker": [112, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s2_BioInfer.d433.s2.p2", "text": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "text_with_entity_marker": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional [E1]talin[/E1] fusion proteins were generated and analyzed for TD77 and [E2]actin[/E2] binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[139, 144]], "entity_1_idx_in_text_with_entity_marker": [143, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s2_BioInfer.d433.s2.p3", "text": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "text_with_entity_marker": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional [E1]talin[/E1] fusion proteins were generated and analyzed for [E2]TD77[/E2] and actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[139, 144]], "entity_1_idx_in_text_with_entity_marker": [143, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TD77", "entity_2_idx": [[193, 197]], "entity_2_idx_in_text_with_entity_marker": [206, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s2_BioInfer.d433.s2.p4", "text": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "text_with_entity_marker": "To investigate the possibility that TD77 disrupts [E1]actin[/E1] stress fibers by binding directly to the C-terminal actin binding site, additional [E2]talin[/E2] fusion proteins were generated and analyzed for TD77 and actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d433.s2_BioInfer.d433.s2.p8", "text": "To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "text_with_entity_marker": "To investigate the possibility that [E1]TD77[/E1] disrupts [E2]actin[/E2] stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TD77", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d460.s0_BioInfer.d460.s0.p0", "text": "One involves talin, which has recently been shown to bind actin directly.", "text_with_entity_marker": "One involves [E1]talin[/E1], which has recently been shown to bind [E2]actin[/E2] directly.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d562.s0_BioInfer.d562.s0.p0", "text": "The actin bundle formation induced by overexpression of cofilin is accompanied with an increase in cell motility of Dictyostelium cells. 4.", "text_with_entity_marker": "The [E1]actin[/E1] bundle formation induced by overexpression of [E2]cofilin[/E2] is accompanied with an increase in cell motility of Dictyostelium cells. 4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s0_BioInfer.d265.s0.p0", "text": "How profilin/barbed-end synergy controls actin polymerization: a kinetic model of the ATP hydrolysis circuit.", "text_with_entity_marker": "How [E1]profilin[/E1]/barbed-end synergy controls [E2]actin[/E2] polymerization: a kinetic model of the ATP hydrolysis circuit.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[41, 46]], "entity_2_idx_in_text_with_entity_marker": [54, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s2_BioInfer.d265.s2.p0", "text": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of actin subunits through filaments are controlled by profilin and free filament barbed ends through their interaction with ATP.", "text_with_entity_marker": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of [E1]actin[/E1] subunits through filaments are controlled by [E2]profilin[/E2] and free filament barbed ends through their interaction with ATP.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s2_BioInfer.d265.s2.p1", "text": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of actin subunits through filaments are controlled by profilin and free filament barbed ends through their interaction with ATP.", "text_with_entity_marker": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized [E1]actin[/E1] and the flux of actin subunits through filaments are controlled by [E2]profilin[/E2] and free filament barbed ends through their interaction with ATP.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p9", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to [E2]E-cadherin[/E2], alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[104, 114]], "entity_2_idx_in_text_with_entity_marker": [117, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p10", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to E-cadherin, [E2]alpha-catenin[/E2], and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p11", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to E-cadherin, alpha-catenin, and [E2]gamma-catenin[/E2] and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p0", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of [E1]actin[/E1]-anchoring proteins vinculin, talin and [E2]paxillin[/E2] in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p1", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of [E1]actin[/E1]-anchoring proteins vinculin, [E2]talin[/E2] and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p2", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of [E1]actin[/E1]-anchoring proteins [E2]vinculin[/E2], talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[62, 70]], "entity_2_idx_in_text_with_entity_marker": [75, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p0", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of [E1]VEGF-receptor-2[/E1] (flk-1/KDR) tyrosine-autophosphorylation by [E2]VEGF[/E2] which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VEGF-receptor-2", "entity_1_idx": [[52, 67]], "entity_1_idx_in_text_with_entity_marker": [56, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p3", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/[E1]KDR[/E1]) tyrosine-autophosphorylation by [E2]VEGF[/E2] which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "KDR", "entity_1_idx": [[75, 78]], "entity_1_idx_in_text_with_entity_marker": [79, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p4", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 ([E1]flk-1[/E1]/KDR) tyrosine-autophosphorylation by [E2]VEGF[/E2] which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "flk-1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d179.s0_BioInfer.d179.s0.p2", "text": "Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.", "text_with_entity_marker": "Double mutants containing N-terminal domain deletions of both [E1]histone[/E1] [E2]H3[/E2] and histone H4 were inviable.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[62, 69]], "entity_1_idx_in_text_with_entity_marker": [66, 73], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[70, 72]], "entity_2_idx_in_text_with_entity_marker": [83, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d179.s0_BioInfer.d179.s0.p3", "text": "Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.", "text_with_entity_marker": "Double mutants containing N-terminal domain deletions of both histone H3 and [E1]histone[/E1] [E2]H4[/E2] were inviable.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[77, 84]], "entity_1_idx_in_text_with_entity_marker": [81, 88], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[85, 87]], "entity_2_idx_in_text_with_entity_marker": [98, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d756.s0_BioInfer.d756.s0.p1", "text": "Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.", "text_with_entity_marker": "Thus, poly-L-proline binding, [E1]actin[/E1] binding, and actin nucleotide exchange are each independent requirements for [E2]profilin[/E2] function in fission yeast.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[113, 121]], "entity_2_idx_in_text_with_entity_marker": [126, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d756.s0_BioInfer.d756.s0.p2", "text": "Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.", "text_with_entity_marker": "Thus, poly-L-proline binding, actin binding, and [E1]actin[/E1] nucleotide exchange are each independent requirements for [E2]profilin[/E2] function in fission yeast.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[113, 121]], "entity_2_idx_in_text_with_entity_marker": [126, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p4", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of [E1]V12Ras[/E1] into keratinocytes promotes the loss of [E2]E-cadherin[/E2] and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "V12Ras", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p5", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of [E1]V12Ras[/E1] into keratinocytes promotes the loss of E-cadherin and [E2]alpha-catenin[/E2] and relocalization of beta-catenin to the cytoplasm and nucleus.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "V12Ras", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d831.s0_BioInfer.d831.s0.p2", "text": "While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.", "text_with_entity_marker": "While levels of most of these proteins decrease, accumulation of cyclin D1 and the [E1]cyclin-dependent kinase inhibitor[/E1] p21 Cip1/[E2]WAF1[/E2] is observed.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[83, 116]], "entity_1_idx_in_text_with_entity_marker": [87, 120], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "WAF1", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d831.s0_BioInfer.d831.s0.p5", "text": "While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.", "text_with_entity_marker": "While levels of most of these proteins decrease, accumulation of cyclin D1 and the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2] Cip1/WAF1 is observed.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[83, 116]], "entity_1_idx_in_text_with_entity_marker": [87, 120], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d831.s0_BioInfer.d831.s0.p9", "text": "While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.", "text_with_entity_marker": "While levels of most of these proteins decrease, accumulation of cyclin D1 and the [E1]cyclin-dependent kinase inhibitor[/E1] p21 [E2]Cip1[/E2]/WAF1 is observed.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[83, 116]], "entity_1_idx_in_text_with_entity_marker": [87, 120], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cip1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p4", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and H4 and the transcription factor [E2]p53[/E2], and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p10", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that [E1]histone[/E1] [E2]H3[/E2] is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[159, 161]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p22", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the [E1]histone[/E1] [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[198, 205]], "entity_1_idx_in_text_with_entity_marker": [202, 209], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p30", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and [E2]H4[/E2] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[89, 91]], "entity_2_idx_in_text_with_entity_marker": [102, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p32", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] H3 and [E2]H4[/E2] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[89, 91]], "entity_2_idx_in_text_with_entity_marker": [102, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p35", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones [E2]H3[/E2] and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[82, 84]], "entity_2_idx_in_text_with_entity_marker": [95, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p39", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] [E2]H3[/E2] and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[82, 84]], "entity_2_idx_in_text_with_entity_marker": [95, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d448.s0_BioInfer.d448.s0.p0", "text": "Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.", "text_with_entity_marker": "[E1]Myo2p[/E1] shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myo2p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d448.s0_BioInfer.d448.s0.p2", "text": "Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.", "text_with_entity_marker": "[E1]Myo2p[/E1] shows homology to the head domains and the coiledcoil tail of the conventional [E2]type II myosin heavy chain[/E2] and carries putative binding sites for ATP and actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myo2p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type II myosin heavy chain", "entity_2_idx": [[85, 111]], "entity_2_idx_in_text_with_entity_marker": [98, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d283.s0_BioInfer.d283.s0.p0", "text": "Human platelets contain profilin, a potential regulator of actin polymerisability.", "text_with_entity_marker": "Human platelets contain [E1]profilin[/E1], a potential regulator of [E2]actin[/E2] polymerisability.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[24, 32]], "entity_1_idx_in_text_with_entity_marker": [28, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[59, 64]], "entity_2_idx_in_text_with_entity_marker": [72, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s0_BioInfer.d169.s0.p0", "text": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.", "text_with_entity_marker": "Depending on the nature of the divalent cation, recombinant plant (birch) [E1]profilin[/E1] exhibited two different modes of interaction with [E2]actin[/E2], like mammalian profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[74, 82]], "entity_1_idx_in_text_with_entity_marker": [78, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s0_BioInfer.d169.s0.p1", "text": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.", "text_with_entity_marker": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with [E1]actin[/E1], like mammalian [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[155, 163]], "entity_2_idx_in_text_with_entity_marker": [168, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p0", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch profilin promoted the polymerization of [E1]actin[/E1] from [E2]A[/E2]:Tbeta4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A", "entity_2_idx": [[91, 92]], "entity_2_idx_in_text_with_entity_marker": [104, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p3", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch [E1]profilin[/E1] promoted the polymerization of [E2]actin[/E2] from A:Tbeta4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p4", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch profilin promoted the polymerization of [E1]actin[/E1] from A:[E2]Tbeta4[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p2", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote [E1]actin[/E1] polymerization from the actin:[E2]thymosin[/E2] beta4 and beta9 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin", "entity_2_idx": [[111, 119], [130, 135]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p3", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the [E1]actin[/E1]:[E2]thymosin[/E2] beta4 and beta9 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin", "entity_2_idx": [[111, 119], [130, 135]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p5", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) [E1]profilin[/E1] was analyzed for its ability to promote [E2]actin[/E2] polymerization from the actin:thymosin beta4 and beta9 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p7", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote [E1]actin[/E1] polymerization from the actin:[E2]thymosin beta4[/E2] and beta9 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[111, 125]], "entity_2_idx_in_text_with_entity_marker": [124, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p8", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the [E1]actin[/E1]:[E2]thymosin beta4[/E2] and beta9 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[111, 125]], "entity_2_idx_in_text_with_entity_marker": [124, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s0_BioInfer.d59.s0.p0", "text": "Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that cofilin was cross-linked with the N-terminal segment of actin containing residues 1-12.", "text_with_entity_marker": "Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that [E1]cofilin[/E1] was cross-linked with the N-terminal segment of [E2]actin[/E2] containing residues 1-12.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p0", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the [E1]cofilin[/E1]-binding site in the [E2]actin[/E2] sequence.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[120, 127]], "entity_1_idx_in_text_with_entity_marker": [124, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p5", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of [E1]cofilin[/E1], a 21,000 molecular weight [E2]actin-binding protein[/E2], from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[51, 72]], "entity_2_idx_in_text_with_entity_marker": [64, 85], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d238.s0_BioInfer.d238.s0.p0", "text": "Here we demonstrate that accessory receptor triggering induces the transient association of cofilin with the actin cytoskeleton.", "text_with_entity_marker": "Here we demonstrate that accessory receptor triggering induces the transient association of [E1]cofilin[/E1] with the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d238.s1_BioInfer.d238.s1.p0", "text": "Recently, we have shown that the small actin-depolymerizing protein cofilin represents a component of a co-stimulatory signaling pathway in human T cells.", "text_with_entity_marker": "Recently, we have shown that the small [E1]actin[/E1]-depolymerizing protein [E2]cofilin[/E2] represents a component of a co-stimulatory signaling pathway in human T cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[68, 75]], "entity_2_idx_in_text_with_entity_marker": [81, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d238.s2_BioInfer.d238.s2.p0", "text": "These results suggest that cofilin provides an as yet missing link between functionally crucial T cell surface receptors and rearrangements of the actin cytoskeleton.", "text_with_entity_marker": "These results suggest that [E1]cofilin[/E1] provides an as yet missing link between functionally crucial T cell surface receptors and rearrangements of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d723.s0_BioInfer.d723.s0.p0", "text": "The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "text_with_entity_marker": "The structural homology between cofilin and [E1]gelsolin[/E1] segment-1 binding to [E2]actin[/E2] was confirmed experimentally by two types of competitive binding assays.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d723.s0_BioInfer.d723.s0.p1", "text": "The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "text_with_entity_marker": "The structural homology between [E1]cofilin[/E1] and gelsolin segment-1 binding to [E2]actin[/E2] was confirmed experimentally by two types of competitive binding assays.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d723.s0_BioInfer.d723.s0.p2", "text": "The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "text_with_entity_marker": "The structural homology between [E1]cofilin[/E1] and [E2]gelsolin[/E2] segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[44, 52]], "entity_2_idx_in_text_with_entity_marker": [57, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p2", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ beta-catenin or [E1]E-cadherin[/E1]/[E2]plakoglobin[/E2] complexes to the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[61, 71]], "entity_1_idx_in_text_with_entity_marker": [65, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[72, 83]], "entity_2_idx_in_text_with_entity_marker": [85, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p3", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ beta-catenin or [E2]E-cadherin[/E2]/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[61, 71]], "entity_2_idx_in_text_with_entity_marker": [74, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p4", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ beta-catenin or [E1]E-cadherin[/E1]/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[61, 71]], "entity_1_idx_in_text_with_entity_marker": [65, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p5", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links [E1]E-cadherin[/E1]/ [E2]beta-catenin[/E2] or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[33, 43]], "entity_1_idx_in_text_with_entity_marker": [37, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[45, 57]], "entity_2_idx_in_text_with_entity_marker": [58, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p7", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ [E2]beta-catenin[/E2] or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[45, 57]], "entity_2_idx_in_text_with_entity_marker": [58, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p8", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ [E1]beta-catenin[/E1] or E-cadherin/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[45, 57]], "entity_1_idx_in_text_with_entity_marker": [49, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p10", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links [E2]E-cadherin[/E2]/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[33, 43]], "entity_2_idx_in_text_with_entity_marker": [46, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p11", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links [E1]E-cadherin[/E1]/ beta-catenin or E-cadherin/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[33, 43]], "entity_1_idx_in_text_with_entity_marker": [37, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p12", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ beta-catenin or E-cadherin/[E2]plakoglobin[/E2] complexes to the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[72, 83]], "entity_2_idx_in_text_with_entity_marker": [85, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p13", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/[E1]plakoglobin[/E1] complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[72, 83]], "entity_1_idx_in_text_with_entity_marker": [76, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p0", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p1", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [190, 192]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p2", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [183, 185]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p5", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the [E2]rad52-20[/E2] allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rad52-20", "entity_2_idx": [[154, 162]], "entity_2_idx_in_text_with_entity_marker": [167, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p18", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[56, 61]], "entity_2_idx_in_text_with_entity_marker": [69, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p10", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p11", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p12", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p13", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p14", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p15", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E1]paxillin[/E1] and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[232, 240]], "entity_1_idx_in_text_with_entity_marker": [236, 244], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p16", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p17", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and [E1]alpha-actinin[/E1] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-actinin", "entity_1_idx": [[137, 150]], "entity_1_idx_in_text_with_entity_marker": [141, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p18", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, [E1]vinculin[/E1] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p19", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d110.s0_BioInfer.d110.s0.p0", "text": "Both complexes are composed of N-cadherin and alpha-catenin which bind to either beta-catenin or plakoglobin in a mutually exclusive manner.", "text_with_entity_marker": "Both complexes are composed of N-cadherin and [E1]alpha-catenin[/E1] which bind to either [E2]beta-catenin[/E2] or plakoglobin in a mutually exclusive manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[81, 93]], "entity_2_idx_in_text_with_entity_marker": [94, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d110.s0_BioInfer.d110.s0.p2", "text": "Both complexes are composed of N-cadherin and alpha-catenin which bind to either beta-catenin or plakoglobin in a mutually exclusive manner.", "text_with_entity_marker": "Both complexes are composed of [E1]N-cadherin[/E1] and alpha-catenin which bind to either [E2]beta-catenin[/E2] or plakoglobin in a mutually exclusive manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[31, 41]], "entity_1_idx_in_text_with_entity_marker": [35, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[81, 93]], "entity_2_idx_in_text_with_entity_marker": [94, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d110.s0_BioInfer.d110.s0.p3", "text": "Both complexes are composed of N-cadherin and alpha-catenin which bind to either beta-catenin or plakoglobin in a mutually exclusive manner.", "text_with_entity_marker": "Both complexes are composed of N-cadherin and [E1]alpha-catenin[/E1] which bind to either beta-catenin or [E2]plakoglobin[/E2] in a mutually exclusive manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[97, 108]], "entity_2_idx_in_text_with_entity_marker": [110, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d110.s0_BioInfer.d110.s0.p4", "text": "Both complexes are composed of N-cadherin and alpha-catenin which bind to either beta-catenin or plakoglobin in a mutually exclusive manner.", "text_with_entity_marker": "Both complexes are composed of [E1]N-cadherin[/E1] and [E2]alpha-catenin[/E2] which bind to either beta-catenin or plakoglobin in a mutually exclusive manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[31, 41]], "entity_1_idx_in_text_with_entity_marker": [35, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[46, 59]], "entity_2_idx_in_text_with_entity_marker": [59, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d110.s0_BioInfer.d110.s0.p5", "text": "Both complexes are composed of N-cadherin and alpha-catenin which bind to either beta-catenin or plakoglobin in a mutually exclusive manner.", "text_with_entity_marker": "Both complexes are composed of [E1]N-cadherin[/E1] and alpha-catenin which bind to either beta-catenin or [E2]plakoglobin[/E2] in a mutually exclusive manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[31, 41]], "entity_1_idx_in_text_with_entity_marker": [35, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[97, 108]], "entity_2_idx_in_text_with_entity_marker": [110, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p0", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[188, 200]], "entity_1_idx_in_text_with_entity_marker": [192, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p1", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[173, 186]], "entity_1_idx_in_text_with_entity_marker": [177, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[188, 200]], "entity_2_idx_in_text_with_entity_marker": [201, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p2", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E1]E-cadherin[/E1] and its cytoplasmic cofactors alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[132, 142]], "entity_1_idx_in_text_with_entity_marker": [136, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[188, 200]], "entity_2_idx_in_text_with_entity_marker": [201, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p5", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[173, 186]], "entity_1_idx_in_text_with_entity_marker": [177, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p6", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E1]E-cadherin[/E1] and its cytoplasmic cofactors alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[132, 142]], "entity_1_idx_in_text_with_entity_marker": [136, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p9", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E1]E-cadherin[/E1] and its cytoplasmic cofactors [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[132, 142]], "entity_1_idx_in_text_with_entity_marker": [136, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d683.s0_BioInfer.d683.s0.p0", "text": "The recombinant material is similar to authentic human platelet profilin based on the measured Kd for rabbit skeletal muscle actin.", "text_with_entity_marker": "The recombinant material is similar to authentic human [E1]platelet profilin[/E1] based on the measured Kd for rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "platelet profilin", "entity_1_idx": [[55, 72]], "entity_1_idx_in_text_with_entity_marker": [59, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[109, 130]], "entity_2_idx_in_text_with_entity_marker": [122, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p0", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1]cortexillin I[/E1] or II, two isoforms of the actin-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cortexillin I", "entity_1_idx": [[160, 173]], "entity_1_idx_in_text_with_entity_marker": [164, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p2", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1]cortexillin[/E1] I or II, two isoforms of the actin-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cortexillin", "entity_1_idx": [[160, 171], [177, 179]], "entity_1_idx_in_text_with_entity_marker": [164, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p3", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the [E1]actin[/E1]-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p11", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of [E1]talin[/E1], a protein that couples the [E2]actin[/E2] network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[104, 109]], "entity_2_idx_in_text_with_entity_marker": [117, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p0", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus [E1]helicase-primase[/E1] complex, a heterotrimer of the [E2]UL5[/E2], UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[25, 41]], "entity_1_idx_in_text_with_entity_marker": [29, 45], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[73, 76]], "entity_2_idx_in_text_with_entity_marker": [86, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p1", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus helicase-primase complex, a heterotrimer of the [E1]UL5[/E1], [E2]UL8[/E2], and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p2", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus helicase-primase complex, a heterotrimer of the [E1]UL5[/E1], UL8, and [E2]UL52[/E2] proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p3", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus [E1]helicase-primase[/E1] complex, a heterotrimer of the UL5, [E2]UL8[/E2], and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[25, 41]], "entity_1_idx_in_text_with_entity_marker": [29, 45], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p4", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus [E1]helicase-primase[/E1] complex, a heterotrimer of the UL5, UL8, and [E2]UL52[/E2] proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[25, 41]], "entity_1_idx_in_text_with_entity_marker": [29, 45], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p5", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, [E1]UL8[/E1], and [E2]UL52[/E2] proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s0_BioInfer.d81.s0.p0", "text": "As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "text_with_entity_marker": "As expected from immunofluorescence experiments, Abp1p, [E1]cofilin[/E1], and [E2]actin[/E2] colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s0_BioInfer.d81.s0.p1", "text": "As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "text_with_entity_marker": "As expected from immunofluorescence experiments, [E1]Abp1p[/E1], [E2]cofilin[/E2], and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s0_BioInfer.d81.s0.p2", "text": "As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "text_with_entity_marker": "As expected from immunofluorescence experiments, [E1]Abp1p[/E1], cofilin, and [E2]actin[/E2] colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p0", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the [E1]actin binding proteins[/E1] Abp1p and [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin binding proteins", "entity_1_idx": [[110, 132]], "entity_1_idx_in_text_with_entity_marker": [114, 136], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[143, 150]], "entity_2_idx_in_text_with_entity_marker": [156, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d325.s0_BioInfer.d325.s0.p7", "text": "In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.", "text_with_entity_marker": "In contrast, [E1]talin[/E1], another putative [E2]actin[/E2]-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[37, 42]], "entity_2_idx_in_text_with_entity_marker": [50, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p0", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use FADD, TRADD, and [E2]RIP[/E2] in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p1", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use FADD, [E2]TRADD[/E2], and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p3", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use [E2]FADD[/E2], TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p6", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use FADD, TRADD, and [E2]RIP[/E2] in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p9", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use FADD, [E2]TRADD[/E2], and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p12", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use [E2]FADD[/E2], TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d463.s0_BioInfer.d463.s0.p2", "text": "One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "text_with_entity_marker": "One such protein is the yeast actin-binding protein [E1]Sac6p[/E1], which is homologous to vertebrate [E2]fimbrin[/E2] (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Sac6p", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[93, 100]], "entity_2_idx_in_text_with_entity_marker": [106, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d796.s0_BioInfer.d796.s0.p1", "text": "We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.", "text_with_entity_marker": "We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in [E1]rhp51[/E1] and rhp54 (homologues of S.cerevisiae [E2]RAD51[/E2] and RAD54, respectively) are not affected.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rhp51", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[191, 196]], "entity_2_idx_in_text_with_entity_marker": [204, 209], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d796.s0_BioInfer.d796.s0.p5", "text": "We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.", "text_with_entity_marker": "We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and [E1]rhp54[/E1] (homologues of S.cerevisiae RAD51 and [E2]RAD54[/E2], respectively) are not affected.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rhp54", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d499.s0_BioInfer.d499.s0.p0", "text": "Protein phosphorylation of cofilin, an actin-binding protein that depolymerizes actin filaments, suppresses its function.", "text_with_entity_marker": "Protein phosphorylation of [E1]cofilin[/E1], an [E2]actin-binding protein[/E2] that depolymerizes actin filaments, suppresses its function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[39, 60]], "entity_2_idx_in_text_with_entity_marker": [52, 73], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d499.s0_BioInfer.d499.s0.p1", "text": "Protein phosphorylation of cofilin, an actin-binding protein that depolymerizes actin filaments, suppresses its function.", "text_with_entity_marker": "Protein phosphorylation of [E1]cofilin[/E1], an actin-binding protein that depolymerizes [E2]actin[/E2] filaments, suppresses its function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p1", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in [E1]beta-catenin[/E1] binding to [E2]cadherin[/E2] or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[11, 23]], "entity_1_idx_in_text_with_entity_marker": [15, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[35, 43]], "entity_2_idx_in_text_with_entity_marker": [48, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p4", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in [E1]beta-catenin[/E1] binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[11, 23]], "entity_1_idx_in_text_with_entity_marker": [15, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p5", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of [E1]beta-catenin[/E1] binding to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[136, 148]], "entity_1_idx_in_text_with_entity_marker": [140, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s1_BioInfer.d134.s1.p14", "text": "Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.", "text_with_entity_marker": "Full-length [E1]beta-catenin[/E1], beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the [E2]alpha-catenin[/E2] binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d105.s0_BioInfer.d105.s0.p0", "text": "Neuropilin-1 is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (VEGF), a potent regulator for vasculogenesis and angiogenesis.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] is also expressed in endothelial cells and shown to bind vascular endothelial growth factor ([E2]VEGF[/E2]), a potent regulator for vasculogenesis and angiogenesis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[106, 110]], "entity_2_idx_in_text_with_entity_marker": [119, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d105.s0_BioInfer.d105.s0.p2", "text": "Neuropilin-1 is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (VEGF), a potent regulator for vasculogenesis and angiogenesis.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] is also expressed in endothelial cells and shown to bind [E2]vascular endothelial growth factor[/E2] (VEGF), a potent regulator for vasculogenesis and angiogenesis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[70, 104]], "entity_2_idx_in_text_with_entity_marker": [83, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d705.s0_BioInfer.d705.s0.p0", "text": "The sequence of the inhibitory region is similar to that of a beta-hairpin region of the actin-binding protein profilin.", "text_with_entity_marker": "The sequence of the inhibitory region is similar to that of a beta-hairpin region of the [E1]actin-binding protein[/E1] [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[89, 110]], "entity_1_idx_in_text_with_entity_marker": [93, 114], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[111, 119]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p20", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, [E2]nucleocapsid[/E2] (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[155, 167], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [168, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p21", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p22", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p23", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein ([E2]P[/E2]), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[148, 149]], "entity_2_idx_in_text_with_entity_marker": [161, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p24", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p25", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] ([E2]P[/E2]), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[148, 149]], "entity_2_idx_in_text_with_entity_marker": [161, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p26", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), [E1]H[/E1], nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[152, 153], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [156, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p27", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p28", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid ([E1]N[/E1]) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[169, 170]], "entity_1_idx_in_text_with_entity_marker": [173, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p29", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s2_BioInfer.d650.s2.p0", "text": "With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "text_with_entity_marker": "With [E1]profilins[/E1], whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with [E2]actin[/E2] alone ([Acc], critical concentration of polymerization).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins", "entity_1_idx": [[5, 14]], "entity_1_idx_in_text_with_entity_marker": [9, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s2_BioInfer.d650.s2.p1", "text": "With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "text_with_entity_marker": "With [E1]profilins[/E1], whose sequestering activity was low, the concentration of free [E2]actin[/E2] monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins", "entity_1_idx": [[5, 14]], "entity_1_idx_in_text_with_entity_marker": [9, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s2_BioInfer.d650.s2.p2", "text": "With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "text_with_entity_marker": "With profilins, whose sequestering activity was low, the concentration of free [E1]actin[/E1] monomers observed at steady-state of polymerization [Afree], was close to that seen with [E2]actin[/E2] alone ([Acc], critical concentration of polymerization).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[79, 84]], "entity_1_idx_in_text_with_entity_marker": [83, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p0", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of [E1]actin[/E1] or myosin and of [E2]myosin heavy chain[/E2] (MHC) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[98, 116]], "entity_2_idx_in_text_with_entity_marker": [111, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p1", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of [E1]actin[/E1] or [E2]myosin[/E2] and of myosin heavy chain (MHC) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[84, 90]], "entity_2_idx_in_text_with_entity_marker": [97, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p2", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of [E1]actin[/E1] or myosin and of myosin heavy chain ([E2]MHC[/E2]) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MHC", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p3", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of actin or [E1]myosin[/E1] and of [E2]myosin heavy chain[/E2] (MHC) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[98, 116]], "entity_2_idx_in_text_with_entity_marker": [111, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p4", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[98, 116]], "entity_1_idx_in_text_with_entity_marker": [102, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p5", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of actin or [E1]myosin[/E1] and of myosin heavy chain ([E2]MHC[/E2]) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MHC", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p10", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and [E2]18S rRNA[/E2], actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S rRNA", "entity_2_idx": [[48, 56]], "entity_2_idx_in_text_with_entity_marker": [61, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p11", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, [E2]profilins Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p12", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p13", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, [E2]actin I[/E2], profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin I", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p14", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, [E2]profilins[/E2] Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[67, 76], [86, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p15", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p16", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, [E2]profilins I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [80, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p17", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p18", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p19", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, [E2]profilins Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p0", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p1", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p2", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p3", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p4", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p5", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p6", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, [E2]RAD53[/E2], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p7", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, [E2]DDC2[/E2] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DDC2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p8", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], [E2]DDC2[/E2] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DDC2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p9", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, [E2]DDC2[/E2] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DDC2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d549.s0_BioInfer.d549.s0.p0", "text": "Spontaneous and mitomycin C-induced SCE levels were significantly reduced for chicken DT40 B cells lacking the key HR genes RAD51 and RAD54 but not for nonhomologous DNA end-joining (NHEJ)-defective KU70(-/-) cells.", "text_with_entity_marker": "Spontaneous and mitomycin C-induced SCE levels were significantly reduced for chicken DT40 B cells lacking the key HR genes [E1]RAD51[/E1] and [E2]RAD54[/E2] but not for nonhomologous DNA end-joining (NHEJ)-defective KU70(-/-) cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d256.s0_BioInfer.d256.s0.p0", "text": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "text_with_entity_marker": "Here, we sought to determine the spatial distributions of [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[85, 97]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d256.s0_BioInfer.d256.s0.p1", "text": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "text_with_entity_marker": "Here, we sought to determine the spatial distributions of E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[70, 83]], "entity_1_idx_in_text_with_entity_marker": [74, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[85, 97]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d256.s0_BioInfer.d256.s0.p2", "text": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "text_with_entity_marker": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2], and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[85, 97]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[103, 114]], "entity_2_idx_in_text_with_entity_marker": [116, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d256.s0_BioInfer.d256.s0.p3", "text": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "text_with_entity_marker": "Here, we sought to determine the spatial distributions of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[70, 83]], "entity_2_idx_in_text_with_entity_marker": [83, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d256.s0_BioInfer.d256.s0.p4", "text": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "text_with_entity_marker": "Here, we sought to determine the spatial distributions of [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2], and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[103, 114]], "entity_2_idx_in_text_with_entity_marker": [116, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d256.s0_BioInfer.d256.s0.p5", "text": "Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "text_with_entity_marker": "Here, we sought to determine the spatial distributions of E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2], and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[70, 83]], "entity_1_idx_in_text_with_entity_marker": [74, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[103, 114]], "entity_2_idx_in_text_with_entity_marker": [116, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p30", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p31", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p32", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p33", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p34", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p35", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p36", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E1]matrix[/E1] (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[301, 307], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [305, 311], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p37", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p38", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p39", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d449.s1_BioInfer.d449.s1.p0", "text": "alpha-Skeletal actin and fast myosin heavy chain mRNAs were detected precociously, before the young myotube stage.", "text_with_entity_marker": "[E1]alpha-Skeletal actin[/E1] and [E2]fast myosin heavy chain[/E2] mRNAs were detected precociously, before the young myotube stage.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-Skeletal actin", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fast myosin heavy chain", "entity_2_idx": [[25, 48]], "entity_2_idx_in_text_with_entity_marker": [38, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s1_BioInfer.d265.s1.p0", "text": "In particular, both profilin and free filament barbed ends have been shown to play major roles in the processing of ATP by actin.", "text_with_entity_marker": "In particular, both [E1]profilin[/E1] and free filament barbed ends have been shown to play major roles in the processing of ATP by [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p40", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p41", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p42", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p43", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p44", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E1]desmin[/E1] and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[175, 181]], "entity_1_idx_in_text_with_entity_marker": [179, 185], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p45", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p46", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p47", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p48", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p49", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p0", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of alpha-catenin, [E1]beta-catenin[/E1], and gamma-catenin is related to histological type and differentiation in NSCLC, although [E2]catenins[/E2] have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[149, 157]], "entity_2_idx_in_text_with_entity_marker": [162, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p1", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and [E1]gamma-catenin[/E1] is related to histological type and differentiation in NSCLC, although [E2]catenins[/E2] have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[64, 77]], "entity_1_idx_in_text_with_entity_marker": [68, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[149, 157]], "entity_2_idx_in_text_with_entity_marker": [162, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p2", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of [E1]alpha-catenin[/E1], beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although [E2]catenins[/E2] have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[149, 157]], "entity_2_idx_in_text_with_entity_marker": [162, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p3", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p4", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p5", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s1_BioInfer.d150.s1.p0", "text": "Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "text_with_entity_marker": "Reduced expression of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[55, 68]], "entity_2_idx_in_text_with_entity_marker": [68, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s1_BioInfer.d150.s1.p1", "text": "Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "text_with_entity_marker": "Reduced expression of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[55, 68]], "entity_2_idx_in_text_with_entity_marker": [68, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s1_BioInfer.d150.s1.p2", "text": "Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "text_with_entity_marker": "Reduced expression of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[37, 49]], "entity_2_idx_in_text_with_entity_marker": [50, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p0", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid [E1]myosin[/E1]: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten [E2]myosin heavy chain[/E2], and Cys-374 of actin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[178, 196]], "entity_2_idx_in_text_with_entity_marker": [191, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p1", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten [E1]myosin heavy chain[/E1], and Cys-374 of [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[178, 196]], "entity_1_idx_in_text_with_entity_marker": [182, 200], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p2", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria [E1]regulatory light chain[/E1], SH-1 on the Aequipecten [E2]myosin heavy chain[/E2], and Cys-374 of actin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "regulatory light chain", "entity_1_idx": [[130, 152]], "entity_1_idx_in_text_with_entity_marker": [134, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[178, 196]], "entity_2_idx_in_text_with_entity_marker": [191, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p3", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid [E1]myosin[/E1]: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p4", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid [E1]myosin[/E1]: those between Cys-55 on the Mercenaria [E2]regulatory light chain[/E2], SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "regulatory light chain", "entity_2_idx": [[130, 152]], "entity_2_idx_in_text_with_entity_marker": [143, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p5", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria [E1]regulatory light chain[/E1], SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "regulatory light chain", "entity_1_idx": [[130, 152]], "entity_1_idx_in_text_with_entity_marker": [134, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p0", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p1", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p2", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p3", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p4", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p5", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E1]H[/E1], F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[153, 154], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [157, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p6", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E1]NP[/E1] and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[159, 161], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [163, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p7", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p8", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E1]F[/E1], [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[156, 157], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [160, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p9", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p30", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p31", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p32", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), [E2]fusion[/E2] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[57, 63], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p33", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p34", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p35", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p36", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p37", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p38", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p39", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p90", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p10", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E1]srs2[/E1] rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2", "entity_1_idx": [[200, 204]], "entity_1_idx_in_text_with_entity_marker": [204, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p11", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p12", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p13", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E1]MEC3[/E1], indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p14", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p15", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p16", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p17", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p18", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p19", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E1]rad54[/E1] and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p40", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p41", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p42", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p43", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E1]MEC3[/E1], indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p44", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E1]MEC3[/E1], indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p45", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E2]RAD17[/E2], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p46", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E2]RAD17[/E2], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p47", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E2]RAD17[/E2], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p48", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E2]RAD17[/E2], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p49", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s0_BioInfer.d419.s0.p0", "text": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "text_with_entity_marker": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of [E1]adenosine kinase[/E1]), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the [E2]A1 adenosine receptor[/E2] binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "adenosine kinase", "entity_1_idx": [[93, 109]], "entity_1_idx_in_text_with_entity_marker": [97, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[283, 304]], "entity_2_idx_in_text_with_entity_marker": [296, 317], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s0_BioInfer.d419.s0.p1", "text": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "text_with_entity_marker": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of [E1]adenosine deaminase[/E1]), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the [E2]A1 adenosine receptor[/E2] binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "adenosine deaminase", "entity_1_idx": [[172, 191]], "entity_1_idx_in_text_with_entity_marker": [176, 195], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[283, 304]], "entity_2_idx_in_text_with_entity_marker": [296, 317], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s0_BioInfer.d419.s0.p2", "text": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "text_with_entity_marker": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of [E1]adenosine kinase[/E1]), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of [E2]adenosine deaminase[/E2]), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "adenosine kinase", "entity_1_idx": [[93, 109]], "entity_1_idx_in_text_with_entity_marker": [97, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "adenosine deaminase", "entity_2_idx": [[172, 191]], "entity_2_idx_in_text_with_entity_marker": [185, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s1_BioInfer.d419.s1.p0", "text": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the A1 adenosine receptor.", "text_with_entity_marker": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the [E1]A1 adenosine receptor[/E1] antagonist 8-cyclopentyltheophylline and [E2]adenosine deaminase[/E2], implicating endogenous adenosine acting at the A1 adenosine receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A1 adenosine receptor", "entity_1_idx": [[81, 102]], "entity_1_idx_in_text_with_entity_marker": [85, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "adenosine deaminase", "entity_2_idx": [[144, 163]], "entity_2_idx_in_text_with_entity_marker": [157, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s1_BioInfer.d419.s1.p1", "text": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the A1 adenosine receptor.", "text_with_entity_marker": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and [E1]adenosine deaminase[/E1], implicating endogenous adenosine acting at the [E2]A1 adenosine receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "adenosine deaminase", "entity_1_idx": [[144, 163]], "entity_1_idx_in_text_with_entity_marker": [148, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[212, 233]], "entity_2_idx_in_text_with_entity_marker": [225, 246], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s1_BioInfer.d419.s1.p2", "text": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the A1 adenosine receptor.", "text_with_entity_marker": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the [E1]A1 adenosine receptor[/E1] antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the [E2]A1 adenosine receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A1 adenosine receptor", "entity_1_idx": [[81, 102]], "entity_1_idx_in_text_with_entity_marker": [85, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[212, 233]], "entity_2_idx_in_text_with_entity_marker": [225, 246], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p0", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, [E1]desmin[/E1], and SM myosin heavy chain isoforms, but not [E2]smoothelin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[145, 155]], "entity_2_idx_in_text_with_entity_marker": [158, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p1", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and [E1]SM myosin heavy chain[/E1] isoforms, but not [E2]smoothelin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[105, 126]], "entity_1_idx_in_text_with_entity_marker": [109, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[145, 155]], "entity_2_idx_in_text_with_entity_marker": [158, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p2", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed [E1]alpha-SM actin[/E1], desmin, and SM myosin heavy chain isoforms, but not [E2]smoothelin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-SM actin", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[145, 155]], "entity_2_idx_in_text_with_entity_marker": [158, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p3", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, [E1]desmin[/E1], and [E2]SM myosin heavy chain[/E2] isoforms, but not smoothelin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[105, 126]], "entity_2_idx_in_text_with_entity_marker": [118, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p4", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed [E1]alpha-SM actin[/E1], [E2]desmin[/E2], and SM myosin heavy chain isoforms, but not smoothelin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-SM actin", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p5", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed [E1]alpha-SM actin[/E1], desmin, and [E2]SM myosin heavy chain[/E2] isoforms, but not smoothelin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-SM actin", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[105, 126]], "entity_2_idx_in_text_with_entity_marker": [118, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p10", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p11", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p12", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p13", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p14", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p15", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p16", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p17", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p18", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and [E1]actin[/E1]) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p19", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d771.s0_BioInfer.d771.s0.p0", "text": "Total protein, myosin heavy chain (MHC), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "text_with_entity_marker": "Total protein, myosin heavy chain ([E1]MHC[/E1]), and [E2]actin[/E2] appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d771.s0_BioInfer.d771.s0.p1", "text": "Total protein, myosin heavy chain (MHC), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "text_with_entity_marker": "Total protein, [E1]myosin heavy chain[/E1] (MHC), and [E2]actin[/E2] appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[15, 33]], "entity_1_idx_in_text_with_entity_marker": [19, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d771.s0_BioInfer.d771.s0.p2", "text": "Total protein, myosin heavy chain (MHC), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "text_with_entity_marker": "Total protein, [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[15, 33]], "entity_1_idx_in_text_with_entity_marker": [19, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[35, 38]], "entity_2_idx_in_text_with_entity_marker": [48, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d120.s0_BioInfer.d120.s0.p0", "text": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or UL52 gene used as control.", "text_with_entity_marker": "By the use of HSV mutants for the [E1]UL9[/E1] gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the [E2]UL8[/E2] or UL52 gene used as control.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d120.s0_BioInfer.d120.s0.p1", "text": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or UL52 gene used as control.", "text_with_entity_marker": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the [E1]UL8[/E1] or [E2]UL52[/E2] gene used as control.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[197, 201]], "entity_2_idx_in_text_with_entity_marker": [210, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d120.s0_BioInfer.d120.s0.p2", "text": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or UL52 gene used as control.", "text_with_entity_marker": "By the use of HSV mutants for the [E1]UL9[/E1] gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or [E2]UL52[/E2] gene used as control.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[197, 201]], "entity_2_idx_in_text_with_entity_marker": [210, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p20", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p21", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p22", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p23", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p24", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p25", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p26", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p27", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p28", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p29", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p0", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed [E1]UL5[/E1], UL8, [E2]UL9[/E2], and UL52 in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p1", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed [E1]UL5[/E1], [E2]UL8[/E2], UL9, and UL52 in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[71, 74]], "entity_2_idx_in_text_with_entity_marker": [84, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p2", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed [E1]UL5[/E1], UL8, UL9, and [E2]UL52[/E2] in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p3", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed UL5, [E1]UL8[/E1], [E2]UL9[/E2], and UL52 in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p4", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed UL5, UL8, [E1]UL9[/E1], and [E2]UL52[/E2] in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p5", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed UL5, [E1]UL8[/E1], UL9, and [E2]UL52[/E2] in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p0", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins (UL5, [E1]UL8[/E1], UL9, and [E2]UL52[/E2]) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p1", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins (UL5, UL8, [E1]UL9[/E1], and [E2]UL52[/E2]) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p2", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins ([E1]UL5[/E1], UL8, UL9, and [E2]UL52[/E2]) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p3", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins (UL5, [E1]UL8[/E1], [E2]UL9[/E2], and UL52) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p4", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins ([E1]UL5[/E1], [E2]UL8[/E2], UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[71, 74]], "entity_2_idx_in_text_with_entity_marker": [84, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p5", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins ([E1]UL5[/E1], UL8, [E2]UL9[/E2], and UL52) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d51.s0_BioInfer.d51.s0.p0", "text": "MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.", "text_with_entity_marker": "[E1]MSH2[/E1] plays a fundamental role in mispair recognition whereas MSH3 and [E2]MSH6[/E2] appear to modify the specificity of this recognition.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d51.s0_BioInfer.d51.s0.p1", "text": "MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.", "text_with_entity_marker": "[E1]MSH2[/E1] plays a fundamental role in mispair recognition whereas [E2]MSH3[/E2] and MSH6 appear to modify the specificity of this recognition.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d51.s0_BioInfer.d51.s0.p2", "text": "MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.", "text_with_entity_marker": "MSH2 plays a fundamental role in mispair recognition whereas [E1]MSH3[/E1] and [E2]MSH6[/E2] appear to modify the specificity of this recognition.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p0", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, [E1]smooth muscle myosin[/E1] (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin", "entity_1_idx": [[78, 98], [100, 111]], "entity_1_idx_in_text_with_entity_marker": [82, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p1", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, [E1]desmin[/E1], smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[70, 76]], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p2", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p3", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins [E1]vimentin[/E1] and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[139, 147]], "entity_1_idx_in_text_with_entity_marker": [143, 151], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p4", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p5", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, [E1]desmin[/E1], [E2]smooth muscle myosin[/E2] (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[70, 76]], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin", "entity_2_idx": [[78, 98], [100, 111]], "entity_2_idx_in_text_with_entity_marker": [91, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p6", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, desmin, [E2]smooth muscle myosin[/E2] (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin", "entity_2_idx": [[78, 98], [100, 111]], "entity_2_idx_in_text_with_entity_marker": [91, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p7", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, [E1]smooth muscle myosin[/E1] (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin", "entity_1_idx": [[78, 98], [100, 111]], "entity_1_idx_in_text_with_entity_marker": [82, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p8", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], desmin, [E2]smooth muscle myosin[/E2] (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin", "entity_2_idx": [[78, 98], [100, 111]], "entity_2_idx_in_text_with_entity_marker": [91, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p9", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, [E2]desmin[/E2], smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p10", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, [E1]desmin[/E1], smooth muscle myosin (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[70, 76]], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p11", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], [E2]desmin[/E2], smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p12", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p13", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], [E2]tropomyosin[/E2], desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[57, 68]], "entity_2_idx_in_text_with_entity_marker": [70, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p14", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p10", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E1]insulin[/E1] also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[250, 257]], "entity_1_idx_in_text_with_entity_marker": [254, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p11", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E1]somatomedin C[/E1], or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "somatomedin C", "entity_1_idx": [[222, 235]], "entity_1_idx_in_text_with_entity_marker": [226, 239], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p12", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E1]EGF[/E1]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EGF", "entity_1_idx": [[207, 210]], "entity_1_idx_in_text_with_entity_marker": [211, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p13", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p14", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E1]epidermal growth factor[/E1] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "epidermal growth factor", "entity_1_idx": [[182, 205]], "entity_1_idx_in_text_with_entity_marker": [186, 209], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p15", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p16", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p17", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E2]somatomedin C[/E2], or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "somatomedin C", "entity_2_idx": [[222, 235]], "entity_2_idx_in_text_with_entity_marker": [235, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p18", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E2]EGF[/E2]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGF", "entity_2_idx": [[207, 210]], "entity_2_idx_in_text_with_entity_marker": [220, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p19", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on [E2]talin[/E2], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s0_BioInfer.d232.s0.p0", "text": "Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles.", "text_with_entity_marker": "Genetic dissection of Drosophila myofibril formation: effects of [E1]actin[/E1] and [E2]myosin heavy chain[/E2] null alleles.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[75, 93]], "entity_2_idx_in_text_with_entity_marker": [88, 106], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p0", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or myosin heavy chain ([E1]Mhc36B[/E1]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Mhc36B", "entity_1_idx": [[69, 75]], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p1", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or [E1]myosin heavy chain[/E1] (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[49, 67]], "entity_1_idx_in_text_with_entity_marker": [53, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p2", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p3", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p4", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas [E1]Mhc36B[/E1]-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Mhc36B", "entity_1_idx": [[133, 139]], "entity_1_idx_in_text_with_entity_marker": [137, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p5", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or [E1]myosin heavy chain[/E1] ([E2]Mhc36B[/E2]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[49, 67]], "entity_1_idx_in_text_with_entity_marker": [53, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p6", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or myosin heavy chain ([E2]Mhc36B[/E2]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p7", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or myosin heavy chain ([E2]Mhc36B[/E2]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p8", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or myosin heavy chain ([E1]Mhc36B[/E1]) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Mhc36B", "entity_1_idx": [[69, 75]], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p9", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or [E2]myosin heavy chain[/E2] (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[49, 67]], "entity_2_idx_in_text_with_entity_marker": [62, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p10", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or [E2]myosin heavy chain[/E2] (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[49, 67]], "entity_2_idx_in_text_with_entity_marker": [62, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p11", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or [E1]myosin heavy chain[/E1] (Mhc36B) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[49, 67]], "entity_1_idx_in_text_with_entity_marker": [53, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p12", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] ([E2]Act88F[/E2]) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[38, 44]], "entity_2_idx_in_text_with_entity_marker": [51, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p13", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p14", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d665.s0_BioInfer.d665.s0.p0", "text": "The presence, in varying quantities, of myosin heavy chain and actin isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.", "text_with_entity_marker": "The presence, in varying quantities, of [E1]myosin heavy chain[/E1] and [E2]actin[/E2] isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[40, 58]], "entity_1_idx_in_text_with_entity_marker": [44, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p0", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2] during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p1", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[114, 126]], "entity_1_idx_in_text_with_entity_marker": [118, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p2", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of [E1]VE-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2] during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[86, 97]], "entity_1_idx_in_text_with_entity_marker": [90, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p3", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[114, 126]], "entity_2_idx_in_text_with_entity_marker": [127, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p4", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of [E1]VE-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[86, 97]], "entity_1_idx_in_text_with_entity_marker": [90, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p5", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of [E1]VE-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[86, 97]], "entity_1_idx_in_text_with_entity_marker": [90, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[114, 126]], "entity_2_idx_in_text_with_entity_marker": [127, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p0", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of [E1]beta-catenin[/E1] was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p1", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin ([E1]E-CD[/E1]) and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-CD", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p2", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of [E1]epithelial cadherin[/E1] (E-CD) and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "epithelial cadherin", "entity_1_idx": [[127, 146]], "entity_1_idx_in_text_with_entity_marker": [131, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p3", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of [E1]beta-catenin[/E1] was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin ([E2]E-CD[/E2]) and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-CD", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p4", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of [E1]beta-catenin[/E1] was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of [E2]epithelial cadherin[/E2] (E-CD) and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epithelial cadherin", "entity_2_idx": [[127, 146]], "entity_2_idx_in_text_with_entity_marker": [140, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p5", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of [E1]epithelial cadherin[/E1] ([E2]E-CD[/E2]) and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "epithelial cadherin", "entity_1_idx": [[127, 146]], "entity_1_idx_in_text_with_entity_marker": [131, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-CD", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s1_BioInfer.d203.s1.p0", "text": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and E-CD was unchanged between them.", "text_with_entity_marker": "In invasive ductal carcinomas, [E1]alpha-catenin[/E1] was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and [E2]E-CD[/E2] was unchanged between them.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-CD", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s1_BioInfer.d203.s1.p1", "text": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and E-CD was unchanged between them.", "text_with_entity_marker": "In invasive ductal carcinomas, [E1]alpha-catenin[/E1] was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of [E2]beta-catenin[/E2] and E-CD was unchanged between them.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[147, 159]], "entity_2_idx_in_text_with_entity_marker": [160, 172], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s1_BioInfer.d203.s1.p2", "text": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and E-CD was unchanged between them.", "text_with_entity_marker": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of [E1]beta-catenin[/E1] and [E2]E-CD[/E2] was unchanged between them.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[147, 159]], "entity_1_idx_in_text_with_entity_marker": [151, 163], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-CD", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d32.s0_BioInfer.d32.s0.p0", "text": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.", "text_with_entity_marker": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, [E1]fimbrin[/E1] or [E2]myosin I[/E2] of the intestinal brush border.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fimbrin", "entity_1_idx": [[225, 232]], "entity_1_idx_in_text_with_entity_marker": [229, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin I", "entity_2_idx": [[236, 244]], "entity_2_idx_in_text_with_entity_marker": [249, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d32.s0_BioInfer.d32.s0.p1", "text": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.", "text_with_entity_marker": "A further outcome of this study is that the [E1]actin[/E1] filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or [E2]myosin I[/E2] of the intestinal brush border.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin I", "entity_2_idx": [[236, 244]], "entity_2_idx_in_text_with_entity_marker": [249, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d32.s0_BioInfer.d32.s0.p2", "text": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.", "text_with_entity_marker": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either [E1]villin[/E1], fimbrin or [E2]myosin I[/E2] of the intestinal brush border.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "villin", "entity_1_idx": [[217, 223]], "entity_1_idx_in_text_with_entity_marker": [221, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin I", "entity_2_idx": [[236, 244]], "entity_2_idx_in_text_with_entity_marker": [249, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d32.s0_BioInfer.d32.s0.p3", "text": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.", "text_with_entity_marker": "A further outcome of this study is that the [E1]actin[/E1] filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, [E2]fimbrin[/E2] or myosin I of the intestinal brush border.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d32.s0_BioInfer.d32.s0.p4", "text": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.", "text_with_entity_marker": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either [E1]villin[/E1], [E2]fimbrin[/E2] or myosin I of the intestinal brush border.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "villin", "entity_1_idx": [[217, 223]], "entity_1_idx_in_text_with_entity_marker": [221, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d32.s0_BioInfer.d32.s0.p5", "text": "A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.", "text_with_entity_marker": "A further outcome of this study is that the [E1]actin[/E1] filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either [E2]villin[/E2], fimbrin or myosin I of the intestinal brush border.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "villin", "entity_2_idx": [[217, 223]], "entity_2_idx_in_text_with_entity_marker": [230, 236], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p30", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p31", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p32", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p33", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p34", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p35", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p36", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p37", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p38", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p39", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), [E2]small hydrophobic[/E2] (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small hydrophobic", "entity_2_idx": [[142, 159], [165, 172]], "entity_2_idx_in_text_with_entity_marker": [155, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p70", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p71", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p72", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p73", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p74", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p75", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p76", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p77", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p78", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p79", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E1]haemagglutinin-neuraminidase[/E1] ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin-neuraminidase", "entity_1_idx": [[174, 202], [208, 215]], "entity_1_idx_in_text_with_entity_marker": [178, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p0", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, [E1]RAD52[/E1], RAD54 and BRCA1 and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p1", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, RAD52, [E1]RAD54[/E1] and BRCA1 and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p2", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], RAD52, RAD54 and BRCA1 and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p3", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and [E1]BRCA1[/E1] and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BRCA1", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p4", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, [E1]RAD52[/E1], [E2]RAD54[/E2] and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p5", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], [E2]RAD52[/E2], RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p6", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, [E1]RAD52[/E1], RAD54 and [E2]BRCA1[/E2] and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p7", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], RAD52, [E2]RAD54[/E2] and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p8", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, RAD52, [E1]RAD54[/E1] and [E2]BRCA1[/E2] and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p9", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], RAD52, RAD54 and [E2]BRCA1[/E2] and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p0", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E1]smooth muscle myosin heavy chain[/E1], collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[167, 199]], "entity_1_idx_in_text_with_entity_marker": [171, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p1", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p2", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p3", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p4", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p5", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p6", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p7", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p8", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E1]smooth muscle myosin heavy chain[/E1], [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[167, 199]], "entity_1_idx_in_text_with_entity_marker": [171, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p9", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E1]smooth muscle myosin heavy chain[/E1], collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[167, 199]], "entity_1_idx_in_text_with_entity_marker": [171, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p30", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p31", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p32", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p33", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p34", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for [E2]desmin[/E2], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p35", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and [E2]CD34[/E2], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p36", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p37", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p38", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p39", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p0", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas [E1]SIR2[/E1], SIR3, and [E2]SIR4[/E2] are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR2", "entity_1_idx": [[163, 167]], "entity_1_idx_in_text_with_entity_marker": [167, 171], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p1", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that [E1]SIR1[/E1] protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas [E2]SIR2[/E2], SIR3, and SIR4 are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR1", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR2", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p2", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas [E1]SIR2[/E1], [E2]SIR3[/E2], and SIR4 are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR2", "entity_1_idx": [[163, 167]], "entity_1_idx_in_text_with_entity_marker": [167, 171], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p3", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that [E1]SIR1[/E1] protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and [E2]SIR4[/E2] are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR1", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p4", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, [E1]SIR3[/E1], and [E2]SIR4[/E2] are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR3", "entity_1_idx": [[169, 173]], "entity_1_idx_in_text_with_entity_marker": [173, 177], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p5", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that [E1]SIR1[/E1] protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, [E2]SIR3[/E2], and SIR4 are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR1", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s1_HPRD50.d32.s1.p1", "text": "Previous studies have demonstrated the immunolocalization of perlecan, a specific heparan sulfate proteoglycan, to the beta-amyloid protein (A beta)-containing amyloid deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "text_with_entity_marker": "Previous studies have demonstrated the immunolocalization of [E1]perlecan[/E1], a specific heparan sulfate proteoglycan, to the [E2]beta-amyloid[/E2] protein (A beta)-containing amyloid deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "perlecan", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "pm0116983", "entity_1_type_id": 114, "entity_2": "beta-amyloid", "entity_2_idx": [[119, 131]], "entity_2_idx_in_text_with_entity_marker": [132, 144], "entity_2_type": "beta-pm0104696", "entity_2_type_id": 119}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s1_HPRD50.d32.s1.p2", "text": "Previous studies have demonstrated the immunolocalization of perlecan, a specific heparan sulfate proteoglycan, to the beta-amyloid protein (A beta)-containing amyloid deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "text_with_entity_marker": "Previous studies have demonstrated the immunolocalization of [E1]perlecan[/E1], a specific heparan sulfate proteoglycan, to the beta-amyloid protein (A beta)-containing [E2]amyloid[/E2] deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "perlecan", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "pm0116983", "entity_1_type_id": 114, "entity_2": "amyloid", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "pm0104696", "entity_2_type_id": 120}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s1_HPRD50.d32.s1.p3", "text": "Previous studies have demonstrated the immunolocalization of perlecan, a specific heparan sulfate proteoglycan, to the beta-amyloid protein (A beta)-containing amyloid deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "text_with_entity_marker": "Previous studies have demonstrated the immunolocalization of perlecan, a specific [E1]heparan sulfate proteoglycan[/E1], to the [E2]beta-amyloid[/E2] protein (A beta)-containing amyloid deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "heparan sulfate proteoglycan", "entity_1_idx": [[82, 110]], "entity_1_idx_in_text_with_entity_marker": [86, 114], "entity_1_type": "pm0112250", "entity_1_type_id": 118, "entity_2": "beta-amyloid", "entity_2_idx": [[119, 131]], "entity_2_idx_in_text_with_entity_marker": [132, 144], "entity_2_type": "beta-pm0104696", "entity_2_type_id": 119}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s1_HPRD50.d32.s1.p4", "text": "Previous studies have demonstrated the immunolocalization of perlecan, a specific heparan sulfate proteoglycan, to the beta-amyloid protein (A beta)-containing amyloid deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "text_with_entity_marker": "Previous studies have demonstrated the immunolocalization of perlecan, a specific [E1]heparan sulfate proteoglycan[/E1], to the beta-amyloid protein (A beta)-containing [E2]amyloid[/E2] deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer's disease (AD) brain", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "heparan sulfate proteoglycan", "entity_1_idx": [[82, 110]], "entity_1_idx_in_text_with_entity_marker": [86, 114], "entity_1_type": "pm0112250", "entity_1_type_id": 118, "entity_2": "amyloid", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "pm0104696", "entity_2_type_id": 120}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s6_HPRD50.d32.s6.p6", "text": "Characterization of EC and SMC PGs bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "text_with_entity_marker": "Characterization of EC and SMC [E1]PGs[/E1] bound to A beta (1-28) revealed strong binding by [E2]perlecan[/E2], weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PGs", "entity_1_idx": [[31, 34]], "entity_1_idx_in_text_with_entity_marker": [35, 38], "entity_1_type": "pm0108066", "entity_1_type_id": 121, "entity_2": "perlecan", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "pm0116983", "entity_2_type_id": 114}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s6_HPRD50.d32.s6.p7", "text": "Characterization of EC and SMC PGs bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "text_with_entity_marker": "Characterization of EC and SMC [E1]PGs[/E1] bound to A beta (1-28) revealed strong binding by perlecan, weak binding by [E2]decorin[/E2] and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PGs", "entity_1_idx": [[31, 34]], "entity_1_idx_in_text_with_entity_marker": [35, 38], "entity_1_type": "pm0108066", "entity_1_type_id": 121, "entity_2": "decorin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "pm0108608", "entity_2_type_id": 116}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s6_HPRD50.d32.s6.p8", "text": "Characterization of EC and SMC PGs bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "text_with_entity_marker": "Characterization of EC and SMC [E1]PGs[/E1] bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and [E2]biglycan[/E2], two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PGs", "entity_1_idx": [[31, 34]], "entity_1_idx_in_text_with_entity_marker": [35, 38], "entity_1_type": "pm0108066", "entity_1_type_id": 121, "entity_2": "biglycan", "entity_2_idx": [[123, 131]], "entity_2_idx_in_text_with_entity_marker": [136, 144], "entity_2_type": "pm0124379", "entity_2_type_id": 115}], "directed": false, "reverse": false}
{"id": "HPRD50.d15.s0_HPRD50.d15.s0.p0", "text": "Physical association of beta 2 integrin with GPI-80, a novel glycosylphosphatidylinositol-anchored protein with potential for regulating adhesion and migration", "text_with_entity_marker": "Physical association of [E1]beta 2 integrin[/E1] with [E2]GPI-80[/E2], a novel glycosylphosphatidylinositol-anchored protein with potential for regulating adhesion and migration", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 2 integrin", "entity_1_idx": [[24, 39]], "entity_1_idx_in_text_with_entity_marker": [28, 43], "entity_1_type": "pm0114514", "entity_1_type_id": 48, "entity_2": "GPI-80", "entity_2_idx": [[45, 51]], "entity_2_idx_in_text_with_entity_marker": [58, 64], "entity_2_type": "pm0100260", "entity_2_type_id": 49}], "directed": false, "reverse": false}
{"id": "HPRD50.d15.s1_HPRD50.d15.s1.p0", "text": "To clarify the mechanisms by which GPI-80 functions on leukocytes, we explored the possibility of its physical association with beta 2 integrin which is important for leukocyte adherence, locomotion, and extravasation", "text_with_entity_marker": "To clarify the mechanisms by which [E1]GPI-80[/E1] functions on leukocytes, we explored the possibility of its physical association with [E2]beta 2 integrin[/E2] which is important for leukocyte adherence, locomotion, and extravasation", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GPI-80", "entity_1_idx": [[35, 41]], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_type": "pm0100260", "entity_1_type_id": 49, "entity_2": "beta 2 integrin", "entity_2_idx": [[128, 143]], "entity_2_idx_in_text_with_entity_marker": [141, 156], "entity_2_type": "pm0114514", "entity_2_type_id": 48}], "directed": false, "reverse": false}
{"id": "HPRD50.d15.s2_HPRD50.d15.s2.p0", "text": "beta 2 integrin, detected by anti-CD18 mAb, was coprecipitated with GPI-80 from human neutrophil lysates by a mAb to GPI-80", "text_with_entity_marker": "[E1]beta 2 integrin[/E1], detected by anti-CD18 mAb, was coprecipitated with [E2]GPI-80[/E2] from human neutrophil lysates by a mAb to GPI-80", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 2 integrin", "entity_1_idx": [[0, 15]], "entity_1_idx_in_text_with_entity_marker": [4, 19], "entity_1_type": "pm0114514", "entity_1_type_id": 48, "entity_2": "GPI-80", "entity_2_idx": [[68, 74]], "entity_2_idx_in_text_with_entity_marker": [81, 87], "entity_2_type": "pm0100260", "entity_2_type_id": 49}], "directed": false, "reverse": false}
{"id": "HPRD50.d15.s4_HPRD50.d15.s4.p0", "text": "These results clearly show that GPI-80 is physically associated with beta 2 integrin in human neutrophils", "text_with_entity_marker": "These results clearly show that [E1]GPI-80[/E1] is physically associated with [E2]beta 2 integrin[/E2] in human neutrophils", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GPI-80", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "pm0100260", "entity_1_type_id": 49, "entity_2": "beta 2 integrin", "entity_2_idx": [[69, 84]], "entity_2_idx_in_text_with_entity_marker": [82, 97], "entity_2_type": "pm0114514", "entity_2_type_id": 48}], "directed": false, "reverse": false}
{"id": "HPRD50.d1.s0_HPRD50.d1.s0.p0", "text": "Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2", "text_with_entity_marker": "Identification of residues in the [E1]monocyte chemotactic protein-1[/E1] that contact the MCP-1 receptor, [E2]CCR2[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "monocyte chemotactic protein-1", "entity_1_idx": [[34, 64]], "entity_1_idx_in_text_with_entity_marker": [38, 68], "entity_1_type": "pm0117207", "entity_1_type_id": 3, "entity_2": "CCR2", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "pm0111607", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s1_HPRD50.d7.s1.p0", "text": "Deletion analysis showed that the element responsible for the PPARgamma effect is located in a region containing the nuclear factor E2 (NF-E2)/AP-1 site (-98/-88), which was indicated to be the major promoter of the TXS gene", "text_with_entity_marker": "Deletion analysis showed that the element responsible for the PPARgamma effect is located in a region containing the nuclear factor E2 ([E1]NF-E2[/E1])/[E2]AP-1[/E2] site (-98/-88), which was indicated to be the major promoter of the TXS gene", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NF-E2", "entity_1_idx": [[136, 141]], "entity_1_idx_in_text_with_entity_marker": [140, 145], "entity_1_type": "pm0120477", "entity_1_type_id": 28, "entity_2": "AP-1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "pm0103880", "entity_2_type_id": 29}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s2_HPRD50.d7.s2.p0", "text": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "text_with_entity_marker": "By electrophoretic mobility shift assay using the [E1]NF-E2[/E1]/[E2]AP-1[/E2] site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NF-E2", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "pm0120477", "entity_1_type_id": 28, "entity_2": "AP-1", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "pm0103880", "entity_2_type_id": 29}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s2_HPRD50.d7.s2.p1", "text": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "text_with_entity_marker": "By electrophoretic mobility shift assay using the [E1]NF-E2[/E1]/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor [E2]NRF2[/E2] (NF-E2-related factor 2)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NF-E2", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "pm0120477", "entity_1_type_id": 28, "entity_2": "NRF2", "entity_2_idx": [[235, 239]], "entity_2_idx_in_text_with_entity_marker": [248, 252], "entity_2_type": "pm0105918||pm0123857", "entity_2_type_id": 27}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s2_HPRD50.d7.s2.p2", "text": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "text_with_entity_marker": "By electrophoretic mobility shift assay using the [E1]NF-E2[/E1]/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 ([E2]NF-E2-related factor 2[/E2])", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NF-E2", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "pm0120477", "entity_1_type_id": 28, "entity_2": "NF-E2-related factor 2", "entity_2_idx": [[241, 263]], "entity_2_idx_in_text_with_entity_marker": [254, 276], "entity_2_type": "pm0105918", "entity_2_type_id": 30}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s2_HPRD50.d7.s2.p3", "text": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "text_with_entity_marker": "By electrophoretic mobility shift assay using the NF-E2/[E1]AP-1[/E1] site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor [E2]NRF2[/E2] (NF-E2-related factor 2)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "AP-1", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "pm0103880", "entity_1_type_id": 29, "entity_2": "NRF2", "entity_2_idx": [[235, 239]], "entity_2_idx_in_text_with_entity_marker": [248, 252], "entity_2_type": "pm0105918||pm0123857", "entity_2_type_id": 27}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s2_HPRD50.d7.s2.p4", "text": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "text_with_entity_marker": "By electrophoretic mobility shift assay using the NF-E2/[E1]AP-1[/E1] site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 ([E2]NF-E2-related factor 2[/E2])", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "AP-1", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "pm0103880", "entity_1_type_id": 29, "entity_2": "NF-E2-related factor 2", "entity_2_idx": [[241, 263]], "entity_2_idx_in_text_with_entity_marker": [254, 276], "entity_2_type": "pm0105918", "entity_2_type_id": 30}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s2_HPRD50.d7.s2.p5", "text": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor NRF2 (NF-E2-related factor 2)", "text_with_entity_marker": "By electrophoretic mobility shift assay using the NF-E2/AP-1 site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor [E1]NRF2[/E1] ([E2]NF-E2-related factor 2[/E2])", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NRF2", "entity_1_idx": [[235, 239]], "entity_1_idx_in_text_with_entity_marker": [239, 243], "entity_1_type": "pm0105918||pm0123857", "entity_1_type_id": 27, "entity_2": "NF-E2-related factor 2", "entity_2_idx": [[241, 263]], "entity_2_idx_in_text_with_entity_marker": [254, 276], "entity_2_type": "pm0105918", "entity_2_type_id": 30}], "directed": false, "reverse": false}
{"id": "HPRD50.d21.s1_HPRD50.d21.s1.p0", "text": "In contrast to OX1R, the potency of direct activation of CB1 was not affected by co-expression with OX1R", "text_with_entity_marker": "In contrast to [E1]OX1R[/E1], the potency of direct activation of [E2]CB1[/E2] was not affected by co-expression with OX1R", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OX1R", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "pm0111533", "entity_1_type_id": 72, "entity_2": "CB1", "entity_2_idx": [[57, 60]], "entity_2_idx_in_text_with_entity_marker": [70, 73], "entity_2_type": "pm0109721", "entity_2_type_id": 71}], "directed": false, "reverse": false}
{"id": "HPRD50.d21.s1_HPRD50.d21.s1.p1", "text": "In contrast to OX1R, the potency of direct activation of CB1 was not affected by co-expression with OX1R", "text_with_entity_marker": "In contrast to [E1]OX1R[/E1], the potency of direct activation of CB1 was not affected by co-expression with [E2]OX1R[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OX1R", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "pm0111533", "entity_1_type_id": 72, "entity_2": "OX1R", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "pm0111533", "entity_2_type_id": 72}], "directed": false, "reverse": false}
{"id": "HPRD50.d21.s1_HPRD50.d21.s1.p2", "text": "In contrast to OX1R, the potency of direct activation of CB1 was not affected by co-expression with OX1R", "text_with_entity_marker": "In contrast to OX1R, the potency of direct activation of [E1]CB1[/E1] was not affected by co-expression with [E2]OX1R[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CB1", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "pm0109721", "entity_1_type_id": 71, "entity_2": "OX1R", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "pm0111533", "entity_2_type_id": 72}], "directed": false, "reverse": false}
{"id": "HPRD50.d21.s2_HPRD50.d21.s2.p0", "text": "In addition, electron microscopy experiments revealed that CB1 and OX1R are closely apposed at the plasma membrane level; they are close enough to form hetero-oligomers", "text_with_entity_marker": "In addition, electron microscopy experiments revealed that [E1]CB1[/E1] and [E2]OX1R[/E2] are closely apposed at the plasma membrane level; they are close enough to form hetero-oligomers", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CB1", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "pm0109721", "entity_1_type_id": 71, "entity_2": "OX1R", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "pm0111533", "entity_2_type_id": 72}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s2_HPRD50.d23.s2.p0", "text": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the Plk1 phosphorylation sites", "text_with_entity_marker": "Downregulation of [E1]NudC[/E1] by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type [E2]NudC[/E2], but not by NudC with mutations in the Plk1 phosphorylation sites", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NudC", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "NudC", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "pm0116104", "entity_2_type_id": 86}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s2_HPRD50.d23.s2.p1", "text": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the Plk1 phosphorylation sites", "text_with_entity_marker": "Downregulation of [E1]NudC[/E1] by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by [E2]NudC[/E2] with mutations in the Plk1 phosphorylation sites", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NudC", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "NudC", "entity_2_idx": [[217, 221]], "entity_2_idx_in_text_with_entity_marker": [230, 234], "entity_2_type": "pm0116104", "entity_2_type_id": 86}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s2_HPRD50.d23.s2.p2", "text": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the Plk1 phosphorylation sites", "text_with_entity_marker": "Downregulation of [E1]NudC[/E1] by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the [E2]Plk1[/E2] phosphorylation sites", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NudC", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "Plk1", "entity_2_idx": [[244, 248]], "entity_2_idx_in_text_with_entity_marker": [257, 261], "entity_2_type": "pm0109061", "entity_2_type_id": 85}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s2_HPRD50.d23.s2.p3", "text": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the Plk1 phosphorylation sites", "text_with_entity_marker": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type [E1]NudC[/E1], but not by [E2]NudC[/E2] with mutations in the Plk1 phosphorylation sites", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NudC", "entity_1_idx": [[200, 204]], "entity_1_idx_in_text_with_entity_marker": [204, 208], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "NudC", "entity_2_idx": [[217, 221]], "entity_2_idx_in_text_with_entity_marker": [230, 234], "entity_2_type": "pm0116104", "entity_2_type_id": 86}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s2_HPRD50.d23.s2.p4", "text": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the Plk1 phosphorylation sites", "text_with_entity_marker": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type [E1]NudC[/E1], but not by NudC with mutations in the [E2]Plk1[/E2] phosphorylation sites", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NudC", "entity_1_idx": [[200, 204]], "entity_1_idx_in_text_with_entity_marker": [204, 208], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "Plk1", "entity_2_idx": [[244, 248]], "entity_2_idx_in_text_with_entity_marker": [257, 261], "entity_2_type": "pm0109061", "entity_2_type_id": 85}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s2_HPRD50.d23.s2.p5", "text": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by NudC with mutations in the Plk1 phosphorylation sites", "text_with_entity_marker": "Downregulation of NudC by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type NudC, but not by [E1]NudC[/E1] with mutations in the [E2]Plk1[/E2] phosphorylation sites", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NudC", "entity_1_idx": [[217, 221]], "entity_1_idx_in_text_with_entity_marker": [221, 225], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "Plk1", "entity_2_idx": [[244, 248]], "entity_2_idx_in_text_with_entity_marker": [257, 261], "entity_2_type": "pm0109061", "entity_2_type_id": 85}], "directed": false, "reverse": false}
{"id": "IEPA.d176.s425_IEPA.d176.s425.p0", "text": "For example, leptin suppresses neuropeptide Y (NPY) expression in the arcuate nucleus", "text_with_entity_marker": "For example, [E1]leptin[/E1] suppresses [E2]neuropeptide Y[/E2] (NPY) expression in the arcuate nucleus", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[31, 45]], "entity_2_idx_in_text_with_entity_marker": [44, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s391_IEPA.d162.s391.p0", "text": "These findings suggest that the regulation of hypothalamic NPY mRNA by leptin may be impaired with age", "text_with_entity_marker": "These findings suggest that the regulation of hypothalamic [E1]NPY[/E1] mRNA by [E2]leptin[/E2] may be impaired with age", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NPY", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[71, 77]], "entity_2_idx_in_text_with_entity_marker": [84, 90], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s393_IEPA.d162.s393.p0", "text": "Leptin infusion diminished hypothalamic NPY levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats", "text_with_entity_marker": "[E1]Leptin[/E1] infusion diminished hypothalamic [E2]NPY[/E2] levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d81.s193_IEPA.d81.s193.p0", "text": "It has been established that amyloid beta peptide (AbetaP) activates phospholipase A2, phospholipase C and phospholipase D of LA-N-2 cells and other cell types", "text_with_entity_marker": "It has been established that [E1]amyloid[/E1] beta peptide (AbetaP) activates phospholipase A2, [E2]phospholipase C[/E2] and phospholipase D of LA-N-2 cells and other cell types", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[29, 36]], "entity_1_idx_in_text_with_entity_marker": [33, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[87, 102]], "entity_2_idx_in_text_with_entity_marker": [100, 115], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d81.s194_IEPA.d81.s194.p0", "text": "(-)Nicotine did not blunt the AbetaP activation of phospholipase C", "text_with_entity_marker": "(-)Nicotine did not blunt the [E1]AbetaP[/E1] activation of [E2]phospholipase C[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AbetaP", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[51, 66]], "entity_2_idx_in_text_with_entity_marker": [64, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d76.s182_IEPA.d76.s182.p0", "text": "Melatonin inhibits oxytocin response to insulin-induced hypoglycemia, but not to angiotensin II in normal men", "text_with_entity_marker": "Melatonin inhibits [E1]oxytocin[/E1] response to [E2]insulin[/E2]-induced hypoglycemia, but not to angiotensin II in normal men", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[19, 27]], "entity_1_idx_in_text_with_entity_marker": [23, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[40, 47]], "entity_2_idx_in_text_with_entity_marker": [53, 60], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d76.s184_IEPA.d76.s184.p0", "text": "In contrast, the oxytocin response to insulin-induced hypoglycemia was significantly reduced by melatonin treatment", "text_with_entity_marker": "In contrast, the [E1]oxytocin[/E1] response to [E2]insulin[/E2]-induced hypoglycemia was significantly reduced by melatonin treatment", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[17, 25]], "entity_1_idx_in_text_with_entity_marker": [21, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d100.s239_IEPA.d100.s239.p0", "text": "If daily oxytocin injections are repeated over a 5-day period, blood pressure is decreased by 10-20 mmHg, the withdrawal latency to heat stimuli is prolonged, cortisol levels are decreased and insulin and cholecystokinin levels are increased", "text_with_entity_marker": "If daily [E1]oxytocin[/E1] injections are repeated over a 5-day period, blood pressure is decreased by 10-20 mmHg, the withdrawal latency to heat stimuli is prolonged, cortisol levels are decreased and [E2]insulin[/E2] and cholecystokinin levels are increased", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d150.s363_IEPA.d150.s363.p0", "text": "Possible central nervous system (CNS) mechanisms could mediate these responses in that leptin receptors are located on hypothalamic neurons that coexpress neuropeptide-Y (NPY) or proopiomelanocortin (POMC) and both peptides that have been implicated as mediators of the CNS action of leptin.", "text_with_entity_marker": "Possible central nervous system (CNS) mechanisms could mediate these responses in that leptin receptors are located on hypothalamic neurons that coexpress [E1]neuropeptide-Y[/E1] (NPY) or proopiomelanocortin (POMC) and both peptides that have been implicated as mediators of the CNS action of [E2]leptin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuropeptide-Y", "entity_1_idx": [[155, 169]], "entity_1_idx_in_text_with_entity_marker": [159, 173], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[284, 290]], "entity_2_idx_in_text_with_entity_marker": [297, 303], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d150.s364_IEPA.d150.s364.p0", "text": "Leptin has been demonstrated to decrease or down regulate NPY expression and increase POMC expression", "text_with_entity_marker": "[E1]Leptin[/E1] has been demonstrated to decrease or down regulate [E2]NPY[/E2] expression and increase POMC expression", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[58, 61]], "entity_2_idx_in_text_with_entity_marker": [71, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d98.s236_IEPA.d98.s236.p0", "text": "We observed that primary microglial cultures and the THP-1 monocytic cell line are stimulated by fibrillar beta-amyloid and prion peptides to activate identical tyrosine kinase-dependent inflammatory signal transduction cascades", "text_with_entity_marker": "We observed that primary microglial cultures and the THP-1 monocytic cell line are stimulated by fibrillar beta-amyloid and [E1]prion[/E1] peptides to activate identical [E2]tyrosine kinase[/E2]-dependent inflammatory signal transduction cascades", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "prion", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[161, 176]], "entity_2_idx_in_text_with_entity_marker": [174, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d97.s234_IEPA.d97.s234.p0", "text": "The specific protein kinase C (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, AVP-, PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively", "text_with_entity_marker": "The specific [E1]protein kinase C[/E1] (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, [E2]AVP[/E2]-, PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[13, 29]], "entity_1_idx_in_text_with_entity_marker": [17, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d97.s235_IEPA.d97.s235.p0", "text": "CONCLUSION: PTH, AVP, PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive PKC isotype", "text_with_entity_marker": "CONCLUSION: PTH, [E1]AVP[/E1], PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive [E2]PKC[/E2] isotype", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[158, 161]], "entity_2_idx_in_text_with_entity_marker": [171, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d52.s135_IEPA.d52.s135.p0", "text": "Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin", "text_with_entity_marker": "[E1]Uncoupling protein-3[/E1] is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and [E2]leptin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Uncoupling protein-3", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[113, 119]], "entity_2_idx_in_text_with_entity_marker": [126, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d52.s136_IEPA.d52.s136.p0", "text": "UCP3 mRNA levels were also regulated by dexamethasone, leptin, and starvation, albeit differently in muscle and brown adipose tissue", "text_with_entity_marker": "[E1]UCP3[/E1] mRNA levels were also regulated by dexamethasone, [E2]leptin[/E2], and starvation, albeit differently in muscle and brown adipose tissue", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d132.s319_IEPA.d132.s319.p0", "text": "The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of gibberellin-inducible alpha-amylase induction in embryoless barley half-seeds", "text_with_entity_marker": "The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of [E1]gibberellin[/E1]-inducible [E2]alpha-amylase[/E2] induction in embryoless barley half-seeds", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[114, 125]], "entity_1_idx_in_text_with_entity_marker": [118, 129], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d132.s320_IEPA.d132.s320.p0", "text": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production", "text_with_entity_marker": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited [E1]gibberellin[/E1]-inducible [E2]alpha-amylase[/E2] induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[226, 237]], "entity_1_idx_in_text_with_entity_marker": [230, 241], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[248, 261]], "entity_2_idx_in_text_with_entity_marker": [261, 274], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s103_IEPA.d42.s103.p0", "text": "Signal transduction in pancreatic beta-cells: Regulation of insulin secretion by information flow in the phospholipase C/Protein kinase C pathway", "text_with_entity_marker": "Signal transduction in pancreatic beta-cells: Regulation of [E1]insulin[/E1] secretion by information flow in the [E2]phospholipase C[/E2]/Protein kinase C pathway", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[60, 67]], "entity_1_idx_in_text_with_entity_marker": [64, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[105, 120]], "entity_2_idx_in_text_with_entity_marker": [118, 133], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s104_IEPA.d42.s104.p0", "text": "The physiologic regulation of glucose-induced insulin secretion is dependent upon the activation of information flow in the phospholipase C (PLC)/protein kinase C (PKC) signal transduction system", "text_with_entity_marker": "The physiologic regulation of glucose-induced [E1]insulin[/E1] secretion is dependent upon the activation of information flow in the [E2]phospholipase C[/E2] (PLC)/protein kinase C (PKC) signal transduction system", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[124, 139]], "entity_2_idx_in_text_with_entity_marker": [137, 152], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s106_IEPA.d42.s106.p0", "text": "Biphasic insulin secretion can be evoked and time-dependent potentiation can be induced in mouse islets by carbachol, an agonist that activates an isozyme of PLC distinct from that activated by glucose", "text_with_entity_marker": "Biphasic [E1]insulin[/E1] secretion can be evoked and time-dependent potentiation can be induced in mouse islets by carbachol, an agonist that activates an isozyme of [E2]PLC[/E2] distinct from that activated by glucose", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[9, 16]], "entity_1_idx_in_text_with_entity_marker": [13, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[158, 161]], "entity_2_idx_in_text_with_entity_marker": [171, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s107_IEPA.d42.s107.p0", "text": "When taken in their entirety, the experimental evidence suggests that the activation of PLC is an essential component in the physiologic regulation of insulin secretion and that disordered activation of the enzyme culminates in disordered insulin release", "text_with_entity_marker": "When taken in their entirety, the experimental evidence suggests that the activation of [E1]PLC[/E1] is an essential component in the physiologic regulation of [E2]insulin[/E2] secretion and that disordered activation of the enzyme culminates in disordered insulin release", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[88, 91]], "entity_1_idx_in_text_with_entity_marker": [92, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s416_IEPA.d172.s416.p0", "text": "Therefore, it was examined whether stimulation of Swiss 3T3 cells with insulin causes changes in the subcellular distribution of EGF receptors and phospholipase Cgamma1 that could potentially explain the observed synergy or costimulation.", "text_with_entity_marker": "Therefore, it was examined whether stimulation of Swiss 3T3 cells with [E1]insulin[/E1] causes changes in the subcellular distribution of EGF receptors and [E2]phospholipase Cgamma1[/E2] that could potentially explain the observed synergy or costimulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[71, 78]], "entity_1_idx_in_text_with_entity_marker": [75, 82], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[147, 168]], "entity_2_idx_in_text_with_entity_marker": [160, 181], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s417_IEPA.d172.s417.p0", "text": "However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.", "text_with_entity_marker": "However, both EGF and [E1]insulin[/E1] stimulated the accumulation of [E2]phospholipase Cgamma1[/E2] at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[61, 82]], "entity_2_idx_in_text_with_entity_marker": [74, 95], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s418_IEPA.d172.s418.p0", "text": "Therefore, it is suggested that the insulin-induced coclustering of the EGF receptor with phospholipase Cgamma1 at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.", "text_with_entity_marker": "Therefore, it is suggested that the [E1]insulin[/E1]-induced coclustering of the EGF receptor with [E2]phospholipase Cgamma1[/E2] at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[36, 43]], "entity_1_idx_in_text_with_entity_marker": [40, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[90, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s257_IEPA.d109.s257.p0", "text": "In this study, we examined the effects of fasting for 2 days and exogenous s.c. leptin, 200 microg every 8 h for 2 days, on the regulation of uncoupling protein (UCP) subtypes in brown adipose tissue (BAT) and gastrocnemius muscle", "text_with_entity_marker": "In this study, we examined the effects of fasting for 2 days and exogenous s.c. [E1]leptin[/E1], 200 microg every 8 h for 2 days, on the regulation of [E2]uncoupling protein[/E2] (UCP) subtypes in brown adipose tissue (BAT) and gastrocnemius muscle", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[80, 86]], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[142, 160]], "entity_2_idx_in_text_with_entity_marker": [155, 173], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s258_IEPA.d109.s258.p0", "text": "Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "text_with_entity_marker": "[E1]Leptin[/E1], compared with vehicle, did not alter BAT [E2]UCP-1[/E2] or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s258_IEPA.d109.s258.p1", "text": "Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "text_with_entity_marker": "[E1]Leptin[/E1], compared with vehicle, did not alter BAT UCP-1 or [E2]UCP-3[/E2] mRNA or protein expression when administered to normal ad libitum fed rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s258_IEPA.d109.s258.p2", "text": "Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "text_with_entity_marker": "Leptin, compared with vehicle, did not alter BAT [E1]UCP-1[/E1] or [E2]UCP-3[/E2] mRNA or protein expression when administered to normal ad libitum fed rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s260_IEPA.d109.s260.p0", "text": "Fasting also significantly decreased BAT UCP-1 protein expression, to 67% of control; however, that effect was not prevented by leptin treatment", "text_with_entity_marker": "Fasting also significantly decreased BAT [E1]UCP-1[/E1] protein expression, to 67% of control; however, that effect was not prevented by [E2]leptin[/E2] treatment", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s262_IEPA.d109.s262.p0", "text": "Fasting significantly enhanced gastrocnemius muscle UCP-3 mRNA (411% of control) and protein expression (168% of control), whereas leptin administration to fasted rats did not alter either of these effects", "text_with_entity_marker": "Fasting significantly enhanced gastrocnemius muscle [E1]UCP-3[/E1] mRNA (411% of control) and protein expression (168% of control), whereas [E2]leptin[/E2] administration to fasted rats did not alter either of these effects", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-3", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d167.s403_IEPA.d167.s403.p0", "text": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced PLC sensitivity to these RTK agonists", "text_with_entity_marker": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal [E1]PLC[/E1] stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not [E2]insulin[/E2], and largely enhanced PLC sensitivity to these RTK agonists", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[174, 177]], "entity_1_idx_in_text_with_entity_marker": [178, 181], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[288, 295]], "entity_2_idx_in_text_with_entity_marker": [301, 308], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d167.s403_IEPA.d167.s403.p1", "text": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced PLC sensitivity to these RTK agonists", "text_with_entity_marker": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal [E1]PLC[/E1] stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced [E2]PLC[/E2] sensitivity to these RTK agonists", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[174, 177]], "entity_1_idx_in_text_with_entity_marker": [178, 181], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[318, 321]], "entity_2_idx_in_text_with_entity_marker": [331, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d167.s403_IEPA.d167.s403.p2", "text": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced PLC sensitivity to these RTK agonists", "text_with_entity_marker": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not [E1]insulin[/E1], and largely enhanced [E2]PLC[/E2] sensitivity to these RTK agonists", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[288, 295]], "entity_1_idx_in_text_with_entity_marker": [292, 299], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[318, 321]], "entity_2_idx_in_text_with_entity_marker": [331, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d8.s14_IEPA.d8.s14.p0", "text": "The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), oxytocin, prostaglandin F2 alpha (PGF2 alpha) and inositol 1,4,5-trisphosphate (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes", "text_with_entity_marker": "The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), [E1]oxytocin[/E1], prostaglandin F2 alpha (PGF2 alpha) and [E2]inositol 1,4,5-trisphosphate[/E2] (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol 1,4,5-trisphosphate", "entity_2_idx": [[144, 172]], "entity_2_idx_in_text_with_entity_marker": [157, 185], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d8.s15_IEPA.d8.s15.p0", "text": "All four agonists caused a biphasic release of 45Ca2+ from non-mitochondrial pool(s), with the rank order of potency: oxytocin > PGF2 alpha > ET-1 > IP3", "text_with_entity_marker": "All four agonists caused a biphasic release of 45Ca2+ from non-mitochondrial pool(s), with the rank order of potency: [E1]oxytocin[/E1] > PGF2 alpha > ET-1 > [E2]IP3[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[118, 126]], "entity_1_idx_in_text_with_entity_marker": [122, 130], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d79.s189_IEPA.d79.s189.p0", "text": "OT evokes the release of Ca2+ from IP3-sensitive intracellular stores", "text_with_entity_marker": "[E1]OT[/E1] evokes the release of Ca2+ from [E2]IP3[/E2]-sensitive intracellular stores", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OT", "entity_1_idx": [[0, 2]], "entity_1_idx_in_text_with_entity_marker": [4, 6], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[35, 38]], "entity_2_idx_in_text_with_entity_marker": [48, 51], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d39.s93_IEPA.d39.s93.p0", "text": "Homogeneous liposome immunoassay for insulin using phospholipase C from Clostridium perfringens", "text_with_entity_marker": "Homogeneous liposome immunoassay for [E1]insulin[/E1] using [E2]phospholipase C[/E2] from Clostridium perfringens", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[51, 66]], "entity_2_idx_in_text_with_entity_marker": [64, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d142.s341_IEPA.d142.s341.p0", "text": "METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the beta2AR with BMI, plasma leptin and UCP-1 mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women", "text_with_entity_marker": "METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the beta2AR with BMI, plasma [E1]leptin[/E1] and [E2]UCP-1[/E2] mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[136, 142]], "entity_1_idx_in_text_with_entity_marker": [140, 146], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d142.s342_IEPA.d142.s342.p0", "text": "Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma leptin or adipose tissue UCP-1 gene expression in either group", "text_with_entity_marker": "Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma [E1]leptin[/E1] or adipose tissue [E2]UCP-1[/E2] gene expression in either group", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[100, 106]], "entity_1_idx_in_text_with_entity_marker": [104, 110], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s352_IEPA.d146.s352.p0", "text": "The protein kinase C (PKC) activator 4beta-phorbol 12-myristate 13-acetate (PMA, 100 pM to 200 nM), also stimulated Ca2+ spiking and this effect was additive with a submaximal concentration of AVP (50 pM)", "text_with_entity_marker": "The [E1]protein kinase C[/E1] (PKC) activator 4beta-phorbol 12-myristate 13-acetate (PMA, 100 pM to 200 nM), also stimulated Ca2+ spiking and this effect was additive with a submaximal concentration of [E2]AVP[/E2] (50 pM)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "protein kinase C", "entity_1_idx": [[4, 20]], "entity_1_idx_in_text_with_entity_marker": [8, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s355_IEPA.d146.s355.p0", "text": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "text_with_entity_marker": "Pretreatment for 24 h with 1 microM PMA downregulated expression of [E1]PKC-alpha[/E1] and -delta, but not [E2]PKC-epsilon[/E2], and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC-alpha", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC-epsilon", "entity_2_idx": [[98, 109]], "entity_2_idx_in_text_with_entity_marker": [111, 122], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s355_IEPA.d146.s355.p1", "text": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "text_with_entity_marker": "Pretreatment for 24 h with 1 microM PMA downregulated expression of [E1]PKC-alpha[/E1] and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM [E2]AVP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC-alpha", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s355_IEPA.d146.s355.p2", "text": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "text_with_entity_marker": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not [E1]PKC-epsilon[/E1], and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM [E2]AVP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC-epsilon", "entity_1_idx": [[98, 109]], "entity_1_idx_in_text_with_entity_marker": [102, 113], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d55.s139_IEPA.d55.s139.p0", "text": "After protein kinase C activity was functionally depleted by treating cells with phorbol 12-myristate 13-acetate for 24 hours, AVP did not augment IL-1beta-induced NO production", "text_with_entity_marker": "After [E1]protein kinase C[/E1] activity was functionally depleted by treating cells with phorbol 12-myristate 13-acetate for 24 hours, [E2]AVP[/E2] did not augment IL-1beta-induced NO production", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "protein kinase C", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[127, 130]], "entity_2_idx_in_text_with_entity_marker": [140, 143], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s233_IEPA.d96.s233.p0", "text": "Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM", "text_with_entity_marker": "Denervation suppressed mRNA levels for [E1]UCP-2[/E1] (49%), [E2]UCP-3[/E2] (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-2", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s233_IEPA.d96.s233.p1", "text": "Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM", "text_with_entity_marker": "Denervation suppressed mRNA levels for [E1]UCP-2[/E1] (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to [E2]leptin[/E2] in SM", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-2", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[119, 125]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s233_IEPA.d96.s233.p2", "text": "Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM", "text_with_entity_marker": "Denervation suppressed mRNA levels for UCP-2 (49%), [E1]UCP-3[/E1] (36%), and COX-IV (59%) and eliminated the acute response to [E2]leptin[/E2] in SM", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-3", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[119, 125]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d10.s0_LLL.d10.s0.p1", "text": "The rocG gene of Bacillus subtilis, encoding a catabolic glutamate dehydrogenase, is transcribed by SigL-containing RNA polymerase and requires for its expression RocR, a member of the NtrC/NifA family of proteins that bind to enhancer-like elements, called upstream activating sequences (UAS).", "text_with_entity_marker": "The [E1]rocG[/E1] gene of Bacillus subtilis, encoding a catabolic glutamate dehydrogenase, is transcribed by [E2]SigL[/E2]-containing RNA polymerase and requires for its expression RocR, a member of the NtrC/NifA family of proteins that bind to enhancer-like elements, called upstream activating sequences (UAS).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rocG", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SigL", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d10.s0_LLL.d10.s0.p2", "text": "The rocG gene of Bacillus subtilis, encoding a catabolic glutamate dehydrogenase, is transcribed by SigL-containing RNA polymerase and requires for its expression RocR, a member of the NtrC/NifA family of proteins that bind to enhancer-like elements, called upstream activating sequences (UAS).", "text_with_entity_marker": "The [E1]rocG[/E1] gene of Bacillus subtilis, encoding a catabolic glutamate dehydrogenase, is transcribed by SigL-containing RNA polymerase and requires for its expression [E2]RocR[/E2], a member of the NtrC/NifA family of proteins that bind to enhancer-like elements, called upstream activating sequences (UAS).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rocG", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "RocR", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d10.s1_LLL.d10.s1.p0", "text": "Unlike the case for other sigma(54)-dependent genes, rocG has no UAS; instead, its expression depends on a sequence located 1.5 kilobases downstream of the rocG promoter, beyond the end of the rocG coding region.", "text_with_entity_marker": "Unlike the case for other [E1]sigma(54)[/E1]-dependent genes, [E2]rocG[/E2] has no UAS; instead, its expression depends on a sequence located 1.5 kilobases downstream of the rocG promoter, beyond the end of the rocG coding region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(54)", "entity_1_idx": [[26, 35]], "entity_1_idx_in_text_with_entity_marker": [30, 39], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "rocG", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d23.s0_LLL.d23.s0.p0", "text": "Transcriptional studies showed that nadE is strongly induced in response to heat, ethanol and salt stress or after starvation for glucose in a sigma B-dependent manner.", "text_with_entity_marker": "Transcriptional studies showed that [E1]nadE[/E1] is strongly induced in response to heat, ethanol and salt stress or after starvation for glucose in a [E2]sigma B[/E2]-dependent manner.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "nadE", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma B", "entity_2_idx": [[143, 150]], "entity_2_idx_in_text_with_entity_marker": [156, 163], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d1.s0_LLL.d1.s0.p1", "text": "In this mutant, expression of the spoIIG gene, whose transcription depends on both sigma(A) and the phosphorylated Spo0A protein, Spo0A~P, a major transcription factor during early stages of sporulation, was greatly reduced at 43 degrees C.", "text_with_entity_marker": "In this mutant, expression of the [E1]spoIIG[/E1] gene, whose transcription depends on both [E2]sigma(A)[/E2] and the phosphorylated Spo0A protein, Spo0A~P, a major transcription factor during early stages of sporulation, was greatly reduced at 43 degrees C.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "spoIIG", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(A)", "entity_2_idx": [[83, 91]], "entity_2_idx_in_text_with_entity_marker": [96, 104], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d1.s0_LLL.d1.s0.p2", "text": "In this mutant, expression of the spoIIG gene, whose transcription depends on both sigma(A) and the phosphorylated Spo0A protein, Spo0A~P, a major transcription factor during early stages of sporulation, was greatly reduced at 43 degrees C.", "text_with_entity_marker": "In this mutant, expression of the [E1]spoIIG[/E1] gene, whose transcription depends on both sigma(A) and the phosphorylated [E2]Spo0A[/E2] protein, Spo0A~P, a major transcription factor during early stages of sporulation, was greatly reduced at 43 degrees C.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "spoIIG", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "Spo0A", "entity_2_idx": [[115, 120]], "entity_2_idx_in_text_with_entity_marker": [128, 133], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d39.s0_LLL.d39.s0.p1", "text": "The addition of ClpX to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but sigmaH-RNAP was observed to be more sensitive to ClpX-dependent stimulation than sigmaA-RNAP.", "text_with_entity_marker": "The addition of ClpX to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but [E1]sigmaH[/E1]-RNAP was observed to be more sensitive to [E2]ClpX[/E2]-dependent stimulation than sigmaA-RNAP.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaH", "entity_1_idx": [[118, 124]], "entity_1_idx_in_text_with_entity_marker": [122, 128], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "ClpX", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d39.s0_LLL.d39.s0.p2", "text": "The addition of ClpX to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but sigmaH-RNAP was observed to be more sensitive to ClpX-dependent stimulation than sigmaA-RNAP.", "text_with_entity_marker": "The addition of ClpX to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but sigmaH-RNAP was observed to be more sensitive to [E1]ClpX[/E1]-dependent stimulation than [E2]sigmaA[/E2]-RNAP.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpX", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaA", "entity_2_idx": [[199, 205]], "entity_2_idx_in_text_with_entity_marker": [212, 218], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d39.s0_LLL.d39.s0.p3", "text": "The addition of ClpX to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but sigmaH-RNAP was observed to be more sensitive to ClpX-dependent stimulation than sigmaA-RNAP.", "text_with_entity_marker": "The addition of [E1]ClpX[/E1] to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but [E2]sigmaH[/E2]-RNAP was observed to be more sensitive to ClpX-dependent stimulation than sigmaA-RNAP.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpX", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaH", "entity_2_idx": [[118, 124]], "entity_2_idx_in_text_with_entity_marker": [131, 137], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d39.s0_LLL.d39.s0.p4", "text": "The addition of ClpX to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but sigmaH-RNAP was observed to be more sensitive to ClpX-dependent stimulation than sigmaA-RNAP.", "text_with_entity_marker": "The addition of [E1]ClpX[/E1] to in vitro transcription reactions resulted in the stimulation of RNAP holoenzyme activity, but sigmaH-RNAP was observed to be more sensitive to ClpX-dependent stimulation than [E2]sigmaA[/E2]-RNAP.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpX", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaA", "entity_2_idx": [[199, 205]], "entity_2_idx_in_text_with_entity_marker": [212, 218], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d6.s0_LLL.d6.s0.p1", "text": "The expression of rsfA is under the control of both sigma(F) and sigma(G).", "text_with_entity_marker": "The expression of [E1]rsfA[/E1] is under the control of both [E2]sigma(F)[/E2] and sigma(G).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rsfA", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(F)", "entity_2_idx": [[52, 60]], "entity_2_idx_in_text_with_entity_marker": [65, 73], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d6.s0_LLL.d6.s0.p2", "text": "The expression of rsfA is under the control of both sigma(F) and sigma(G).", "text_with_entity_marker": "The expression of [E1]rsfA[/E1] is under the control of both sigma(F) and [E2]sigma(G)[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rsfA", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(G)", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
